1	Psychiatry	NNP	O	Psychiatry	nn	2	SENT_1	[p1l822t81r951b108],
2	Research	NNP	O	Research	_	0	SENT_1	[p1l961t81r1072b103],
3	208	CD	NUMBER	208	number	4	SENT_1	[p1l1082t82r1128b103],
4	(	CD	NUMBER	(	dep	2	SENT_1	[p1l1139t81r1218b108],
5	2013	CD	DATE	2013	dep	4	SENT_1	[p1l1139t81r1218b108],
6	)	CD	NUMBER	)	num	7	SENT_1	[p1l1139t81r1218b108],
7	285-287	CD	NUMBER	285-287	dep	2	SENT_1	[p1l1229t82r1337b103],

1	Contents	NNS	O	contents	_	0	SENT_2	[p1l701t189r837b214],
2	lists	NNS	O	list	dep	1	SENT_2	[p1l851t188r911b214],
3	available	JJ	O	available	amod	2	SENT_2	[p1l925t188r1059b214],
4	at	IN	O	at	_	0	SENT_2	[p1l1073t192r1102b214],
5	SciVerse	NNP	O	SciVerse	nn	6	SENT_2	[p1l1115t188r1243b214],
6	ScienceDirect	NNP	O	ScienceDirect	prep_at	3	SENT_2	[p1l1257t188r1466b214],

1	Psychiatry	NNP	O	Psychiatry	_	0	SENT_3	[p1l813t292r1092b349],
2	Research	NNP	O	Research	dep	1	SENT_3	[p1l1115t291r1354b338],
3	p	NN	O	p	dep	2	SENT_3	[p1l20t322r118b395],
4	-	:	O	-	_	0	SENT_3	[p1l20t322r118b395],
5	:	:	O	:	_	0	SENT_3	[p1l20t322r118b395],
6	+	CC	O	+	dep	9	SENT_3	[p1l20t322r118b395],
7	ELSEVIER	NNP	O	ELSEVIER	nn	9	SENT_3	[p1l12t417r249b452],
8	journal	NN	O	journal	nn	9	SENT_3	[p1l603t420r725b451],
9	homepage	NN	O	homepage	parataxis	1	SENT_3	[p1l744t420r935b451],
10	:	:	O	:	_	0	SENT_3	[p1l744t420r935b451],
11	www	NN	O	www	dep	9	SENT_3	[p1l951t420r1505b451],
12	.	.	O	.	_	0	SENT_3	[p1l951t420r1505b451],

1	e	LS	O	e	_	0	SENT_4	[p1l951t420r1505b451],
2	|	SYM	O	|	dep	3	SENT_4	[p1l951t420r1505b451],
3	sevier.com/locate/psych	VBP	O	sevier.com/locate/psych	dep	1	SENT_4	[p1l951t420r1505b451],
4	res	NNS	O	re	dep	3	SENT_4	[p1l1513t427r1561b445],

1	Brief	JJ	O	brief	amod	2	SENT_5	[p1l6t537r96b569],
2	report	NN	O	report	_	0	SENT_5	[p1l108t542r224b577],
3	Catechol	NNP	PERSON	Catechol	dep	2	SENT_5	[p1l6t615r795b671],
4	.	.	O	.	_	0	SENT_5	[p1l6t615r795b671],

1	—	NN	O	—	_	0	SENT_6	[p1l6t615r795b671],
2	.	.	O	.	_	0	SENT_6	[p1l6t615r795b671],

1	O	NN	O	o	_	0	SENT_7	[p1l6t615r795b671],
2	.	.	O	.	_	0	SENT_7	[p1l6t615r795b671],

1	—	NN	O	—	_	0	SENT_8	[p1l6t615r795b671],
2	.	.	O	.	_	0	SENT_8	[p1l6t615r795b671],

1	methyltransferase	NN	O	methyltransferase	nn	2	SENT_9	[p1l6t615r795b671],
2	genotype	NN	O	genotype	_	0	SENT_9	[p1l818t622r1061b671],
3	as	IN	O	as	_	0	SENT_9	[p1l1085t628r1136b660],
4	modiﬁer	NN	O	modiﬁer	prep_as	2	SENT_9	[p1l1161t615r1386b660],
5	of	IN	O	of	_	0	SENT_9	[p1l1407t615r1462b660],
6	superior	JJ	O	superior	amod	7	SENT_9	[p1l1479t616r1698b671],
7	responses	NNS	O	response	prep_of	2	SENT_9	[p1l6t700r264b743],
8	to	TO	O	to	dep	2	SENT_9	[p1l288t693r338b732],
9	venlafaxine	NN	O	venlafaxine	nn	10	SENT_9	[p1l359t687r663b732],
10	treatment	NN	O	treatment	pobj	8	SENT_9	[p1l686t693r951b732],
11	in	IN	O	in	dep	2	SENT_9	[p1l973t687r1021b731],
12	major	JJ	O	major	amod	14	SENT_9	[p1l1045t687r1198b743],
13	depressive	JJ	O	depressive	amod	14	SENT_9	[p1l1219t687r1497b743],
14	disorder	NN	O	disorder	pobj	11	SENT_9	[p1l1521t687r1740b732],

1	®	NN	O	®	nn	2	SENT_10	[p1l6t813r93b899],
2	CrossMark	NN	O	crossmark	_	0	SENT_10	[p1l102t847r235b870],

1	Seth	NNP	PERSON	Seth	nn	4	SENT_11	[p1l6t974r95b1009],
2	C.	NNP	PERSON	C.	nn	4	SENT_11	[p1l113t975r147b1009],
3	Hopkins	NNP	PERSON	Hopkins	nn	4	SENT_11	[p1l166t974r336b1018],
4	*	NNP	O	*	_	0	SENT_11	[p1l346t972r373b1015],
5	,	,	O	,	_	0	SENT_11	[p1l346t972r373b1015],
6	David	NNP	PERSON	David	nn	8	SENT_11	[p1l392t974r508b1009],
7	S.	NNP	PERSON	S.	nn	8	SENT_11	[p1l527t975r558b1009],
8	Reasner	NNP	PERSON	Reasner	appos	4	SENT_11	[p1l577t976r748b1015],
9	,	,	O	,	_	0	SENT_11	[p1l577t976r748b1015],
10	Kenneth	NNP	PERSON	Kenneth	nn	15	SENT_11	[p1l767t974r940b1009],
11	S.	NNP	PERSON	S.	nn	15	SENT_11	[p1l959t975r989b1009],
12	Koblan	NNP	PERSON	Koblan	nn	15	SENT_11	[p1l1008t974r1150b1009],
13	Sunovion	NNP	ORGANIZATION	Sunovion	nn	15	SENT_11	[p1l6t1044r117b1066],
14	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	nn	15	SENT_11	[p1l127t1044r325b1066],
15	Inc	NNP	ORGANIZATION	Inc	appos	4	SENT_11	[p1l335t1045r375b1069],
16	,	,	O	,	_	0	SENT_11	[p1l335t1045r375b1069],
17	84	CD	NUMBER	84	num	19	SENT_11	[p1l388t1045r416b1066],
18	Waterford	NNP	ORGANIZATION	Waterford	nn	19	SENT_11	[p1l428t1044r549b1071],
19	Dr.	NNP	ORGANIZATION	Dr.	appos	4	SENT_11	[p1l558t1045r597b1069],
20	,	,	O	,	_	0	SENT_11	[p1l558t1045r597b1069],
21	Marlborough	NNP	LOCATION	Marlborough	appos	4	SENT_11	[p1l609t1044r770b1071],
22	,	,	O	,	_	0	SENT_11	[p1l609t1044r770b1071],
23	MA	NNP	O	MA	appos	4	SENT_11	[p1l782t1045r822b1066],
24	01752	CD	DATE	01752	num	23	SENT_11	[p1l833t1045r909b1069],
25	,	,	O	,	_	0	SENT_11	[p1l833t1045r909b1069],
26	USA	NNP	LOCATION	USA	appos	4	SENT_11	[p1l922t1045r968b1066],

1	ARTICLEINFO	NNP	O	ARTICLEINFO	_	0	SENT_12	[p1l6t1156r376b1178],
2	ABSTRACT	NN	O	abstract	dep	1	SENT_12	[p1l691t1156r955b1178],

1	Article	NNP	O	Article	nn	2	SENT_13	[p1l6t1239r85b1261],
2	history	NN	O	history	_	0	SENT_13	[p1l96t1239r185b1268],
3	:	:	O	:	_	0	SENT_13	[p1l96t1239r185b1268],
4	Responses	NNS	O	response	nsubjpass	13	SENT_13	[p1l8t1287r151b1316],
5	to	TO	O	to	_	0	SENT_13	[p1l167t1289r194b1310],
6	venlafaxine	NN	O	venlafaxine	nn	7	SENT_13	[p1l208t1285r370b1310],
7	treatment	NN	O	treatment	prep_to	4	SENT_13	[p1l386t1289r526b1310],
8	in	IN	O	in	_	0	SENT_13	[p1l541t1286r567b1310],
9	major	JJ	O	major	amod	11	SENT_13	[p1l582t1286r664b1316],
10	depressive	JJ	O	depressive	amod	11	SENT_13	[p1l678t1286r827b1316],
11	disorder	NN	O	disorder	prep_in	7	SENT_13	[p1l842t1286r959b1310],
12	were	VBD	O	be	auxpass	13	SENT_13	[p1l973t1293r1043b1310],
13	Stratiﬁed	VBN	O	stratiﬁed	dep	2	SENT_13	[p1l1058t1285r1183b1310],
14	by	IN	O	by	_	0	SENT_13	[p1l1199t1286r1232b1316],
15	COMT	NN	O	comt	nn	16	SENT_13	[p1l1247t1287r1332b1310],
16	genotypes	NNS	O	genotype	agent	13	SENT_13	[p1l1344t1289r1487b1316],
17	ReC	NN	O	rec	nn	20	SENT_13	[p1l6t1322r115b1344],
18	€	CD	NUMBER	€	num	20	SENT_13	[p1l6t1322r115b1344],
19	iV	NN	O	iv	nn	20	SENT_13	[p1l6t1322r115b1344],
20	€	NN	O	€	tmod	13	SENT_13	[p1l6t1322r115b1344],
21	d	NN	O	d	nsubj	26	SENT_13	[p1l6t1322r115b1344],
22	22	CD	DATE	22	num	21	SENT_13	[p1l128t1323r157b1343],
23	February	NNP	DATE	February	tmod	21	SENT_13	[p1l171t1322r282b1349],
24	2013	CD	DATE	2013	num	23	SENT_13	[p1l293t1323r351b1344],
25	(	CD	NUMBER	(	num	26	SENT_13	[p1l698t1326r867b1356],
26	Val158Met	NN	O	val158met	rcmod	20	SENT_13	[p1l698t1326r867b1356],
27	,	,	O	,	_	0	SENT_13	[p1l698t1326r867b1356],
28	rs4680	NN	O	rs4680	nn	29	SENT_13	[p1l884t1326r991b1356],
29	)	NN	O	)	appos	26	SENT_13	[p1l884t1326r991b1356],
30	in	IN	O	in	advmod	32	SENT_13	[p1l1007t1326r1033b1350],
31	a	DT	O	a	dep	30	SENT_13	[p1l1049t1333r1063b1350],
32	randomized	VBN	O	randomize	partmod	29	SENT_13	[p1l1079t1326r1254b1354],
33	,	,	O	,	_	0	SENT_13	[p1l1079t1326r1254b1354],
34	double-blind	JJ	O	double-blind	amod	36	SENT_13	[p1l1271t1326r1459b1354],
35	,	,	O	,	_	0	SENT_13	[p1l1271t1326r1459b1354],
36	placebo-controlled	JJ	O	placebo-controlled	amod	38	SENT_13	[p1l1475t1326r1739b1356],
37	clinical	JJ	O	clinical	amod	38	SENT_13	[p1l1756t1326r1853b1350],
38	trial	NN	O	trial	dobj	26	SENT_13	[p1l1870t1326r1933b1350],
39	.	.	O	.	_	0	SENT_13	[p1l1870t1326r1933b1350],

1	Improvements	NNP	O	Improvements	_	0	SENT_14	[p1l1950t1327r2154b1356],

1	Received	VBN	O	receive	_	0	SENT_15	[p1l203t1358r312b1379],
2	in	IN	O	in	_	0	SENT_15	[p1l324t1358r347b1379],
3	revised	JJ	O	revised	amod	4	SENT_15	[p1l358t1358r447b1379],
4	form	NN	O	form	prep_in	1	SENT_15	[p1l459t1358r519b1379],
5	16	CD	DATE	16	num	4	SENT_15	[p1l204t1395r232b1415],
6	April	NNP	DATE	April	tmod	4	SENT_15	[p1l241t1394r302b1420],
7	2013	CD	DATE	2013	num	6	SENT_15	[p1l314t1395r372b1415],
8	Accepted	JJ	O	accepted	amod	9	SENT_15	[p1l202t1429r316b1456],
9	25	CD	DATE	25	tmod	1	SENT_15	[p1l327t1430r357b1451],
10	April	NNP	DATE	April	dep	9	SENT_15	[p1l367t1429r428b1456],
11	2013	CD	DATE	2013	num	10	SENT_15	[p1l440t1430r498b1451],

1	depression	NN	O	depression	nn	2	SENT_16	[p1l6t1458r227b1502],
2	scores	NNS	O	score	nsubj	9	SENT_16	[p1l243t1468r367b1493],
3	among	IN	O	among	_	0	SENT_16	[p1l383t1468r523b1502],
4	subjects	NNS	O	subject	prep_among	2	SENT_16	[p1l538t1458r701b1502],
5	with	IN	O	with	_	0	SENT_16	[p1l716t1458r810b1493],
6	Val/Val	JJ	O	val/val	amod	7	SENT_16	[p1l824t1458r970b1502],
7	genotypes	NNS	O	genotype	prep_with	4	SENT_16	[p1l985t1464r1193b1502],
8	were	VBD	O	be	cop	9	SENT_16	[p1l1208t1468r1310b1493],
9	larger	JJR	O	larger	_	0	SENT_16	[p1l1326t1458r1445b1502],
10	than	IN	O	than	_	0	SENT_16	[p1l1459t1458r1550b1493],
11	those	DT	O	those	prep_than	9	SENT_16	[p1l1566t1458r1675b1493],
12	in	IN	O	in	_	0	SENT_16	[p1l1692t1459r1729b1493],
13	Met/Met	NN	O	met/met	nn	14	SENT_16	[p1l1745t1458r1922b1502],
14	genotypes	NNS	O	genotype	prep_in	11	SENT_16	[p1l1936t1464r2154b1502],
15	,	,	O	,	_	0	SENT_16	[p1l1936t1464r2154b1502],
16	suggesting	VBG	O	suggest	xcomp	9	SENT_16	[p1l6t1517r223b1560],
17	that	IN	O	that	complm	20	SENT_16	[p1l240t1516r322b1551],
18	venlafaxine	NN	O	venlafaxine	nsubj	20	SENT_16	[p1l338t1516r573b1551],
19	may	MD	O	may	aux	20	SENT_16	[p1l592t1526r679b1560],
20	alter	VB	O	alter	ccomp	16	SENT_16	[p1l694t1516r787b1551],
21	noradrenergic	JJ	O	noradrenergic	amod	22	SENT_16	[p1l804t1516r1091b1560],
22	ﬂux	NN	O	ﬂux	dobj	20	SENT_16	[p1l1109t1516r1186b1551],
23	differentially	RB	O	differentially	advmod	20	SENT_16	[p1l1203t1516r1466b1560],
24	according	VBG	O	accord	_	0	SENT_16	[p1l1481t1516r1680b1560],
25	to	TO	O	to	prepc_according_to	20	SENT_16	[p1l1697t1521r1736b1551],
26	COMT	NN	O	comt	nn	27	SENT_16	[p1l1754t1518r1878b1551],
27	activity	NN	O	activity	pobj	20	SENT_16	[p1l1892t1517r2048b1560],
28	.	.	O	.	_	0	SENT_16	[p1l1892t1517r2048b1560],

1	©	RB	O	©	advmod	2	SENT_17	[p1l1175t1581r1204b1609],
2	2013	CD	DATE	2013	_	0	SENT_17	[p1l1222t1576r1316b1609],
3	Elsevier	NNP	ORGANIZATION	Elsevier	nn	5	SENT_17	[p1l1337t1574r1496b1609],
4	Ireland	NNP	ORGANIZATION	Ireland	nn	5	SENT_17	[p1l1513t1574r1655b1609],
5	Ltd.	NNP	ORGANIZATION	Ltd.	dep	2	SENT_17	[p1l1674t1574r1746b1609],
6	.	.	O	.	_	0	SENT_17	[p1l1674t1574r1746b1609],

1	All	DT	O	all	det	2	SENT_18	[p1l1762t1574r1817b1609],
2	rights	NNS	O	rights	nsubj	3	SENT_18	[p1l1836t1574r1952b1618],
3	reserved	VBN	O	reserve	_	0	SENT_18	[p1l1971t1574r2154b1609],
4	.	.	O	.	_	0	SENT_18	[p1l1971t1574r2154b1609],

1	in	IN	O	in	_	0	SENT_19	[p1l6t1406r32b1429],

1	Keywords	NNPS	O	Keywords	_	0	SENT_20	[p1l6t1705r250b1757],
2	:	:	O	:	_	0	SENT_20	[p1l6t1705r250b1757],
3	COMT	NNP	O	COMT	nn	7	SENT_20	[p1l8t1776r157b1816],
4	Venlafaxine	NNP	O	Venlafaxine	nn	7	SENT_20	[p1l6t1843r295b1885],
5	Major	NNP	O	Major	nn	7	SENT_20	[p1l9t1913r151b1965],
6	depressive	JJ	O	depressive	amod	7	SENT_20	[p1l170t1913r427b1965],
7	disorder	NN	O	disorder	dep	1	SENT_20	[p1l449t1912r653b1954],

1	1	LS	NUMBER	1	_	0	SENT_21	[p1l10t2139r60b2189],
2	.	.	O	.	_	0	SENT_21	[p1l10t2139r60b2189],

1	Introduction	NN	O	introduction	_	0	SENT_22	[p1l112t2136r524b2189],

1	Low	JJ	PERSON	low	amod	5	SENT_23	[p1l107t2310r232b2359],
2	and	CC	O	and	_	0	SENT_23	[p1l280t2307r391b2359],
3	variable	JJ	O	variable	conj_and	1	SENT_23	[p1l442t2307r684b2359],
4	response	NN	O	response	nn	5	SENT_23	[p1l737t2322r1007b2371],
5	rates	NNS	O	rate	nsubj	10	SENT_23	[p1l1061t2315r1205b2359],
6	following	VBG	O	follow	_	0	SENT_23	[p1l1258t2307r1546b2371],
7	antidepressant	JJ	O	antidepressant	amod	8	SENT_23	[p1l1596t2307r2050b2371],
8	treatment	NN	O	treatment	prep_following	5	SENT_23	[p1l8t2397r314b2441],
9	are	VBP	O	be	cop	10	SENT_23	[p1l343t2405r435b2441],
10	suggestive	JJ	O	suggestive	_	0	SENT_23	[p1l467t2390r783b2454],
11	of	IN	O	of	_	0	SENT_23	[p1l814t2389r877b2441],
12	genetic	JJ	O	genetic	amod	13	SENT_23	[p1l899t2390r1120b2454],
13	factors	NNS	O	factor	prep_of	10	SENT_23	[p1l1150t2389r1351b2441],
14	contributing	VBG	O	contribute	partmod	13	SENT_23	[p1l1383t2390r1761b2454],
15	to	TO	O	to	_	0	SENT_23	[p1l1791t2397r1848b2441],
16	treatment	NN	O	treatment	nn	17	SENT_23	[p1l1879t2397r2048b2441, p1l9t2480r168b2524],
17	response	NN	O	response	prep_to	14	SENT_23	[p1l188t2487r473b2537],
18	.	.	O	.	_	0	SENT_23	[p1l188t2487r473b2537],

1	While	IN	O	while	mark	12	SENT_24	[p1l491t2472r675b2524],
2	understanding	VBG	O	understand	csubj	12	SENT_24	[p1l696t2472r1142b2537],
3	the	DT	O	the	det	4	SENT_24	[p1l1162t2472r1258b2524],
4	characteristics	NNS	O	characteristic	dobj	2	SENT_24	[p1l1279t2472r1714b2524],
5	of	IN	O	of	_	0	SENT_24	[p1l1737t2472r1800b2524],
6	a	DT	O	a	det	8	SENT_24	[p1l1813t2487r1843b2524],
7	moreresponsive	JJ	O	moreresponsive	amod	8	SENT_24	[p1l1864t2487r2048b2524, p1l9t2556r334b2620],
8	subpopulation	NN	O	subpopulation	prep_of	4	SENT_24	[p1l364t2555r802b2620],
9	is	VBZ	O	be	cop	12	SENT_24	[p1l831t2556r875b2607],
10	a	DT	O	a	det	12	SENT_24	[p1l905t2570r935b2607],
11	speciﬁc	JJ	O	speciﬁc	amod	12	SENT_24	[p1l964t2555r1189b2620],
12	research	NN	O	research	advcl	39	SENT_24	[p1l1218t2555r1473b2607],
13	objective	NN	O	objective	nn	15	SENT_24	[p1l1502t2555r1776b2620],
14	(	CD	NUMBER	(	num	15	SENT_24	[p1l1805t2555r2047b2619],
15	Collins	NNP	ORGANIZATION	Collins	dep	12	SENT_24	[p1l1805t2555r2047b2619],
16	,	,	O	,	_	0	SENT_24	[p1l1805t2555r2047b2619],
17	2010	CD	DATE	2010	appos	15	SENT_24	[p1l9t2641r171b2698],
18	;	:	O	;	_	0	SENT_24	[p1l9t2641r171b2698],
19	Malhotra	NNP	PERSON	Malhotra	dep	15	SENT_24	[p1l217t2638r493b2690],
20	et	FW	O	et	nn	21	SENT_24	[p1l532t2646r589b2690],
21	a1.	FW	O	a1.	dep	19	SENT_24	[p1l628t2638r708b2698],
22	,	,	O	,	_	0	SENT_24	[p1l628t2638r708b2698],
23	2004	CD	DATE	2004	appos	21	SENT_24	[p1l749t2641r920b2698],
24	;	:	O	;	_	0	SENT_24	[p1l749t2641r920b2698],
25	Leuchter	NNP	PERSON	Leuchter	dep	15	SENT_24	[p1l966t2638r1230b2690],
26	et	FW	O	et	nn	27	SENT_24	[p1l1268t2646r1325b2690],
27	al.	FW	O	al.	dep	25	SENT_24	[p1l1364t2638r1443b2698],
28	,	,	O	,	_	0	SENT_24	[p1l1364t2638r1443b2698],
29	2009	CD	DATE	2009	num	30	SENT_24	[p1l1485t2638r1676b2703],
30	)	NN	O	)	nsubj	39	SENT_24	[p1l1485t2638r1676b2703],
31	,	,	O	,	_	0	SENT_24	[p1l1485t2638r1676b2703],
32	identifying	VBG	O	identify	partmod	39	SENT_24	[p1l1718t2638r2049b2703],
33	genetic	JJ	O	genetic	amod	34	SENT_24	[p1l8t2722r229b2786],
34	modiﬁers	NNS	O	modiﬁers	dobj	32	SENT_24	[p1l280t2721r568b2773],
35	of	IN	O	of	_	0	SENT_24	[p1l621t2721r684b2773],
36	treatment	NN	O	treatment	nn	37	SENT_24	[p1l729t2729r1035b2773],
37	response	NN	O	response	prep_of	34	SENT_24	[p1l1086t2736r1356b2786],
38	would	MD	O	would	aux	39	SENT_24	[p1l1406t2721r1597b2773],
39	increase	VB	O	increase	_	0	SENT_24	[p1l1651t2722r1898b2773],
40	the	DT	O	the	det	46	SENT_24	[p1l1951t2721r2047b2773],
41	efﬁciency	NN	O	efﬁciency	nn	43	SENT_24	[p1l9t2804r310b2869],
42	,	,	O	,	_	0	SENT_24	[p1l9t2804r310b2869],
43	safety	NN	O	safety	nn	46	SENT_24	[p1l339t2804r517b2869],
44	and	CC	O	and	_	0	SENT_24	[p1l541t2805r651b2856],
45	economic	JJ	O	economic	conj_and	43	SENT_24	[p1l679t2805r972b2856],
46	beneﬁt	NN	O	beneﬁt	dobj	39	SENT_24	[p1l998t2804r1212b2856],
47	of	IN	O	of	_	0	SENT_24	[p1l1237t2804r1299b2856],
48	existing	VBG	O	exist	amod	49	SENT_24	[p1l1319t2805r1557b2869],
49	therapies	NNS	O	therapy	prep_of	46	SENT_24	[p1l1583t2805r1879b2869],
50	.	.	O	.	_	0	SENT_24	[p1l1583t2805r1879b2869],

1	COMT	NNP	ORGANIZATION	COMT	nsubj	2	SENT_25	[p1l106t2890r291b2939],
2	contributes	VBZ	O	contribute	_	0	SENT_25	[p1l315t2888r659b2939],
3	to	TO	O	to	_	0	SENT_25	[p1l690t2895r748b2939],
4	the	DT	O	the	det	5	SENT_25	[p1l777t2888r873b2939],
5	catabolism	NN	O	catabolism	prep_to	2	SENT_25	[p1l904t2888r1232b2939],
6	of	IN	O	of	_	0	SENT_25	[p1l1262t2887r1325b2939],
7	dopamine	NN	O	dopamine	prep_of	5	SENT_25	[p1l1348t2888r1652b2952],
8	and	CC	O	and	_	0	SENT_25	[p1l1683t2888r1794b2939],
9	norepinephrine	NN	O	norepinephrine	prep_of	5	SENT_25	[p1l1825t2888r2048b2952, p1l9t2970r284b3035],
10	with	IN	O	with	_	0	SENT_25	[p1l307t2970r447b3022],
11	differential	JJ	O	differential	amod	12	SENT_25	[p1l471t2970r806b3022],
12	activity	NN	O	activity	prep_with	7	SENT_25	[p1l831t2971r1056b3035],
13	according	VBG	O	accord	_	0	SENT_25	[p1l1077t2970r1373b3035],
14	to	TO	O	to	prepc_according_to	2	SENT_25	[p1l1397t2978r1454b3022],
15	the	DT	O	the	det	16	SENT_25	[p1l1479t2970r1575b3022],
16	polymorphism	NN	O	polymorphism	pobj	2	SENT_25	[p1l1600t2970r2048b3035],
17	Val158Met	NN	O	val158met	nn	19	SENT_25	[p1l6t3053r338b3105],
18	(	CD	NUMBER	(	num	19	SENT_25	[p1l363t3053r571b3118],
19	Gogos	NNP	O	Gogos	dep	16	SENT_25	[p1l363t3053r571b3118],
20	et	FW	O	et	nn	21	SENT_25	[p1l598t3061r655b3105],
21	al.	FW	O	al.	dep	16	SENT_25	[p1l680t3053r759b3113],
22	,	,	O	,	_	0	SENT_25	[p1l680t3053r759b3113],
23	1998	CD	DATE	1998	appos	21	SENT_25	[p1l785t3056r946b3113],
24	;	:	O	;	_	0	SENT_25	[p1l785t3056r946b3113],
25	Axelrod	NNP	PERSON	Axelrod	dep	21	SENT_25	[p1l975t3053r1212b3105],
26	and	CC	O	and	_	0	SENT_25	[p1l1238t3053r1349b3105],
27	Tomchick	NNP	PERSON	Tomchick	conj_and	25	SENT_25	[p1l1373t3053r1680b3113],
28	,	,	O	,	_	0	SENT_25	[p1l1373t3053r1680b3113],
29	1958	CD	DATE	1958	appos	25	SENT_25	[p1l1706t3056r1868b3113],
30	;	:	O	;	_	0	SENT_25	[p1l1706t3056r1868b3113],
31	Lotta	NNP	PERSON	Lotta	dep	21	SENT_25	[p1l1899t3056r2048b3105],
32	et	FW	O	et	nn	33	SENT_25	[p1l9t3144r66b3188],
33	a1.	FW	O	a1.	dep	31	SENT_25	[p1l100t3136r180b3196],
34	,	,	O	,	_	0	SENT_25	[p1l100t3136r180b3196],
35	1995	CD	DATE	1995	num	36	SENT_25	[p1l215t3137r397b3201],
36	)	NN	O	)	appos	16	SENT_25	[p1l215t3137r397b3201],
37	.	.	O	.	_	0	SENT_25	[p1l215t3137r397b3201],

1	COMT	NN	O	comt	nn	3	SENT_26	[p1l434t3139r619b3188],
2	activity	NN	O	activity	nn	3	SENT_26	[p1l648t3137r872b3201],
3	inﬂuences	NNS	O	inﬂuences	nn	5	SENT_26	[p1l907t3136r1215b3188],
4	dopamine	NN	O	dopamine	nn	5	SENT_26	[p1l1252t3136r1557b3201],
5	levels	NNS	O	level	_	0	SENT_26	[p1l1594t3136r1763b3188],
6	in	IN	O	in	_	0	SENT_26	[p1l1801t3137r1856b3188],
7	brain	NN	O	brain	nn	8	SENT_26	[p1l1891t3136r2049b3188],
8	areas	NNS	O	area	prep_in	5	SENT_26	[p1l9t3234r163b3271],
9	where	WRB	O	where	advmod	14	SENT_26	[p1l197t3219r390b3271],
10	dopamine	NN	O	dopamine	nn	12	SENT_26	[p1l425t3219r730b3284],
11	transporter	NN	O	transporter	nn	12	SENT_26	[p1l764t3227r1110b3284],
12	expression	NN	O	expression	nsubj	14	SENT_26	[p1l1142t3220r1468b3284],
13	is	VBZ	O	be	cop	14	SENT_26	[p1l1503t3220r1547b3271],
14	low	JJ	O	low	rcmod	5	SENT_26	[p1l1582t3219r1704b3279],
15	,	,	O	,	_	0	SENT_26	[p1l1582t3219r1704b3279],
16	but	CC	O	but	_	0	SENT_26	[p1l1738t3219r1839b3271],
17	dopamine	NN	O	dopamine	nsubjpass	21	SENT_26	[p1l1872t3219r2047b3284, p1l9t3303r161b3354],
18	can	MD	O	can	aux	21	SENT_26	[p1l194t3318r297b3354],
19	also	RB	O	also	advmod	21	SENT_26	[p1l329t3303r446b3354],
20	be	VB	O	be	auxpass	21	SENT_26	[p1l478t3303r547b3354],
21	cleared	VBN	O	clear	rcmod	5	SENT_26	[p1l581t3303r799b3354],
22	by	IN	O	by	_	0	SENT_26	[p1l830t3303r904b3367],
23	a	DT	O	a	det	24	SENT_26	[p1l932t3318r963b3354],
24	norepinephrine	NN	O	norepinephrine	agent	21	SENT_26	[p1l995t3303r1469b3367],
25	transporter	NN	O	transporter	nn	27	SENT_26	[p1l1502t3310r1849b3367],
26	(	CD	NUMBER	(	num	27	SENT_26	[p1l1879t3303r2048b3367],
27	NET	NNP	O	NET	dep	24	SENT_26	[p1l1879t3303r2048b3367],
28	)	CD	NUMBER	)	number	29	SENT_26	[p1l1879t3303r2048b3367],
29	(	CD	NUMBER	(	num	30	SENT_26	[p1l9t3386r236b3450],
30	Moron	NNP	O	Moron	dep	27	SENT_26	[p1l9t3386r236b3450],
31	et	FW	O	et	nn	32	SENT_26	[p1l268t3393r325b3437],
32	al.	FW	O	al.	dep	5	SENT_26	[p1l355t3386r435b3445],
33	,	,	O	,	_	0	SENT_26	[p1l355t3386r435b3445],
34	2002	CD	DATE	2002	appos	32	SENT_26	[p1l468t3388r639b3445],
35	;	:	O	;	_	0	SENT_26	[p1l468t3388r639b3445],
36	Carboni	NNP	PERSON	Carboni	dep	5	SENT_26	[p1l677t3386r911b3437],
37	et	FW	O	et	nn	38	SENT_26	[p1l944t3393r1001b3437],
38	al.	FW	O	al.	dep	36	SENT_26	[p1l1032t3386r1112b3445],
39	,	,	O	,	_	0	SENT_26	[p1l1032t3386r1112b3445],
40	1990	CD	DATE	1990	num	41	SENT_26	[p1l1143t3386r1325b3450],
41	)	NN	O	)	appos	38	SENT_26	[p1l1143t3386r1325b3450],
42	.	.	O	.	_	0	SENT_26	[p1l1143t3386r1325b3450],

1	We	PRP	O	we	nsubj	2	SENT_27	[p1l1356t3389r1457b3437],
2	hypothesized	VBD	O	hypothesize	_	0	SENT_27	[p1l1490t3386r1895b3450],
3	that	IN	O	that	complm	5	SENT_27	[p1l1927t3386r2050b3437],
4	COMT	NNP	O	COMT	dep	5	SENT_27	[p1l9t3471r195b3520],
5	functional	JJ	O	functional	dep	2	SENT_27	[p1l227t3468r533b3520],
6	variant	JJ	O	variant	amod	10	SENT_27	[p1l566t3469r782b3520],
7	rs4680	NN	O	rs4680	nn	10	SENT_27	[p1l816t3471r1023b3520],
8	(	CD	NUMBER	(	num	10	SENT_27	[p1l1059t3468r1435b3532],
9	Val158Met	NN	O	val158met	nn	10	SENT_27	[p1l1059t3468r1435b3532],
10	)	NN	O	)	nsubj	13	SENT_27	[p1l1059t3468r1435b3532],
11	might	MD	O	might	aux	13	SENT_27	[p1l1472t3468r1652b3533],
12	also	RB	O	also	advmod	13	SENT_27	[p1l1685t3468r1802b3520],
13	exhibit	VB	O	exhibit	ccomp	5	SENT_27	[p1l1838t3468r2050b3520],
14	noradrenergic	JJ	O	noradrenergic	amod	15	SENT_27	[p1l9t3551r438b3616],
15	effects	NNS	O	effect	dobj	13	SENT_27	[p1l470t3551r664b3603],
16	when	WRB	O	when	advmod	19	SENT_27	[p1l695t3551r867b3603],
17	NET	NNP	O	NET	nsubjpass	19	SENT_27	[p1l900t3554r1022b3602],
18	is	VBZ	O	be	auxpass	19	SENT_27	[p1l1052t3552r1096b3603],
19	inhibited	VBN	O	inhibit	advcl	13	SENT_27	[p1l1129t3551r1402b3603],
20	therapeutically	RB	O	therapeutically	advmod	19	SENT_27	[p1l1434t3551r1894b3616],
21	(	CD	NUMBER	(	dobj	19	SENT_27	[p1l1925t3551r2047b3616],
22	e.g.	FW	O	e.g.	amod	21	SENT_27	[p1l1925t3551r2047b3616],
23	by	IN	O	by	_	0	SENT_27	[p1l8t3634r81b3699],
24	the	DT	O	the	det	27	SENT_27	[p1l106t3634r202b3686],
25	SNRI	NNP	O	SNRI	nn	27	SENT_27	[p1l230t3637r371b3686],
26	venlafaxine	NN	O	venlafaxine	nn	27	SENT_27	[p1l397t3634r787b3699],
27	)	NN	O	)	agent	19	SENT_27	[p1l397t3634r787b3699],
28	.	.	O	.	_	0	SENT_27	[p1l397t3634r787b3699],

1	Here	RB	O	here	_	0	SENT_28	[p1l107t3721r249b3770],
2	we	PRP	O	we	nsubj	3	SENT_28	[p1l281t3733r371b3770],
3	analyzed	VBD	O	analyze	rcmod	1	SENT_28	[p1l405t3718r674b3782],
4	the	DT	O	the	det	7	SENT_28	[p1l709t3718r805b3770],
5	venlafaxine	NN	O	venlafaxine	nn	7	SENT_28	[p1l839t3718r1191b3770],
6	treatment	NN	O	treatment	nn	7	SENT_28	[p1l1226t3725r1532b3770],
7	arm	NN	O	arm	dobj	3	SENT_28	[p1l1565t3733r1685b3770],
8	of	IN	O	of	_	0	SENT_28	[p1l1719t3718r1782b3770],
9	a	DT	O	a	det	10	SENT_28	[p1l1809t3733r1840b3770],
10	Phase	NN	O	phase	prep_of	7	SENT_28	[p1l1875t3718r2048b3770],

1	2	CD	NUMBER	2	num	3	SENT_29	[p2l9t18r41b67],
2	clinical	JJ	O	clinical	amod	3	SENT_29	[p2l78t16r290b67],
3	trial	NN	O	trial	_	0	SENT_29	[p2l324t16r446b67],
4	in	IN	O	in	_	0	SENT_29	[p2l481t16r537b67],
5	depression	NN	O	depression	prep_in	3	SENT_29	[p2l571t16r915b80],
6	,	,	O	,	_	0	SENT_29	[p2l571t16r915b80],
7	in	IN	O	in	_	0	SENT_29	[p2l952t16r1007b67],
8	which	WDT	O	which	rel	12	SENT_29	[p2l1038t16r1226b67],
9	subjects	NNS	O	subject	nsubjpass	12	SENT_29	[p2l1261t16r1504b80],
10	were	VBD	O	be	auxpass	12	SENT_29	[p2l1538t31r1689b67],
11	also	RB	O	also	advmod	12	SENT_29	[p2l1723t16r1840b67],
12	genotyped	VBN	O	genotype	rcmod	5	SENT_29	[p2l1874t31r2047b80, p2l8t98r180b163],
13	for	IN	O	for	_	0	SENT_29	[p2l226t98r310b150],
14	the	DT	O	the	det	17	SENT_29	[p2l352t98r448b150],
15	COMT	NNP	O	COMT	nn	17	SENT_29	[p2l493t101r678b150],
16	Va1158Met	NN	O	va1158met	nn	17	SENT_29	[p2l720t98r1052b150],
17	polymorphism	NN	O	polymorphism	prep_for	12	SENT_29	[p2l1095t98r1557b163],
18	.	.	O	.	_	0	SENT_29	[p2l1095t98r1557b163],

1	The	DT	O	the	det	4	SENT_30	[p2l1600t98r1711b150],
2	improved	VBN	O	improve	amod	4	SENT_30	[p2l1756t98r2047b163],
3	venlafaxine	NN	O	venlafaxine	nn	4	SENT_30	[p2l7t181r360b233],
4	response	NN	O	response	dep	5	SENT_30	[p2l400t196r670b246],
5	apparent	JJ	O	apparent	_	0	SENT_30	[p2l709t189r984b246],
6	in	IN	O	in	_	0	SENT_30	[p2l1022t182r1078b232],
7	Val/Val	JJ	O	val/val	amod	8	SENT_30	[p2l1115t181r1333b246],
8	genotypes	NNS	O	genotype	nsubj	9	SENT_30	[p2l1372t189r1684b246],
9	outlined	VBD	O	outline	dep	24	SENT_30	[p2l1724t181r1976b233],
10	a	DT	O	a	det	13	SENT_30	[p2l2018t196r2049b233],
11	genetic	JJ	O	genetic	amod	13	SENT_30	[p2l8t265r229b329],
12	modiﬁer	NN	O	modiﬁer	nn	13	SENT_30	[p2l266t264r527b316],
13	hypothesis	NN	O	hypothesis	dobj	9	SENT_30	[p2l563t264r889b329],
14	with	IN	O	with	_	0	SENT_30	[p2l927t264r1067b316],
15	an	DT	O	a	det	18	SENT_30	[p2l1105t279r1176b316],
16	associated	JJ	O	associated	amod	18	SENT_30	[p2l1214t264r1526b316],
17	effect	NN	O	effect	nn	18	SENT_30	[p2l1565t264r1732b316],
18	size	NN	O	size	prep_with	9	SENT_30	[p2l1770t265r1882b316],
19	proposed	VBN	O	propose	partmod	18	SENT_30	[p2l1920t279r2048b329, p2l9t347r186b412],
20	for	IN	O	for	_	0	SENT_30	[p2l215t347r299b399],
21	a	DT	O	a	det	22	SENT_30	[p2l324t362r355b399],
22	priori	FW	O	priori	prep_for	19	SENT_30	[p2l378t348r543b412],
23	clinical	JJ	O	clinical	amod	24	SENT_30	[p2l570t347r782b399],
24	testing	NN	O	testing	prep_in	5	SENT_30	[p2l809t348r1030b412],
25	.	.	O	.	_	0	SENT_30	[p2l809t348r1030b412],

1	*	NN	O	*	_	0	SENT_31	[p2l61t587r82b608],
2	Corresponding	VBG	O	correspond	partmod	1	SENT_31	[p2l98t589r458b641],
3	author	NN	O	author	dobj	2	SENT_31	[p2l478t589r648b631],
4	.	.	O	.	_	0	SENT_31	[p2l478t589r648b631],

1	Tel.	NNP	O	Tel.	_	0	SENT_32	[p2l668t589r764b631],
2	:	:	O	:	_	0	SENT_32	[p2l668t589r764b631],
3	+1	CD	NUMBER	+1	number	4	SENT_32	[p2l785t591r843b633],
4	5083577706	CD	NUMBER	5083577706	dep	1	SENT_32	[p2l867t591r1180b631],
5	.	.	O	.	_	0	SENT_32	[p2l867t591r1180b631],

1	E-mail	NN	O	e-mail	nn	2	SENT_33	[p2l105t666r260b708],
2	address	NN	O	address	_	0	SENT_33	[p2l280t666r472b709],
3	:	:	O	:	_	0	SENT_33	[p2l280t666r472b709],
4	seth.hopkins@sunovion.com	NNP	O	seth.hopkins@sunovion.com	nn	7	SENT_33	[p2l495t666r1190b719],
5	(	CD	NUMBER	(	num	7	SENT_33	[p2l1211t667r1312b719],
6	S.C.	NNP	LOCATION	S.C.	nn	7	SENT_33	[p2l1211t667r1312b719],
7	Hopkins	NNP	LOCATION	Hopkins	dep	2	SENT_33	[p2l1334t666r1566b719],
8	)	NN	O	)	dep	7	SENT_33	[p2l1334t666r1566b719],
9	.	.	O	.	_	0	SENT_33	[p2l1334t666r1566b719],

1	0165-1781	CD	DURATION	0165-1781	nsubj	5	SENT_34	[p2l8t800r430b854],
2	/	:	O	/	punct	3	SENT_34	[p2l8t800r430b854],
3	$	$	MONEY	$	dep	1	SENT_34	[p2l8t800r430b854],
4	-	:	O	-	_	0	SENT_34	[p2l8t800r430b854],
5	see	VB	O	see	_	0	SENT_34	[p2l8t800r430b854],
6	front	JJ	O	front	amod	7	SENT_34	[p2l452t801r572b843],
7	matter	NN	O	matter	dobj	5	SENT_34	[p2l592t808r756b843],
8	©	CD	NUMBER	©	num	12	SENT_34	[p2l775t809r811b843],
9	2013	CD	DATE	2013	num	12	SENT_34	[p2l832t804r945b843],
10	Elsevier	NNP	ORGANIZATION	Elsevier	nn	12	SENT_34	[p2l969t801r1160b843],
11	Ireland	NNP	ORGANIZATION	Ireland	nn	12	SENT_34	[p2l1180t801r1350b843],
12	Ltd.	NNP	ORGANIZATION	Ltd.	dep	7	SENT_34	[p2l1372t801r1458b844],
13	.	.	O	.	_	0	SENT_34	[p2l1372t801r1458b844],

1	All	DT	O	all	det	2	SENT_35	[p2l1478t801r1544b843],
2	rights	NNS	O	rights	nsubj	3	SENT_35	[p2l1566t801r1704b854],
3	reserved	VBN	O	reserve	_	0	SENT_35	[p2l1727t801r1946b844],
4	.	.	O	.	_	0	SENT_35	[p2l1727t801r1946b844],

1	http://dx.doi.org/10.1016/j.psychres.2013.04.021	NN	O	http://dx.doi.org/10.1016/j.psychres.2013.04.021	_	0	SENT_36	[p2l9t871r1176b923],

1	2	LS	NUMBER	2	_	0	SENT_37	[p2l53t1228r95b1269],
2	.	.	O	.	_	0	SENT_37	[p2l53t1228r95b1269],

1	Methods	NNS	O	method	_	0	SENT_38	[p2l147t1226r376b1268],

1	Study	NNP	O	Study	nn	2	SENT_39	[p2l153t1393r293b1446],
2	NCTOO584974	NNP	O	NCTOO584974	nsubj	5	SENT_39	[p2l322t1395r668b1436],
3	was	VBD	O	be	cop	5	SENT_39	[p2l698t1406r793b1436],
4	a	DT	O	a	det	5	SENT_39	[p2l824t1406r850b1436],
5	Phase	NN	O	phase	dep	18	SENT_39	[p2l882t1393r1021b1436],
6	2	CD	NUMBER	2	dep	5	SENT_39	[p2l1053t1395r1093b1442],
7	,	,	O	,	_	0	SENT_39	[p2l1053t1395r1093b1442],
8	randomized	VBN	O	randomize	partmod	5	SENT_39	[p2l1125t1393r1432b1442],
9	,	,	O	,	_	0	SENT_39	[p2l1125t1393r1432b1442],
10	double	JJ	O	double	advmod	12	SENT_39	[p2l1464t1393r1792b1442],
11	—	RB	O	—	advmod	12	SENT_39	[p2l1464t1393r1792b1442],
12	blind	JJ	O	blind	ccomp	18	SENT_39	[p2l1464t1393r1792b1442],
13	,	,	O	,	_	0	SENT_39	[p2l1464t1393r1792b1442],
14	placebo	NN	O	placebo	nsubj	18	SENT_39	[p2l1825t1393r2146b1446],
15	—	CD	NUMBER	—	num	14	SENT_39	[p2l1825t1393r2146b1446],
16	con	NN	O	con	dep	14	SENT_39	[p2l1825t1393r2146b1446],
17	—	CD	NUMBER	—	num	16	SENT_39	[p2l1825t1393r2146b1446],
18	trolled	VBD	O	troll	_	0	SENT_39	[p2l53t1463r225b1512],
19	,	,	O	,	_	0	SENT_39	[p2l53t1463r225b1512],
20	multicenter	JJ	O	multicenter	amod	21	SENT_39	[p2l242t1463r530b1506],
21	study	NN	O	study	dep	32	SENT_39	[p2l546t1463r682b1517],
22	of	IN	O	of	_	0	SENT_39	[p2l695t1463r748b1506],
23	daily	JJ	SET	daily	amod	24	SENT_39	[p2l757t1463r875b1517],
24	doses	NNS	O	dose	prep_of	21	SENT_39	[p2l890t1463r1025b1506],
25	of	IN	O	of	_	0	SENT_39	[p2l1043t1463r1094b1506],
26	experimental	JJ	O	experimental	amod	28	SENT_39	[p2l1104t1463r1431b1517],
27	drug	NN	O	drug	nn	28	SENT_39	[p2l1447t1463r1561b1517],
28	candidate	NN	O	candidate	prep_of	24	SENT_39	[p2l1577t1463r1815b1506],
29	(	CD	NUMBER	(	num	30	SENT_39	[p2l1832t1464r2145b1516],
30	SEP	NN	DATE	sep	dep	32	SENT_39	[p2l1832t1464r2145b1516],
31	—	CD	NUMBER	—	number	32	SENT_39	[p2l1832t1464r2145b1516],
32	225289	CD	NUMBER	225289	dep	36	SENT_39	[p2l1832t1464r2145b1516],
33	at	IN	O	at	_	0	SENT_39	[p2l53t1539r99b1575],
34	2	CD	NUMBER	2	num	35	SENT_39	[p2l131t1535r158b1575],
35	doses	NNS	O	dose	prep_at	32	SENT_39	[p2l194t1533r349b1586],
36	)	CD	NUMBER	)	dep	42	SENT_39	[p2l194t1533r349b1586],
37	or	CC	O	or	_	0	SENT_39	[p2l383t1545r435b1575],
38	venlafaxine	NN	O	venlafaxine	nn	39	SENT_39	[p2l465t1533r749b1575],
39	(	NN	O	(	dep	42	SENT_39	[p2l783t1533r890b1586],
40	150	CD	NUMBER	150	num	42	SENT_39	[p2l783t1533r890b1586],
41	mg	NN	O	mg	nn	42	SENT_39	[p2l907t1533r1002b1586],
42	)	NN	O	)	dep	54	SENT_39	[p2l907t1533r1002b1586],
43	for	IN	O	for	_	0	SENT_39	[p2l1037t1533r1105b1575],
44	8	CD	DURATION	8	num	45	SENT_39	[p2l1138t1535r1164b1575],
45	weeks	NNS	NUMBER	week	prep_for	42	SENT_39	[p2l1198t1533r1353b1575],
46	in	IN	O	in	_	0	SENT_39	[p2l1388t1533r1434b1575],
47	adult	JJ	O	adult	amod	48	SENT_39	[p2l1467t1533r1593b1575],
48	subjects	NNS	O	subject	prep_in	45	SENT_39	[p2l1627t1533r1823b1586],
49	with	IN	O	with	_	0	SENT_39	[p2l1856t1533r1970b1575],
50	major	JJ	O	major	amod	52	SENT_39	[p2l2004t1533r2147b1586],
51	depressive	JJ	O	depressive	amod	52	SENT_39	[p2l53t1603r312b1656],
52	disorder	NN	O	disorder	prep_with	48	SENT_39	[p2l333t1603r538b1646],
53	(	CD	NUMBER	(	num	54	SENT_39	[p2l557t1603r732b1656],
54	MDD	NN	O	mdd	dep	55	SENT_39	[p2l557t1603r732b1656],
55	)	NN	O	)	dep	18	SENT_39	[p2l557t1603r732b1656],
56	.	.	O	.	_	0	SENT_39	[p2l557t1603r732b1656],

1	Subjects	NNS	O	subject	nsubj	12	SENT_40	[p2l754t1603r955b1656],
2	were	VBD	O	be	_	0	SENT_40	[p2l975t1616r1097b1646],
3	between	IN	O	between	_	0	SENT_40	[p2l1118t1603r1331b1646],
4	the	DT	O	the	det	5	SENT_40	[p2l1350t1603r1428b1646],
5	ages	NNS	O	age	prep_between	2	SENT_40	[p2l1449t1616r1555b1656],
6	of	IN	O	of	_	0	SENT_40	[p2l1575t1603r1627b1646],
7	18	CD	NUMBER	18	nn	10	SENT_40	[p2l1644t1605r1694b1646],
8	and	CC	O	and	_	0	SENT_40	[p2l1717t1603r1807b1646],
9	55	CD	DURATION	55	nn	10	SENT_40	[p2l1829t1606r1885b1646],
10	years	NNS	NUMBER	year	prep_of	5	SENT_40	[p2l1906t1616r2035b1656],
11	and	CC	O	and	_	0	SENT_40	[p2l2056t1603r2145b1646],
12	met	VBD	O	meet	conj_and	2	SENT_40	[p2l54t1679r150b1715],
13	DSM	NNP	ORGANIZATION	DSM	dobj	12	SENT_40	[p2l167t1675r358b1715],
14	.	.	O	.	_	0	SENT_40	[p2l167t1675r358b1715],

1	—	NN	O	—	_	0	SENT_41	[p2l167t1675r358b1715],
2	.	.	O	.	_	0	SENT_41	[p2l167t1675r358b1715],

1	IV	CD	NUMBER	iv	num	2	SENT_42	[p2l167t1675r358b1715],
2	criteria	NNS	O	criterion	_	0	SENT_42	[p2l375t1673r547b1715],
3	for	IN	O	for	_	0	SENT_42	[p2l567t1672r634b1715],
4	MDD	NN	ORGANIZATION	mdd	prep_for	2	SENT_42	[p2l652t1675r789b1722],
5	,	,	O	,	_	0	SENT_42	[p2l652t1675r789b1722],
6	with	IN	O	with	_	0	SENT_42	[p2l806t1672r921b1715],
7	current	JJ	DATE	current	amod	21	SENT_42	[p2l939t1673r1331b1726],
8	—	CD	NUMBER	—	num	10	SENT_42	[p2l939t1673r1331b1726],
9	episode	NN	O	episode	nn	10	SENT_42	[p2l939t1673r1331b1726],
10	duration	NN	O	duration	nn	21	SENT_42	[p2l1349t1673r1560b1715],
11	of	IN	O	of	_	0	SENT_42	[p2l1578t1672r1630b1715],
12	at	IN	DURATION	at	quantmod	14	SENT_42	[p2l1642t1679r1688b1715],
13	least	JJS	DURATION	least	mwe	12	SENT_42	[p2l1705t1672r1820b1715],
14	1	CD	DURATION	1	num	15	SENT_42	[p2l1839t1675r1858b1715],
15	month	NN	NUMBER	month	prep_of	10	SENT_42	[p2l1884t1673r2047b1715],
16	but	CC	O	but	_	0	SENT_42	[p2l2065t1672r2148b1715],
17	not	RB	O	not	neg	18	SENT_42	[p2l54t1749r134b1785],
18	longer	JJR	O	longer	conj_but	10	SENT_42	[p2l149t1743r307b1796],
19	than	IN	O	than	_	0	SENT_42	[p2l320t1743r432b1785],
20	12	CD	DURATION	12	prep_than	18	SENT_42	[p2l451t1745r503b1785],
21	months	NNS	NUMBER	month	prep_with	2	SENT_42	[p2l522t1743r721b1786],
22	.	.	O	.	_	0	SENT_42	[p2l522t1743r721b1786],

1	The	DT	O	the	det	2	SENT_43	[p2l735t1743r826b1785],
2	analysis	NN	O	analysis	nsubjpass	4	SENT_43	[p2l842t1743r1034b1796],
3	was	VBD	O	be	auxpass	4	SENT_43	[p2l1050t1755r1145b1785],
4	conducted	VBN	O	conduct	_	0	SENT_43	[p2l1162t1743r1418b1785],
5	on	IN	O	on	_	0	SENT_43	[p2l1435t1755r1496b1785],
6	N	NN	O	n	prep_on	4	SENT_43	[p2l1510t1745r1594b1785],
7	:	:	O	:	_	0	SENT_43	[p2l1510t1745r1594b1785],
8	126	CD	NUMBER	126	num	9	SENT_43	[p2l1606t1745r1692b1785],
9	subjects	NNS	O	subject	nsubj	27	SENT_43	[p2l1709t1743r1906b1796],
10	receiving	VBG	O	receive	partmod	9	SENT_43	[p2l1923t1743r2147b1796],
11	at	IN	O	at	quantmod	13	SENT_43	[p2l53t1819r99b1856],
12	least	JJS	O	least	mwe	11	SENT_43	[p2l124t1813r238b1856],
13	one	CD	NUMBER	one	num	14	SENT_43	[p2l262t1826r351b1856],
14	dose	NN	O	dose	dobj	10	SENT_43	[p2l378t1813r490b1856],
15	of	IN	O	of	_	0	SENT_43	[p2l517t1813r569b1856],
16	venlafaxine	NN	O	venlafaxine	nn	19	SENT_43	[p2l587t1813r871b1856],
17	(	CD	NUMBER	(	num	19	SENT_43	[p2l897t1813r992b1866],
18	ITT	NNP	O	ITT	nn	19	SENT_43	[p2l897t1813r992b1866],
19	population	NN	O	population	prep_of	14	SENT_43	[p2l1018t1813r1303b1866],
20	)	CD	NUMBER	)	num	19	SENT_43	[p2l1018t1813r1303b1866],
21	compared	VBN	O	compare	_	0	SENT_43	[p2l1330t1813r1575b1866],
22	with	IN	O	with	prepc_compared_with	10	SENT_43	[p2l1601t1813r1715b1856],
23	N	NN	O	n	pobj	10	SENT_43	[p2l1739t1815r1920b1856],
24	=	JJ	O	=	amod	23	SENT_43	[p2l1739t1815r1920b1856],
25	128	CD	NUMBER	128	num	26	SENT_43	[p2l1739t1815r1920b1856],
26	subjects	NNS	O	subject	dep	24	SENT_43	[p2l1949t1813r2145b1866],
27	treated	VBN	O	treat	parataxis	4	SENT_43	[p2l53t1882r227b1925],
28	with	IN	O	with	_	0	SENT_43	[p2l263t1883r378b1925],
29	placebo	NN	O	placebo	prep_with	27	SENT_43	[p2l416t1882r615b1936],
30	.	.	O	.	_	0	SENT_43	[p2l416t1882r615b1936],

1	The	DT	O	the	det	4	SENT_44	[p2l651t1882r742b1925],
2	venlafaxine	NN	O	venlafaxine	nn	4	SENT_44	[p2l779t1882r1063b1925],
3	treatment	NN	O	treatment	nn	4	SENT_44	[p2l1101t1889r1348b1925],
4	group	NN	O	group	nsubj	5	SENT_44	[p2l1383t1895r1527b1936],
5	had	VBD	O	have	_	0	SENT_44	[p2l1566t1882r1655b1925],
6	a	DT	O	a	det	8	SENT_44	[p2l1694t1895r1719b1925],
7	greater	JJR	O	greater	amod	8	SENT_44	[p2l1756t1889r1933b1936],
8	rate	NN	O	rate	dobj	5	SENT_44	[p2l1969t1889r2062b1925],
9	of	IN	O	of	_	0	SENT_44	[p2l2101t1882r2153b1925],
10	discontinuations	NNS	O	discontinuation	prep_of	8	SENT_44	[p2l53t1953r460b1996],
11	during	IN	O	during	_	0	SENT_44	[p2l493t1953r655b2007],
12	the	DT	O	the	det	16	SENT_44	[p2l686t1953r764b1996],
13	double	JJ	O	double	amod	16	SENT_44	[p2l796t1953r1113b1996],
14	—	NN	O	—	nn	16	SENT_44	[p2l796t1953r1113b1996],
15	blind	JJ	O	blind	amod	16	SENT_44	[p2l796t1953r1113b1996],
16	period	NN	O	period	prep_during	10	SENT_44	[p2l1145t1953r1303b2007],
17	overall	RB	O	overall	advmod	5	SENT_44	[p2l1334t1953r1499b1996],
18	than	IN	O	than	_	0	SENT_44	[p2l1530t1953r1642b1996],
19	the	DT	O	the	det	21	SENT_44	[p2l1672t1953r1750b1996],
20	placebo	NN	O	placebo	nn	21	SENT_44	[p2l1783t1953r1971b2007],
21	group	NN	O	group	prep_than	5	SENT_44	[p2l2001t1966r2145b2007],
22	(	CD	PERCENT	(	number	23	SENT_44	[p2l53t2023r164b2076],
23	37	CD	PERCENT	37	dep	24	SENT_44	[p2l53t2023r164b2076],
24	%	NN	PERCENT	%	dep	21	SENT_44	[p2l53t2023r164b2076],
25	vs.	CC	O	vs.	prep	21	SENT_44	[p2l185t2035r249b2065],
26	25	CD	PERCENT	25	num	27	SENT_44	[p2l272t2025r377b2072],
27	%	NN	PERCENT	%	dep	25	SENT_44	[p2l272t2025r377b2072],
28	,	,	O	,	_	0	SENT_44	[p2l272t2025r377b2072],
29	respectively	RB	O	respectively	advmod	27	SENT_44	[p2l401t2023r726b2076],
30	)	CD	NUMBER	)	dep	27	SENT_44	[p2l401t2023r726b2076],
31	.	.	O	.	_	0	SENT_44	[p2l401t2023r726b2076],

1	Venlafaxine	JJ	O	venlafaxine	amod	2	SENT_45	[p2l747t2022r1037b2065],
2	doses	NNS	O	dose	nsubj	7	SENT_45	[p2l1062t2022r1196b2065],
3	were	VBD	O	be	cop	7	SENT_45	[p2l1219t2035r1341b2065],
4	75	CD	NUMBER	75	num	7	SENT_45	[p2l1366t2025r1423b2065],
5	mg	NN	O	mg	nn	7	SENT_45	[p2l1441t2035r1519b2076],
6	(	NN	O	(	nn	7	SENT_45	[p2l1542t2022r1723b2076],
7	Weeks	NNS	DURATION	week	_	0	SENT_45	[p2l1542t2022r1723b2076],
8	1	CD	NUMBER	1	dep	7	SENT_45	[p2l1750t2025r1783b2072],
9	,	,	O	,	_	0	SENT_45	[p2l1750t2025r1783b2072],
10	2	CD	NUMBER	2	num	8	SENT_45	[p2l1807t2025r1847b2072],
11	,	,	O	,	_	0	SENT_45	[p2l1807t2025r1847b2072],
12	and	CC	NUMBER	and	_	0	SENT_45	[p2l1870t2022r1960b2065],
13	9	CD	NUMBER	9	dep	7	SENT_45	[p2l1984t2023r2032b2075],
14	)	NN	O	)	dep	7	SENT_45	[p2l1984t2023r2032b2075],
15	and	CC	O	and	_	0	SENT_45	[p2l2056t2022r2145b2065],
16	150	CD	NUMBER	150	num	19	SENT_45	[p2l56t2095r140b2135],
17	mg	NN	O	mg	nn	19	SENT_45	[p2l157t2105r235b2146],
18	(	NN	O	(	nn	19	SENT_45	[p2l250t2093r432b2146],
19	Weeks	NNS	DURATION	week	conj_and	7	SENT_45	[p2l250t2093r432b2146],
20	3	CD	NUMBER	3	dep	19	SENT_45	[p2l449t2095r476b2135],
21	through	IN	O	through	_	0	SENT_45	[p2l495t2093r692b2146],
22	8	CD	NUMBER	8	num	23	SENT_45	[p2l709t2093r768b2146],
23	)	NN	O	)	prep_through	7	SENT_45	[p2l709t2093r768b2146],
24	,	,	O	,	_	0	SENT_45	[p2l709t2093r768b2146],
25	and	CC	O	and	_	0	SENT_45	[p2l785t2093r875b2135],
26	no	DT	O	no	det	28	SENT_45	[p2l893t2105r953b2135],
27	psychiatric	JJ	O	psychiatric	amod	28	SENT_45	[p2l971t2093r1236b2146],
28	comorbidities	NNS	O	comorbidity	nsubjpass	30	SENT_45	[p2l1253t2093r1590b2135],
29	were	VBD	O	be	auxpass	30	SENT_45	[p2l1606t2105r1728b2135],
30	allowed	VBN	O	allow	conj_and	7	SENT_45	[p2l1745t2093r1950b2136],
31	.	.	O	.	_	0	SENT_45	[p2l1745t2093r1950b2136],

1	Clinical	JJ	O	clinical	amod	3	SENT_46	[p2l1968t2093r2145b2135],
2	Global	JJ	O	global	amod	3	SENT_46	[p2l53t2163r209b2206],
3	Impressions	NNS	O	impression	nsubj	4	SENT_46	[p2l226t2164r521b2217],
4	(	VBP	O	(	_	0	SENT_46	[p2l539t2163r662b2216],
5	CGI	NN	O	cgus	nn	6	SENT_46	[p2l539t2163r662b2216],
6	)	NN	O	)	dobj	4	SENT_46	[p2l539t2163r662b2216],
7	and	CC	O	and	_	0	SENT_46	[p2l679t2163r769b2206],
8	17	CD	NUMBER	17	number	9	SENT_46	[p2l789t2164r977b2206],
9	—	CD	NUMBER	—	num	10	SENT_46	[p2l789t2164r977b2206],
10	item	NN	O	item	dobj	4	SENT_46	[p2l789t2164r977b2206],
11	Hamilton	NNP	O	Hamilton	nn	16	SENT_46	[p2l994t2163r1224b2206],
12	Depression	NNP	O	Depression	nn	16	SENT_46	[p2l1240t2164r1513b2217],
13	Rating	NNP	O	Rating	nn	16	SENT_46	[p2l1530t2164r1687b2217],
14	Scale	NNP	O	Scale	nn	16	SENT_46	[p2l1703t2163r1825b2206],
15	(	NNP	O	(	nn	16	SENT_46	[p2l1843t2163r2145b2216],
16	HAM	NNP	O	HAM	dep	10	SENT_46	[p2l1843t2163r2145b2216],
17	.	.	O	.	_	0	SENT_46	[p2l1843t2163r2145b2216],

1	—	NN	O	—	_	0	SENT_47	[p2l1843t2163r2145b2216],
2	.	.	O	.	_	0	SENT_47	[p2l1843t2163r2145b2216],

1	D	NN	O	d	_	0	SENT_48	[p2l1843t2163r2145b2216],
2	.	.	O	.	_	0	SENT_48	[p2l1843t2163r2145b2216],

1	—	NN	O	—	_	0	SENT_49	[p2l1843t2163r2145b2216],
2	.	.	O	.	_	0	SENT_49	[p2l1843t2163r2145b2216],

1	17	CD	NUMBER	17	number	2	SENT_50	[p2l1843t2163r2145b2216],
2	)	CD	NUMBER	)	num	3	SENT_50	[p2l1843t2163r2145b2216],
3	assessments	NNS	O	assessment	nsubjpass	5	SENT_50	[p2l53t2239r355b2275],
4	were	VBD	O	be	auxpass	5	SENT_50	[p2l375t2245r499b2275],
5	conducted	VBN	O	conduct	_	0	SENT_50	[p2l520t2233r776b2275],
6	weekly	RB	SET	weekly	advmod	5	SENT_50	[p2l795t2232r972b2286],
7	by	IN	O	by	_	0	SENT_50	[p2l992t2232r1051b2286],
8	a	DT	O	a	det	9	SENT_50	[p2l1070t2245r1095b2275],
9	psychiatrist	NN	O	psychiatrist	agent	5	SENT_50	[p2l1117t2233r1401b2286],
10	and	CC	O	and	_	0	SENT_50	[p2l1421t2233r1511b2275],
11	a	DT	O	a	det	13	SENT_50	[p2l1533t2245r1558b2275],
12	trained	JJ	O	trained	amod	13	SENT_50	[p2l1579t2233r1754b2275],
13	rater	NN	O	rater	agent	5	SENT_50	[p2l1776t2239r1900b2275],
14	.	.	O	.	_	0	SENT_50	[p2l1776t2239r1900b2275],

1	Pre	VB	O	pre	dep	6	SENT_51	[p2l153t2303r476b2356],
2	—	CD	NUMBER	—	num	4	SENT_51	[p2l153t2303r476b2356],
3	speciﬁed	JJ	O	speciﬁed	amod	4	SENT_51	[p2l153t2303r476b2356],
4	analyses	NNS	O	analysis	dobj	1	SENT_51	[p2l517t2303r725b2356],
5	were	VBD	O	be	auxpass	6	SENT_51	[p2l763t2315r888b2345],
6	conducted	VBN	O	conduct	_	0	SENT_51	[p2l927t2303r1187b2345],
7	on	IN	O	on	_	0	SENT_51	[p2l1227t2315r1288b2345],
8	HAM-D	NN	O	ham-d	prep_on	6	SENT_51	[p2l1328t2305r1594b2345],
9	—	CD	NUMBER	—	num	8	SENT_51	[p2l1328t2305r1594b2345],
10	17	CD	NUMBER	17	num	12	SENT_51	[p2l1328t2305r1594b2345],
11	mean	JJ	O	mean	amod	12	SENT_51	[p2l1635t2315r1772b2345],
12	change	NN	O	change	tmod	6	SENT_51	[p2l1812t2303r1988b2356],
13	from	IN	O	from	_	0	SENT_51	[p2l2027t2303r2146b2345],
14	baseline	NN	O	baseline	prep_from	12	SENT_51	[p2l53t2373r257b2416],
15	using	VBG	O	use	xcomp	6	SENT_51	[p2l280t2374r415b2427],
16	an	DT	O	a	det	17	SENT_51	[p2l437t2386r496b2416],
17	analysis	NN	O	analysis	dobj	15	SENT_51	[p2l519t2373r715b2427],
18	of	IN	O	of	_	0	SENT_51	[p2l739t2373r791b2416],
19	covariance	NN	O	covariance	prep_of	17	SENT_51	[p2l808t2374r1073b2416],
20	(	CD	NUMBER	(	num	19	SENT_51	[p2l1097t2373r1352b2426],
21	ANCOVA	NNP	O	ANCOVA	nn	23	SENT_51	[p2l1097t2373r1352b2426],
22	)	CD	NUMBER	)	num	23	SENT_51	[p2l1097t2373r1352b2426],
23	model	NN	O	model	nsubjpass	6	SENT_51	[p2l1376t2373r1532b2416],
24	that	WDT	O	that	nsubj	25	SENT_51	[p2l1556t2373r1656b2416],
25	included	VBD	O	include	rcmod	23	SENT_51	[p2l1679t2373r1894b2416],
26	the	DT	O	the	det	28	SENT_51	[p2l1917t2373r1997b2416],
27	main	JJ	O	main	amod	28	SENT_51	[p2l2020t2374r2145b2416],
28	effects	NNS	O	effect	dobj	25	SENT_51	[p2l53t2443r213b2486],
29	for	IN	O	for	_	0	SENT_51	[p2l240t2443r309b2486],
30	treatment	NN	O	treatment	prep_for	25	SENT_51	[p2l333t2449r584b2486],
31	and	CC	O	and	_	0	SENT_51	[p2l609t2443r699b2486],
32	site	NN	O	site	conj_and	30	SENT_51	[p2l727t2444r812b2486],
33	as	IN	O	as	_	0	SENT_51	[p2l837t2456r886b2486],
34	main	JJ	O	main	amod	35	SENT_51	[p2l913t2444r1038b2486],
35	effects	NNS	O	effect	prep_as	25	SENT_51	[p2l1064t2443r1236b2492],
36	,	,	O	,	_	0	SENT_51	[p2l1064t2443r1236b2492],
37	and	CC	O	and	_	0	SENT_51	[p2l1263t2443r1354b2486],
38	baseline	NN	O	baseline	nsubjpass	6	SENT_51	[p2l1379t2443r1584b2486],
39	as	IN	O	as	_	0	SENT_51	[p2l1611t2456r1659b2486],
40	a	DT	O	a	det	41	SENT_51	[p2l1686t2456r1711b2486],
41	covariate	NN	O	covariate	prep_as	38	SENT_51	[p2l1737t2444r1975b2486],
42	.	.	O	.	_	0	SENT_51	[p2l1737t2444r1975b2486],

1	A	DT	O	a	det	3	SENT_52	[p2l1999t2445r2036b2485],
2	last	JJ	O	last	amod	3	SENT_52	[p2l2060t2443r2146b2486],
3	observations	NNS	O	observation	nsubj	4	SENT_52	[p2l53t2513r369b2556],
4	carried	VBD	O	carry	_	0	SENT_52	[p2l397t2513r569b2556],
5	forward	RB	O	forward	advmod	4	SENT_52	[p2l597t2513r794b2556],
6	(	JJ	O	(	amod	9	SENT_52	[p2l821t2513r984b2566],
7	LOCF	NN	O	locf	nn	9	SENT_52	[p2l821t2513r984b2566],
8	)	NN	O	)	nn	9	SENT_52	[p2l821t2513r984b2566],
9	approach	NN	O	approach	nsubjpass	11	SENT_52	[p2l1011t2513r1243b2567],
10	was	VBD	O	be	auxpass	11	SENT_52	[p2l1268t2526r1364b2556],
11	used	VBN	O	use	ccomp	4	SENT_52	[p2l1390t2513r1505b2556],
12	to	TO	O	to	aux	13	SENT_52	[p2l1532t2520r1580b2556],
13	account	VB	O	account	xcomp	11	SENT_52	[p2l1606t2520r1802b2556],
14	for	IN	O	for	_	0	SENT_52	[p2l1828t2513r1897b2556],
15	dropouts	NNS	O	dropout	prep_for	13	SENT_52	[p2l1922t2513r2145b2567],
16	during	IN	O	during	_	0	SENT_52	[p2l53t2583r218b2636],
17	the	DT	O	the	det	22	SENT_52	[p2l246t2583r326b2625],
18	double	JJ	O	double	amod	22	SENT_52	[p2l356t2583r678b2625],
19	—	NN	O	—	nn	22	SENT_52	[p2l356t2583r678b2625],
20	blind	JJ	O	blind	amod	22	SENT_52	[p2l356t2583r678b2625],
21	treatment	NN	O	treatment	nn	22	SENT_52	[p2l708t2589r960b2625],
22	period	NN	O	period	prep_during	13	SENT_52	[p2l988t2583r1160b2636],
23	.	.	O	.	_	0	SENT_52	[p2l988t2583r1160b2636],

1	The	DT	O	the	det	3	SENT_53	[p2l1189t2583r1280b2625],
2	statistical	JJ	O	statistical	amod	3	SENT_53	[p2l1311t2583r1546b2625],
3	analysis	NN	O	analysis	nsubjpass	15	SENT_53	[p2l1577t2583r1772b2636],
4	of	IN	O	of	_	0	SENT_53	[p2l1802t2583r1854b2625],
5	HAM-D	NN	O	ham-d	prep_of	3	SENT_53	[p2l1878t2585r2144b2625],
6	—	CD	NUMBER	—	number	7	SENT_53	[p2l1878t2585r2144b2625],
7	17	CD	NUMBER	17	num	8	SENT_53	[p2l1878t2585r2144b2625],
8	scores	NNS	O	score	npadvmod	5	SENT_53	[p2l54t2666r206b2696],
9	by	IN	O	by	_	0	SENT_53	[p2l228t2653r289b2706],
10	genotype	NN	O	genotype	prep_by	5	SENT_53	[p2l308t2659r539b2706],
11	at	IN	O	at	_	0	SENT_53	[p2l563t2659r609b2696],
12	Week	NN	DURATION	week	prep_at	10	SENT_53	[p2l629t2653r773b2696],
13	8	CD	NUMBER	8	num	12	SENT_53	[p2l795t2655r822b2696],
14	was	VBD	O	be	auxpass	15	SENT_53	[p2l845t2666r941b2696],
15	speciﬁed	VBN	O	speciﬁed	_	0	SENT_53	[p2l966t2653r1184b2706],
16	a	DT	O	a	det	17	SENT_53	[p2l1208t2666r1234b2696],
17	priori	FW	O	priori	xcomp	15	SENT_53	[p2l1254t2654r1402b2706],
18	,	,	O	,	_	0	SENT_53	[p2l1254t2654r1402b2706],
19	while	IN	O	while	mark	26	SENT_53	[p2l1424t2653r1564b2696],
20	response	NN	O	response	nn	21	SENT_53	[p2l1588t2666r1809b2706],
21	rates	NNS	O	rate	nsubjpass	26	SENT_53	[p2l1833t2659r1951b2696],
22	among	IN	O	among	_	0	SENT_53	[p2l1975t2666r2146b2706],
23	genotypes	NNS	O	genotype	prep_among	21	SENT_53	[p2l52t2729r307b2776],
24	were	VBD	O	be	auxpass	26	SENT_53	[p2l328t2735r452b2765],
25	graphically	RB	O	graphically	advmod	26	SENT_53	[p2l474t2722r752b2776],
26	analyzed	VBN	O	analyze	advcl	15	SENT_53	[p2l770t2722r991b2776],
27	post	NN	O	post	nn	28	SENT_53	[p2l1010t2722r1231b2776],
28	—	NN	O	—	dobj	26	SENT_53	[p2l1010t2722r1231b2776],
29	hoc	FW	O	hoc	amod	28	SENT_53	[p2l1010t2722r1231b2776],
30	.	.	O	.	_	0	SENT_53	[p2l1010t2722r1231b2776],

1	3	LS	NUMBER	3	_	0	SENT_54	[p2l52t2929r106b2980],
2	.	.	O	.	_	0	SENT_54	[p2l52t2929r106b2980],

1	Results	NNS	O	result	_	0	SENT_55	[p2l159t2926r393b2980],

1	Venlafaxine	NN	O	venlafaxine	nn	2	SENT_56	[p2l151t3101r521b3154],
2	treatment	NN	O	treatment	nsubj	3	SENT_56	[p2l545t3109r858b3154],
3	reduced	VBD	O	reduce	_	0	SENT_56	[p2l880t3101r1130b3154],
4	baseline	NN	O	baseline	nn	5	SENT_56	[p2l1154t3101r1409b3154],
5	HAM-D	NN	O	ham-d	iobj	3	SENT_56	[p2l1433t3103r1766b3153],
6	—	CD	NUMBER	—	number	7	SENT_56	[p2l1433t3103r1766b3153],
7	17	CD	NUMBER	17	num	9	SENT_56	[p2l1433t3103r1766b3153],
8	total	JJ	O	total	amod	9	SENT_56	[p2l1791t3101r1931b3154],
9	scores	NNS	O	score	dobj	3	SENT_56	[p2l1955t3116r2144b3154],
10	over	IN	O	over	_	0	SENT_56	[p3l54t39r191b76],
11	8	CD	DURATION	8	num	12	SENT_56	[p3l217t26r250b76],
12	weeks	NNS	NUMBER	week	prep_over	3	SENT_56	[p3l279t23r476b76],
13	of	IN	O	of	_	0	SENT_56	[p3l505t23r570b76],
14	treatment	NN	O	treatment	prep_of	12	SENT_56	[p3l591t31r905b76],
15	to	TO	O	to	_	0	SENT_56	[p3l931t31r991b76],
16	a	DT	O	a	det	18	SENT_56	[p3l1020t39r1051b76],
17	greater	JJR	O	greater	amod	18	SENT_56	[p3l1079t31r1303b90],
18	extent	NN	O	extent	prep_to	3	SENT_56	[p3l1329t31r1526b76],
19	than	IN	O	than	_	0	SENT_56	[p3l1553t23r1693b76],
20	placebo	NN	O	placebo	prep_than	18	SENT_56	[p3l1721t23r1959b90],
21	(	CD	NUMBER	(	num	20	SENT_56	[p3l1988t23r2145b89],
22	-3.6	CD	NUMBER	-3.6	num	23	SENT_56	[p3l1988t23r2145b89],
23	points	NNS	O	point	dep	20	SENT_56	[p3l54t110r261b176],
24	,	,	O	,	_	0	SENT_56	[p3l54t110r261b176],
25	p-value	NN	O	p-value	dobj	3	SENT_56	[p3l283t109r518b176],
26	of	IN	O	of	_	0	SENT_56	[p3l545t109r610b162],
27	0.0006	CD	NUMBER	0.0006	num	28	SENT_56	[p3l628t109r867b175],
28	)	NN	O	)	prep_of	25	SENT_56	[p3l628t109r867b175],
29	with	IN	O	with	_	0	SENT_56	[p3l892t109r1036b162],
30	a	DT	O	a	det	34	SENT_56	[p3l1061t125r1093b162],
31	95	CD	PERCENT	95	number	32	SENT_56	[p3l1119t112r1236b162],
32	%	NN	PERCENT	%	amod	34	SENT_56	[p3l1119t112r1236b162],
33	conﬁdence	NN	O	conﬁdence	nn	34	SENT_56	[p3l1262t109r1600b162],
34	interval	NN	O	interval	prep_with	28	SENT_56	[p3l1627t109r1864b162],
35	of	IN	O	of	_	0	SENT_56	[p3l1890t109r1955b162],
36	(	CD	NUMBER	(	num	37	SENT_56	[p3l1973t109r2144b175],
37	-5.2	CD	NUMBER	-5.2	prep_of	34	SENT_56	[p3l1973t109r2144b175],
38	,	,	O	,	_	0	SENT_56	[p3l1973t109r2144b175],
39	-1.5	CD	NUMBER	-1.5	num	40	SENT_56	[p3l55t196r219b262],
40	)	NN	O	)	appos	34	SENT_56	[p3l55t196r219b262],
41	.	.	O	.	_	0	SENT_56	[p3l55t196r219b262],

1	In	IN	O	in	_	0	SENT_57	[p3l254t199r313b248],
2	N	NN	O	n	prep_in	11	SENT_57	[p3l344t199r395b248],
3	:35	CD	NUMBER	:35	num	5	SENT_57	[p3l403t198r535b249],
4	Val/Val	JJ	O	val/val	amod	5	SENT_57	[p3l568t195r792b262],
5	subjects	NNS	O	subject	dep	2	SENT_57	[p3l827t195r1092b262],
6	,	,	O	,	_	0	SENT_57	[p3l827t195r1092b262],
7	venlafaxine	NN	O	venlafaxine	nn	9	SENT_57	[p3l1126t195r1488b249],
8	treatment	NN	O	treatment	nn	9	SENT_57	[p3l1521t203r1835b249],
9	response	NN	O	response	nsubj	11	SENT_57	[p3l1868t211r2144b262],
10	appeared	VBD	O	appear	cop	11	SENT_57	[p3l54t281r342b348],
11	larger	JJR	O	larger	_	0	SENT_57	[p3l395t281r577b348],
12	(	CD	NUMBER	(	number	13	SENT_57	[p3l628t282r783b348],
13	-5.9	CD	NUMBER	-5.9	num	14	SENT_57	[p3l628t282r783b348],
14	points	NNS	O	point	tmod	11	SENT_57	[p3l837t282r1044b348],
15	,	,	O	,	_	0	SENT_57	[p3l837t282r1044b348],
16	p-value	JJ	O	p-value	amod	17	SENT_57	[p3l1093t281r1328b348],
17	0.0013	CD	NUMBER	0.0013	appos	14	SENT_57	[p3l1381t284r1584b335],
18	versus	CC	O	versus	prep	17	SENT_57	[p3l1637t297r1837b335],
19	placebo	NN	O	placebo	dep	18	SENT_57	[p3l1890t281r2144b348],
20	,	,	O	,	_	0	SENT_57	[p3l1890t281r2144b348],
21	unadjusted	JJ	O	unadjusted	appos	14	SENT_57	[p3l54t368r402b434],
22	for	IN	O	for	_	0	SENT_57	[p3l442t368r528b421],
23	multiplicity	NN	O	multiplicity	nn	24	SENT_57	[p3l566t368r967b434],
24	)	NN	O	)	prep_for	21	SENT_57	[p3l566t368r967b434],
25	,	,	O	,	_	0	SENT_57	[p3l566t368r967b434],
26	when	WRB	O	when	advmod	45	SENT_57	[p3l1006t368r1182b421],
27	compared	VBN	O	compare	_	0	SENT_57	[p3l1221t368r1532b434],
28	to	TO	O	to	prepc_compared_to	45	SENT_57	[p3l1571t376r1631b421],
29	N	NN	O	n	pobj	45	SENT_57	[p3l1668t371r1859b421],
30	=	JJ	O	=	amod	32	SENT_57	[p3l1668t371r1859b421],
31	58	CD	NUMBER	58	tmod	30	SENT_57	[p3l1668t371r1859b421],
32	Val/Met	NN	O	val/met	nsubj	45	SENT_57	[p3l1897t368r2147b434],
33	and	CC	O	and	_	0	SENT_57	[p3l54t454r167b507],
34	N	NN	O	n	nn	38	SENT_57	[p3l205t456r395b506],
35	=	JJ	O	=	amod	38	SENT_57	[p3l205t456r395b506],
36	14	CD	NUMBER	14	num	38	SENT_57	[p3l205t456r395b506],
37	Met/Met	JJ	O	met/met	amod	38	SENT_57	[p3l435t453r707b520],
38	subjects	NNS	O	subject	conj_and	32	SENT_57	[p3l746t454r1012b520],
39	,	,	O	,	_	0	SENT_57	[p3l746t454r1012b520],
40	although	IN	O	although	mark	41	SENT_57	[p3l1053t454r1331b520],
41	with	IN	O	with	dep	32	SENT_57	[p3l1369t454r1513b507],
42	overlapping	VBG	O	overlap	amod	44	SENT_57	[p3l1554t454r1927b520],
43	conﬁdence	NN	O	conﬁdence	nn	44	SENT_57	[p3l1966t453r2144b507, p3l54t539r236b592],
44	intervals	NNS	O	interval	pobj	41	SENT_57	[p3l260t539r527b592],
45	(	VBP	O	(	dep	14	SENT_57	[p3l551t539r673b605],
46	see	VB	O	see	xcomp	45	SENT_57	[p3l551t539r673b605],
47	Supplementary	NNP	O	Supplementary	nn	48	SENT_57	[p3l698t539r1177b606],
48	Table	NNP	O	Table	dobj	46	SENT_57	[p3l1196t539r1360b592],
49	1	CD	NUMBER	1	num	50	SENT_57	[p3l1386t539r1459b605],
50	)	CD	NUMBER	)	dep	14	SENT_57	[p3l1386t539r1459b605],
51	.	.	O	.	_	0	SENT_57	[p3l1386t539r1459b605],

1	To	TO	O	to	aux	2	SENT_58	[p3l1480t542r1552b592],
2	visualize	VB	O	visualize	_	0	SENT_58	[p3l1573t539r1844b592],
3	response	NN	O	response	nn	4	SENT_58	[p3l1868t555r2144b606],
4	rate	NN	O	rate	dobj	2	SENT_58	[p3l54t633r173b678],
5	by	IN	O	by	_	0	SENT_58	[p3l199t625r275b692],
6	genotype	NN	O	genotype	prep_by	2	SENT_58	[p3l297t633r601b692],
7	,	,	O	,	_	0	SENT_58	[p3l297t633r601b692],
8	in	IN	O	in	_	0	SENT_58	[p3l630t626r688b678],
9	a	DT	O	a	det	10	SENT_58	[p3l715t641r746b678],
10	manner	NN	O	manner	prep_in	2	SENT_58	[p3l773t641r1017b678],
11	which	WDT	O	which	nsubj	13	SENT_58	[p3l1041t625r1234b678],
12	is	VBZ	O	be	cop	13	SENT_58	[p3l1261t626r1306b678],
13	independent	JJ	O	independent	rcmod	10	SENT_58	[p3l1335t625r1734b692],
14	of	IN	O	of	_	0	SENT_58	[p3l1759t625r1824b678],
15	any	DT	O	any	prep_of	13	SENT_58	[p3l1843t641r1954b692],
16	given	VBN	O	give	partmod	15	SENT_58	[p3l1977t626r2145b692],

1	286	CD	NUMBER	286	num	3	SENT_59	[p3l351t768r397b789],
2	S.C.	NNP	O	S.C.	nn	3	SENT_59	[p3l1060t768r1100b789],
3	Hopkins	NNP	O	Hopkins	_	0	SENT_59	[p3l1111t767r1209b794],
4	et	FW	O	et	nn	5	SENT_59	[p3l1220t770r1242b789],
5	al.	FW	O	al.	dep	3	SENT_59	[p3l1252t767r1277b789],
6	/	:	O	/	punct	3	SENT_59	[p3l1286t767r1298b794],
7	Psychiatry	NNP	O	Psychiatry	nn	8	SENT_59	[p3l1306t767r1430b794],
8	Research	NNP	O	Research	dep	3	SENT_59	[p3l1440t767r1546b789],
9	208	CD	NUMBER	208	number	10	SENT_59	[p3l1555t768r1601b789],
10	(	CD	NUMBER	(	num	11	SENT_59	[p3l1612t767r1689b794],
11	2013	CD	DATE	2013	dep	8	SENT_59	[p3l1612t767r1689b794],
12	)	CD	NUMBER	)	number	13	SENT_59	[p3l1612t767r1689b794],
13	285-287	CD	NUMBER	285-287	num	11	SENT_59	[p3l1698t768r1808b789],

1	100	CD	NUMBER	100	number	2	SENT_60	[p3l126t923r224b970],
2	90	CD	NUMBER	90	num	3	SENT_60	[p3l157t1045r224b1093],
3	Menlaﬂzxilieresponse	NN	O	menlaﬂzxilieresponse	_	0	SENT_60	[p3l314t994r1042b1068],

1	—	NN	O	—	_	0	SENT_61	[p3l355t1143r436b1160],
2	All	DT	O	all	det	3	SENT_61	[p3l479t1125r559b1178],
3	genotypes	NNS	O	genotype	dep	1	SENT_61	[p3l575t1133r873b1190],

1	%	NN	O	%	_	0	SENT_62	[p3l45t1237r92b1303],
2	—	CD	NUMBER	—	num	1	SENT_62	[p3l355t1235r437b1252],
3	Va	NNP	O	Va	dep	1	SENT_62	[p3l488t1215r701b1278],
4	!	.	O	!	_	0	SENT_62	[p3l488t1215r701b1278],

1	/	:	O	/	punct	2	SENT_63	[p3l488t1215r701b1278],
2	Val	NN	O	val	_	0	SENT_63	[p3l488t1215r701b1278],
3	.	.	O	.	_	0	SENT_63	[p3l75t1337r79b1338],

1	70	CD	NUMBER	70	_	0	SENT_64	[p3l157t1290r224b1337],
2	i	FW	O	i	nn	3	SENT_64	[p3l283t1313r322b1314],
3	_	FW	O	_	dep	1	SENT_64	[p3l355t1327r393b1343],
4	.	.	O	.	_	0	SENT_64	[p3l422t1327r436b1343],

1	4	CD	PERCENT	4	num	4	SENT_65	[p3l34t1306r80b1391],
2	%	NN	PERCENT	%	nn	4	SENT_65	[p3l34t1306r80b1391],
3	Val/Met	NN	O	val/met	nn	4	SENT_65	[p3l488t1306r724b1370],
4	M	NN	O	m	dep	13	SENT_65	[p3l773t1374r781b1376],
5	§	CD	NUMBER	§	dep	4	SENT_65	[p3l44t1392r80b1472],
6	50	CD	NUMBER	50	number	7	SENT_65	[p3l157t1412r224b1460],
7	—	CD	NUMBER	—	num	9	SENT_65	[p3l355t1419r436b1427],
8	Met/Met	JJ	PERCENT	met/met	quantmod	7	SENT_65	[p3l485t1394r747b1459],
9	%	NN	PERCENT	%	dep	5	SENT_65	[p3l32t1510r80b1600],
10	50	CD	NUMBER	50	num	11	SENT_65	[p3l157t1533r224b1582],
11	.2	NN	NUMBER	.2	dep	13	SENT_65	[p3l32t1602r79b1643],
12	:3	CD	NUMBER	:3	num	13	SENT_65	[p3l32t1645r80b1708],
13	40	CD	NUMBER	40	_	0	SENT_65	[p3l155t1655r224b1704],
14	5	CD	NUMBER	5	num	15	SENT_65	[p3l45t1714r80b1741],
15	E	NN	O	e	dep	13	SENT_65	[p3l45t1747r80b1827],
16	30	CD	NUMBER	30	num	17	SENT_65	[p3l157t1778r224b1826],
17	o	NN	O	o	dep	15	SENT_65	[p3l32t1833r80b1875],
18	,	,	O	,	_	0	SENT_65	[p3l265t1859r270b1860],
19	20	CD	NUMBER	20	appos	17	SENT_65	[p3l157t1900r224b1949],

1	HAM-D-17	JJ	O	ham-d-17	amod	2	SENT_66	[p3l585t2316r877b2363],
2	change	NN	O	change	_	0	SENT_66	[p3l899t2316r1103b2375],
3	from	IN	O	from	dep	2	SENT_66	[p3l1121t2316r1245b2363],
4	baseline	NN	O	baseline	pobj	3	SENT_66	[p3l1268t2316r1498b2363],
5	at	IN	O	at	dep	2	SENT_66	[p3l1518t2318r1570b2363],
6	Week	NN	DURATION	week	pobj	5	SENT_66	[p3l1586t2316r1747b2363],
7	8	CD	NUMBER	8	num	6	SENT_66	[p3l1767t2316r1798b2363],

1	Fig	NN	O	fig	_	0	SENT_67	[p3l13t2438r105b2493],
2	.	.	O	.	_	0	SENT_67	[p3l13t2438r105b2493],

1	1	LS	NUMBER	1	_	0	SENT_68	[p3l124t2441r166b2482],
2	.	.	O	.	_	0	SENT_68	[p3l124t2441r166b2482],

1	Venlafaxine	NNP	O	Venlafaxine	nn	4	SENT_69	[p3l196t2438r498b2482],
2	antidepressant	JJ	O	antidepressant	amod	4	SENT_69	[p3l521t2438r900b2493],
3	response	NN	O	response	nn	4	SENT_69	[p3l921t2451r1146b2493],
4	rates	NNS	O	rate	nsubj	8	SENT_69	[p3l1170t2445r1291b2482],
5	by	IN	O	by	_	0	SENT_69	[p3l1313t2438r1375b2493],
6	COMT	NN	O	comt	nn	7	SENT_69	[p3l1396t2440r1551b2482],
7	genotypes	NNS	O	genotype	prep_by	4	SENT_69	[p3l1568t2445r1827b2493],
8	(	VBP	O	(	_	0	SENT_69	[p3l1851t2438r2143b2492],
9	HAM-D	NN	O	ham-d	nsubj	14	SENT_69	[p3l1851t2438r2143b2492],
10	—	CD	NUMBER	—	number	11	SENT_69	[p3l1851t2438r2143b2492],
11	17	CD	NUMBER	17	num	14	SENT_69	[p3l1851t2438r2143b2492],
12	total	JJ	O	total	amod	14	SENT_69	[p3l13t2510r126b2553],
13	score	NN	NUMBER	score	nn	14	SENT_69	[p3l149t2522r279b2553],
14	change	NN	O	change	xcomp	8	SENT_69	[p3l301t2510r479b2564],
15	from	IN	O	from	_	0	SENT_69	[p3l501t2509r622b2553],
16	baseline	NN	O	baseline	nn	17	SENT_69	[p3l642t2510r882b2564],
17	)	NN	O	)	prep_from	14	SENT_69	[p3l642t2510r882b2564],
18	.	.	O	.	_	0	SENT_69	[p3l642t2510r882b2564],

1	Response	NN	O	response	nn	2	SENT_70	[p3l905t2512r1142b2564],
2	rates	NNS	O	rate	nsubjpass	4	SENT_70	[p3l1164t2516r1284b2553],
3	are	VBP	O	be	auxpass	4	SENT_70	[p3l1306t2522r1383b2553],
4	expressed	VBN	O	express	_	0	SENT_70	[p3l1404t2510r1657b2564],
5	as	IN	O	as	_	0	SENT_70	[p3l1679t2522r1728b2553],
6	a	DT	O	a	det	7	SENT_70	[p3l1750t2522r1776b2553],
7	percentage	NN	O	percentage	prep_as	4	SENT_70	[p3l1796t2516r2077b2564],
8	of	IN	O	of	_	0	SENT_70	[p3l2098t2510r2151b2553],
9	subjects	NNS	O	subject	prep_of	7	SENT_70	[p3l14t2582r217b2636],
10	(	JJ	O	(	amod	11	SENT_70	[p3l238t2582r428b2636],
11	y	NN	O	y	tmod	4	SENT_70	[p3l238t2582r428b2636],
12	—	CD	NUMBER	—	num	11	SENT_70	[p3l238t2582r428b2636],
13	axis	NN	O	axis	dep	11	SENT_70	[p3l238t2582r428b2636],
14	)	CD	NUMBER	)	num	13	SENT_70	[p3l238t2582r428b2636],
15	attaining	VBG	O	attain	xcomp	4	SENT_70	[p3l448t2583r675b2636],
16	a	DT	O	a	det	17	SENT_70	[p3l694t2595r720b2626],
17	change	NN	O	change	dobj	15	SENT_70	[p3l739t2582r918b2636],
18	from	IN	O	from	_	0	SENT_70	[p3l938t2582r1059b2626],
19	baseline	NN	O	baseline	prep_from	15	SENT_70	[p3l1077t2582r1285b2626],
20	superior	JJ	O	superior	amod	19	SENT_70	[p3l1306t2583r1518b2636],
21	or	CC	O	or	_	0	SENT_70	[p3l1536t2595r1588b2626],
22	equal	JJ	O	equal	conj_or	20	SENT_70	[p3l1605t2582r1741b2636],
23	to	TO	O	to	_	0	SENT_70	[p3l1761t2588r1809b2626],
24	the	DT	O	the	det	25	SENT_70	[p3l1828t2582r1908b2626],
25	value	NN	O	value	prep_to	15	SENT_70	[p3l1927t2582r2061b2626],
26	on	IN	O	on	_	0	SENT_70	[p3l2082t2595r2144b2626],
27	the	DT	O	the	det	28	SENT_70	[p3l13t2654r94b2697],
28	x-axis	NN	O	x-axis	prep_on	25	SENT_70	[p3l126t2655r288b2698],
29	.	.	O	.	_	0	SENT_70	[p3l126t2655r288b2698],

1	Red	NNP	O	Red	nn	2	SENT_71	[p3l324t2654r417b2697],
2	curves	NNS	O	curve	nsubj	3	SENT_71	[p3l452t2666r615b2697],
3	represent	VBP	O	represent	ccomp	15	SENT_71	[p3l650t2660r893b2708],
4	venlafaxine	NN	O	venlafaxine	nn	6	SENT_71	[p3l924t2654r1219b2697],
5	response	NN	O	response	nn	6	SENT_71	[p3l1254t2666r1480b2708],
6	rates	NNS	O	rate	dobj	3	SENT_71	[p3l1514t2660r1635b2697],
7	for	IN	O	for	_	0	SENT_71	[p3l1670t2654r1741b2697],
8	intent-to	JJ	O	intent-to	amod	11	SENT_71	[p3l1774t2655r2146b2697],
9	—	NN	O	—	nn	11	SENT_71	[p3l1774t2655r2146b2697],
10	treat	NN	O	treat	nn	11	SENT_71	[p3l1774t2655r2146b2697],
11	population	NN	O	population	prep_for	6	SENT_71	[p3l14t2726r302b2781],
12	,	,	O	,	_	0	SENT_71	[p3l14t2726r302b2781],
13	grey/black	NN	O	grey/black	nn	14	SENT_71	[p3l336t2726r601b2781],
14	curves	NNS	O	curve	nsubj	15	SENT_71	[p3l633t2739r796b2770],
15	are	VBP	O	be	_	0	SENT_71	[p3l830t2739r907b2770],
16	by	IN	O	by	_	0	SENT_71	[p3l940t2726r1001b2781],
17	COMT	NNP	O	COMT	nn	18	SENT_71	[p3l1033t2728r1188b2770],
18	genotype	NN	O	genotype	prep_by	15	SENT_71	[p3l1215t2733r1463b2781],
19	.	.	O	.	_	0	SENT_71	[p3l1215t2733r1463b2781],

1	Insets	NNS	O	inset	nsubj	5	SENT_72	[p3l1498t2729r1644b2770],
2	and	CC	O	and	_	0	SENT_72	[p3l1679t2726r1771b2770],
3	green	JJ	O	green	amod	4	SENT_72	[p3l1804t2739r1947b2781],
4	curves	NNS	O	curve	conj_and	1	SENT_72	[p3l1981t2739r2144b2770],
5	represent	VBP	O	represent	_	0	SENT_72	[p3l14t2804r257b2852],
6	placebo	NN	O	placebo	nn	7	SENT_72	[p3l298t2797r492b2852],
7	responses	NNS	O	response	dobj	5	SENT_72	[p3l535t2810r785b2852],
8	by	IN	O	by	_	0	SENT_72	[p3l828t2797r889b2852],
9	genotype	NN	O	genotype	prep_by	5	SENT_72	[p3l927t2804r1163b2852],
10	and	CC	O	and	cc	9	SENT_72	[p3l1205t2797r1297b2841],
11	overall	RB	O	overall	advmod	9	SENT_72	[p3l1341t2797r1524b2848],
12	,	,	O	,	_	0	SENT_72	[p3l1341t2797r1524b2848],
13	respectively	RB	O	respectively	advmod	5	SENT_72	[p3l1567t2797r1880b2852],
14	.	.	O	.	_	0	SENT_72	[p3l1567t2797r1880b2852],

1	Between	IN	O	between	_	0	SENT_73	[p3l1924t2800r2144b2841],
2	treatments	NNS	O	treatment	prep_between	13	SENT_73	[p3l13t2876r292b2913],
3	or	CC	O	or	_	0	SENT_73	[p3l324t2882r377b2913],
4	genotypes	NNS	O	genotype	prep_between	13	SENT_73	[p3l407t2876r679b2924],
5	,	,	O	,	_	0	SENT_73	[p3l407t2876r679b2924],
6	a	DT	O	a	det	7	SENT_73	[p3l713t2882r738b2913],
7	curve	NN	O	curve	nsubj	13	SENT_73	[p3l771t2882r909b2913],
8	that	WDT	O	that	nsubj	9	SENT_73	[p3l941t2870r1043b2913],
9	shifts	VBZ	O	shift	rcmod	7	SENT_73	[p3l1075t2870r1209b2913],
10	to	TO	O	to	_	0	SENT_73	[p3l1242t2876r1290b2913],
11	the	DT	O	the	det	12	SENT_73	[p3l1322t2870r1402b2913],
12	left	JJ	O	left	prep_to	9	SENT_73	[p3l1436t2870r1518b2913],
13	indicates	VBZ	O	indicate	_	0	SENT_73	[p3l1550t2870r1775b2913],
14	an	DT	O	a	det	16	SENT_73	[p3l1808t2882r1868b2913],
15	improved	JJ	O	improved	amod	16	SENT_73	[p3l1900t2870r2144b2924],
16	response	NN	O	response	dobj	13	SENT_73	[p3l14t2940r252b2982],
17	.	.	O	.	_	0	SENT_73	[p3l14t2940r252b2982],

1	deﬁnition	NN	O	deﬁnition	nsubjpass	16	SENT_74	[p3l14t3125r323b3179],
2	of	IN	O	of	_	0	SENT_74	[p3l357t3125r423b3179],
3	response	NN	O	response	nn	4	SENT_74	[p3l448t3141r730b3193],
4	threshold	NN	O	threshold	prep_of	1	SENT_74	[p3l764t3125r1083b3188],
5	,	,	O	,	_	0	SENT_74	[p3l764t3125r1083b3188],
6	the	DT	O	the	det	8	SENT_74	[p3l1117t3125r1217b3179],
7	cumulative	JJ	O	cumulative	amod	8	SENT_74	[p3l1252t3125r1604b3179],
8	fraction	NN	O	fraction	appos	4	SENT_74	[p3l1639t3125r1881b3179],
9	of	IN	O	of	_	0	SENT_74	[p3l1915t3125r1981b3179],
10	subjects	NNS	O	subject	prep_of	8	SENT_74	[p3l2007t3125r2143b3179, p3l7t3213r156b3280],
11	achieving	VBG	O	achieve	partmod	10	SENT_74	[p3l190t3213r495b3280],
12	a	DT	O	a	det	14	SENT_74	[p3l527t3228r559b3267],
13	given	VBN	O	give	amod	14	SENT_74	[p3l590t3213r761b3280],
14	response	NN	O	response	dobj	11	SENT_74	[p3l795t3228r1077b3280],
15	was	VBD	O	be	auxpass	16	SENT_74	[p3l1107t3228r1229b3267],
16	calculated	VBN	O	calculate	_	0	SENT_74	[p3l1263t3213r1582b3267],
17	(	CD	NUMBER	(	num	18	SENT_74	[p3l1616t3213r1746b3280],
18	Fig	NN	O	fig	dobj	16	SENT_74	[p3l1616t3213r1746b3280],
19	.	.	O	.	_	0	SENT_74	[p3l1616t3213r1746b3280],

1	1	CD	NUMBER	1	_	0	SENT_75	[p3l1779t3213r1852b3280],
2	)	NN	O	)	dep	1	SENT_75	[p3l1779t3213r1852b3280],
3	.	.	O	.	_	0	SENT_75	[p3l1779t3213r1852b3280],

1	A	DT	O	a	det	3	SENT_76	[p3l1883t3215r1930b3266],
2	larger	JJR	O	larger	amod	3	SENT_76	[p3l1960t3213r2146b3280],
3	portion	NN	O	portion	nsubj	7	SENT_76	[p3l15t3300r248b3367],
4	of	IN	O	of	_	0	SENT_76	[p3l282t3299r348b3354],
5	Val/Val	JJ	O	val/val	amod	6	SENT_76	[p3l370t3299r597b3367],
6	subjects	NNS	O	subject	prep_of	3	SENT_76	[p3l632t3300r886b3367],
7	attained	VBD	O	attain	_	0	SENT_76	[p3l921t3299r1180b3354],
8	improvements	NNS	O	improvement	dobj	7	SENT_76	[p3l1215t3300r1677b3367],
9	in	IN	O	in	_	0	SENT_76	[p3l1712t3300r1770b3353],
10	HAM-D-17	NN	O	ham-d-17	nn	11	SENT_76	[p3l1803t3302r2142b3353],
11	scores	NNS	O	score	prep_in	7	SENT_76	[p3l15t3402r208b3440],
12	by	IN	O	by	_	0	SENT_76	[p3l262t3386r339b3454],
13	Week	NN	DURATION	week	prep_by	7	SENT_76	[p3l387t3386r570b3440],
14	8	CD	NUMBER	8	num	13	SENT_76	[p3l623t3389r656b3440],
15	of	IN	O	of	_	0	SENT_76	[p3l713t3386r778b3440],
16	venlafaxine	NN	O	venlafaxine	nn	17	SENT_76	[p3l822t3386r1190b3440],
17	treatment	NN	O	treatment	prep_of	13	SENT_76	[p3l1244t3394r1564b3440],
18	than	IN	O	than	_	0	SENT_76	[p3l1615t3386r1758b3440],
19	any	DT	O	any	det	21	SENT_76	[p3l1812t3402r1924b3454],
20	other	JJ	O	other	amod	21	SENT_76	[p3l1976t3386r2146b3440],
21	genotypes	NNS	O	genotype	prep_than	17	SENT_76	[p3l13t3482r353b3541],
22	.	.	O	.	_	0	SENT_76	[p3l13t3482r353b3541],

1	For	IN	O	for	_	0	SENT_77	[p3l390t3477r491b3528],
2	example	NN	O	example	prep_for	6	SENT_77	[p3l523t3474r807b3541],
3	,	,	O	,	_	0	SENT_77	[p3l523t3474r807b3541],
4	all	DT	O	all	det	5	SENT_77	[p3l844t3474r916b3528],
5	genotypes	NNS	O	genotype	nsubj	6	SENT_77	[p3l951t3482r1275b3541],
6	responded	VBD	O	respond	_	0	SENT_77	[p3l1312t3474r1647b3541],
7	to	TO	O	to	_	0	SENT_77	[p3l1682t3482r1743b3528],
8	venlafaxine	NN	O	venlafaxine	nn	9	SENT_77	[p3l1775t3474r2143b3528],
9	treatment	NN	O	treatment	prep_to	6	SENT_77	[p3l14t3568r333b3614],
10	by	IN	O	by	_	0	SENT_77	[p3l352t3560r429b3628],
11	18	CD	NUMBER	18	num	12	SENT_77	[p3l451t3563r517b3614],
12	percentage	NN	O	percentage	prep_by	6	SENT_77	[p3l541t3561r1119b3628],
13	—	CD	NUMBER	—	num	14	SENT_77	[p3l541t3561r1119b3628],
14	points	NNS	O	point	npadvmod	15	SENT_77	[p3l541t3561r1119b3628],
15	more	RBR	O	more	advmod	6	SENT_77	[p3l1142t3576r1306b3614],
16	than	IN	O	than	_	0	SENT_77	[p3l1327t3560r1470b3614],
17	placebo	NN	O	placebo	prep_than	6	SENT_77	[p3l1491t3560r1733b3628],
18	(	CD	PERCENT	(	number	19	SENT_77	[p3l1756t3560r1901b3627],
19	46	CD	PERCENT	46	num	20	SENT_77	[p3l1756t3560r1901b3627],
20	%	NN	PERCENT	%	nsubj	53	SENT_77	[p3l1756t3560r1901b3627],
21	vs.	CC	O	vs.	prep	20	SENT_77	[p3l1920t3576r2002b3615],
22	28	CD	PERCENT	28	num	23	SENT_77	[p3l2024t3563r2144b3614],
23	%	NN	PERCENT	%	dep	21	SENT_77	[p3l2024t3563r2144b3614],
24	of	IN	O	of	_	0	SENT_77	[p3l14t3647r80b3701],
25	subjects	NNS	O	subject	prep_of	23	SENT_77	[p3l103t3647r373b3715],
26	,	,	O	,	_	0	SENT_77	[p3l103t3647r373b3715],
27	respectively	RB	O	respectively	advmod	25	SENT_77	[p3l406t3647r797b3715],
28	,	,	O	,	_	0	SENT_77	[p3l406t3647r797b3715],
29	achieved	VBN	O	achieve	partmod	25	SENT_77	[p3l829t3647r1108b3701],
30	at	IN	O	at	quantmod	33	SENT_77	[p3l1139t3655r1198b3701],
31	least	JJS	O	least	mwe	30	SENT_77	[p3l1227t3647r1373b3701],
32	a	DT	O	a	quantmod	33	SENT_77	[p3l1402t3663r1434b3701],
33	-15	CD	NUMBER	-15	num	37	SENT_77	[p3l1464t3650r1574b3701],
34	point	NN	O	point	nn	37	SENT_77	[p3l1608t3648r1775b3715],
35	HAM-D-17	NN	O	ham-d-17	nn	37	SENT_77	[p3l1803t3650r2142b3701],
36	improvement	NN	O	improvement	nn	37	SENT_77	[p3l15t3735r488b3802],
37	)	NN	O	)	dobj	29	SENT_77	[p3l15t3735r488b3802],
38	,	,	O	,	_	0	SENT_77	[p3l15t3735r488b3802],
39	while	IN	O	while	mark	42	SENT_77	[p3l512t3735r690b3789],
40	Val/Val	JJ	O	val/val	amod	41	SENT_77	[p3l713t3734r940b3802],
41	genotypes	NNS	O	genotype	nsubj	42	SENT_77	[p3l964t3743r1289b3802],
42	responded	VBD	O	respond	dep	37	SENT_77	[p3l1315t3735r1650b3802],
43	at	IN	O	at	_	0	SENT_77	[p3l1675t3743r1734b3789],
44	this	DT	O	this	det	45	SENT_77	[p3l1757t3735r1872b3789],
45	level	NN	O	level	prep_at	42	SENT_77	[p3l1898t3735r2045b3789],
46	by	IN	O	by	_	0	SENT_77	[p3l2070t3735r2146b3802],
47	an	DT	O	a	det	50	SENT_77	[p4l14t32r89b70],
48	additional	JJ	O	additional	amod	50	SENT_77	[p4l126t16r446b70],
49	26	CD	PERCENT	26	num	50	SENT_77	[p4l485t19r561b70],
50	percentage	NN	PERCENT	percentage	prep_by	42	SENT_77	[p4l600t17r1178b84],
51	—	CD	PERCENT	—	num	52	SENT_77	[p4l600t17r1178b84],
52	points	NNS	PERCENT	point	dep	50	SENT_77	[p4l600t17r1178b84],
53	(	VBP	PERCENT	(	rcmod	17	SENT_77	[p4l1218t16r1363b83],
54	65	CD	PERCENT	65	num	55	SENT_77	[p4l1218t16r1363b83],
55	%	NN	PERCENT	%	dobj	53	SENT_77	[p4l1218t16r1363b83],
56	vs.	CC	O	vs.	prep	55	SENT_77	[p4l1398t32r1480b71],
57	39	CD	PERCENT	39	num	58	SENT_77	[p4l1517t19r1638b70],
58	%	NN	PERCENT	%	dep	56	SENT_77	[p4l1517t19r1638b70],
59	for	IN	O	for	_	0	SENT_77	[p4l1677t16r1765b70],
60	Val/Val	NNP	O	Val/Val	prep_for	58	SENT_77	[p4l1798t16r2026b84],
61	vs.	CC	O	vs.	prep	60	SENT_77	[p4l2062t32r2143b71],
62	Met/Met	NNP	O	Met/Met	dep	61	SENT_77	[p4l15t103r330b171],
63	)	CD	NUMBER	)	num	62	SENT_77	[p4l15t103r330b171],
64	.	.	O	.	_	0	SENT_77	[p4l15t103r330b171],

1	The	DT	O	the	det	4	SENT_78	[p4l357t103r472b157],
2	increased	VBN	O	increase	amod	4	SENT_78	[p4l501t103r802b157],
3	response	NN	O	response	nn	4	SENT_78	[p4l831t119r1112b171],
4	rates	NNS	O	rate	nsubj	9	SENT_78	[p4l1142t111r1292b157],
5	among	IN	O	among	_	0	SENT_78	[p4l1321t119r1539b171],
6	Val/Val	JJ	O	val/val	amod	7	SENT_78	[p4l1563t103r1790b171],
7	genotypes	NNS	O	genotype	prep_among	4	SENT_78	[p4l1818t111r2143b171],
8	are	VBP	O	be	cop	9	SENT_78	[p4l14t207r109b246],
9	evident	JJ	O	evident	_	0	SENT_78	[p4l133t191r372b246],
10	as	IN	O	as	_	0	SENT_78	[p4l394t207r456b246],
11	further	JJ	O	further	amod	12	SENT_78	[p4l480t191r704b246],
12	increases	NNS	O	increase	prep_as	9	SENT_78	[p4l726t192r1015b246],
13	above	IN	O	above	_	0	SENT_78	[p4l1039t191r1223b246],
14	those	DT	O	those	prep_above	12	SENT_78	[p4l1246t191r1417b246],
15	attained	VBN	O	attain	partmod	14	SENT_78	[p4l1441t191r1700b246],
16	in	IN	O	in	_	0	SENT_78	[p4l1725t192r1784b245],
17	the	DT	O	the	det	19	SENT_78	[p4l1806t191r1906b246],
18	overall	JJ	O	overall	amod	19	SENT_78	[p4l1930t191r2144b246],
19	population	NN	O	population	prep_in	15	SENT_78	[p4l15t278r360b346],
20	by	IN	O	by	_	0	SENT_78	[p4l391t278r467b346],
21	venlafaxine	NN	O	venlafaxine	agent	15	SENT_78	[p4l495t278r863b332],
22	relative	JJ	O	relative	advmod	21	SENT_78	[p4l896t278r1131b332],
23	to	TO	O	to	_	0	SENT_78	[p4l1163t286r1223b332],
24	placebo	NN	O	placebo	prep_to	22	SENT_78	[p4l1256t278r1514b346],
25	.	.	O	.	_	0	SENT_78	[p4l1256t278r1514b346],

1	There	EX	O	there	expl	2	SENT_79	[p4l1544t278r1726b332],
2	appeared	VBD	O	appear	_	0	SENT_79	[p4l1757t278r2051b346],
3	to	TO	O	to	aux	6	SENT_79	[p4l2083t286r2144b332],
4	be	VB	O	be	cop	6	SENT_79	[p4l14t366r86b420],
5	no	DT	O	no	det	6	SENT_79	[p4l127t381r204b420],
6	effect	NN	O	effect	xcomp	2	SENT_79	[p4l244t365r419b420],
7	of	IN	O	of	_	0	SENT_79	[p4l456t365r522b420],
8	genotype	NN	O	genotype	prep_of	6	SENT_79	[p4l553t374r847b433],
9	on	IN	O	on	_	0	SENT_79	[p4l887t381r965b420],
10	the	DT	O	the	det	11	SENT_79	[p4l1004t366r1105b420],
11	placebo	NN	O	placebo	prep_on	2	SENT_79	[p4l1145t366r1387b433],
12	response	NN	O	response	nn	13	SENT_79	[p4l1429t381r1711b433],
13	rates	NNS	O	rate	nsubj	14	SENT_79	[p4l1751t374r1901b420],
14	(	VBP	O	(	rcmod	11	SENT_79	[p4l1942t366r2072b433],
15	Fig	NN	O	fig	dobj	14	SENT_79	[p4l1942t366r2072b433],
16	.	.	O	.	_	0	SENT_79	[p4l1942t366r2072b433],

1	1	CD	NUMBER	1	num	2	SENT_80	[p4l2111t369r2135b419],
2	insets	NNS	O	inset	_	0	SENT_80	[p4l15t453r238b520],
3	)	CD	NUMBER	)	dep	2	SENT_80	[p4l15t453r238b520],
4	.	.	O	.	_	0	SENT_80	[p4l15t453r238b520],

1	Likewise	RB	O	likewise	advmod	24	SENT_81	[p4l283t453r571b515],
2	,	,	O	,	_	0	SENT_81	[p4l283t453r571b515],
3	increased	VBD	O	increase	parataxis	24	SENT_81	[p4l616t453r916b507],
4	response	NN	O	response	nsubj	13	SENT_81	[p4l961t468r1243b520],
5	was	VBD	O	be	cop	6	SENT_81	[p4l1284t468r1406b507],
6	evident	JJ	O	evident	ccomp	3	SENT_81	[p4l1451t453r1690b507],
7	according	VBG	O	accord	_	0	SENT_81	[p4l1732t453r2041b520],
8	to	TO	O	to	prepc_according_to	6	SENT_81	[p4l2083t461r2144b507],
9	improved	VBN	O	improve	amod	11	SENT_81	[p4l15t539r319b607],
10	CGI-I	NN	O	cgi-i	nn	11	SENT_81	[p4l353t542r509b593],
11	scores	NNS	O	score	pobj	6	SENT_81	[p4l545t555r737b593],
12	and	CC	O	and	_	0	SENT_81	[p4l771t539r886b593],
13	corresponded	VBD	O	correspond	conj_and	6	SENT_81	[p4l921t539r1356b607],
14	with	IN	O	with	_	0	SENT_81	[p4l1389t539r1535b593],
15	decreased	VBN	O	decrease	amod	17	SENT_81	[p4l1568t539r1884b593],
16	plasma	NN	O	plasma	nn	17	SENT_81	[p4l1919t539r2144b607],
17	concentrations	NNS	O	concentration	prep_with	13	SENT_81	[p4l14t627r486b680],
18	of	IN	O	of	_	0	SENT_81	[p4l527t626r593b680],
19	norepinephrine	NN	O	norepinephrine	nn	20	SENT_81	[p4l627t626r1122b694],
20	metabolite	NN	O	metabolite	prep_of	17	SENT_81	[p4l1165t626r1506b680],
21	3,4	CD	NUMBER	3,4	num	22	SENT_81	[p4l1546t626r2143b694, p4l15t713r295b781],
22	dihydroxyphenylglycol	NN	O	dihydroxyphenylglycol	nsubj	3	SENT_81	[p4l1546t626r2143b694, p4l15t713r295b781],
23	(	CD	NUMBER	(	nsubj	24	SENT_81	[p4l324t714r449b781],
24	see	VBP	O	see	_	0	SENT_81	[p4l324t714r449b781],
25	Supplementary	NNP	O	Supplementary	nn	26	SENT_81	[p4l478t713r966b781],
26	Figs	NNP	O	Figs	dobj	24	SENT_81	[p4l993t714r1128b781],
27	.	.	O	.	_	0	SENT_81	[p4l993t714r1128b781],

1	1	CD	NUMBER	1	_	0	SENT_82	[p4l1156t716r1180b767],
2	and	CC	O	and	_	0	SENT_82	[p4l1216t713r1332b767],
3	2	CD	NUMBER	2	conj_and	1	SENT_82	[p4l1360t714r1437b781],
4	)	NN	O	)	dep	1	SENT_82	[p4l1360t714r1437b781],
5	.	.	O	.	_	0	SENT_82	[p4l1360t714r1437b781],

1	4	LS	NUMBER	4	_	0	SENT_83	[p4l12t937r68b989],
2	.	.	O	.	_	0	SENT_83	[p4l12t937r68b989],

1	Discussion	NN	O	discussion	_	0	SENT_84	[p4l122t934r478b988],

1	The	DT	O	the	det	3	SENT_85	[p4l113t1111r229b1166],
2	treatment	NN	O	treatment	nn	3	SENT_85	[p4l270t1119r590b1166],
3	response	NN	O	response	nsubj	10	SENT_85	[p4l630t1127r912b1179],
4	vs.	CC	O	vs.	prep	3	SENT_85	[p4l951t1127r1031b1166],
5	placebo	NN	O	placebo	dep	4	SENT_85	[p4l1074t1111r1317b1179],
6	in	IN	O	in	_	0	SENT_85	[p4l1359t1112r1417b1165],
7	Val/Val	JJ	O	val/val	amod	8	SENT_85	[p4l1456t1111r1683b1179],
8	subjects	NNS	O	subject	prep_in	5	SENT_85	[p4l1726t1111r1980b1179],
9	was	VBD	O	be	cop	10	SENT_85	[p4l2021t1127r2143b1166],
10	large	JJ	O	large	_	0	SENT_85	[p4l15t1198r184b1266],
11	,	,	O	,	_	0	SENT_85	[p4l15t1198r184b1266],
12	having	VBG	O	have	xcomp	10	SENT_85	[p4l239t1198r452b1266],
13	an	DT	O	a	det	15	SENT_85	[p4l504t1214r578b1252],
14	effect	NN	O	effect	nn	15	SENT_85	[p4l631t1198r806b1252],
15	size	NN	O	size	dobj	12	SENT_85	[p4l859t1199r975b1252],
16	of	IN	O	of	_	0	SENT_85	[p4l1029t1198r1095b1252],
17	approximately	RB	O	approximately	quantmod	18	SENT_85	[p4l1140t1198r1603b1266],
18	1	CD	NUMBER	1	prep_of	15	SENT_85	[p4l1658t1201r1700b1253],
19	.	.	O	.	_	0	SENT_85	[p4l1658t1201r1700b1253],

1	The	DT	O	the	det	3	SENT_86	[p4l1751t1198r1867b1252],
2	clinical	JJ	O	clinical	amod	3	SENT_86	[p4l1921t1198r2143b1252],
3	improvement	NN	O	improvement	nsubj	11	SENT_86	[p4l15t1286r449b1353],
4	in	IN	O	in	_	0	SENT_86	[p4l506t1286r564b1339],
5	Val/Val	JJ	O	val/val	amod	6	SENT_86	[p4l621t1285r848b1353],
6	genotypes	NNS	O	genotype	prep_in	3	SENT_86	[p4l906t1294r1230b1353],
7	treated	VBN	O	treat	partmod	6	SENT_86	[p4l1290t1286r1515b1340],
8	with	IN	O	with	_	0	SENT_86	[p4l1572t1285r1719b1340],
9	venlafaxine	NN	O	venlafaxine	prep_with	7	SENT_86	[p4l1775t1285r2143b1340],
10	appeared	VBD	O	appear	cop	11	SENT_86	[p4l14t1373r308b1440],
11	larger	JJR	O	larger	_	0	SENT_86	[p4l347t1373r532b1440],
12	than	IN	O	than	prep	11	SENT_86	[p4l567t1373r710b1427],
13	in	IN	O	in	pcomp	12	SENT_86	[p4l748t1373r807b1426],
14	Met/Met	NN	O	met/met	nn	15	SENT_86	[p4l845t1372r1121b1440],
15	genotypes	NNS	O	genotype	pobj	13	SENT_86	[p4l1156t1381r1497b1440],
16	,	,	O	,	_	0	SENT_86	[p4l1156t1381r1497b1440],
17	when	WRB	O	when	advmod	18	SENT_86	[p4l1534t1373r1714b1427],
18	analyzed	VBN	O	analyze	advcl	11	SENT_86	[p4l1751t1373r2031b1440],
19	by	IN	O	by	_	0	SENT_86	[p4l2070t1373r2146b1440],
20	either	CC	O	either	preconj	21	SENT_86	[p4l14t1459r202b1513],
21	HAM-D-17	NN	O	ham-d-17	prep_by	18	SENT_86	[p4l235t1461r573b1513],
22	or	CC	O	or	_	0	SENT_86	[p4l609t1475r674b1513],
23	CGI	NN	O	cgus	nn	24	SENT_86	[p4l707t1462r814b1513],
24	scales	NNS	O	scale	conj_or	21	SENT_86	[p4l850t1459r1047b1514],
25	.	.	O	.	_	0	SENT_86	[p4l850t1459r1047b1514],

1	Venlafaxine	NNP	O	Venlafaxine	nsubj	9	SENT_87	[p4l1080t1459r1472b1521],
2	,	,	O	,	_	0	SENT_87	[p4l1080t1459r1472b1521],
3	at	IN	O	at	_	0	SENT_87	[p4l1507t1467r1567b1513],
4	the	DT	O	the	det	7	SENT_87	[p4l1598t1459r1699b1513],
5	current	JJ	DATE	current	amod	7	SENT_87	[p4l1733t1467r1967b1513],
6	dose	NN	O	dose	nn	7	SENT_87	[p4l1999t1459r2143b1513],
7	level	NN	O	level	prep_at	9	SENT_87	[p4l15t1546r177b1609],
8	,	,	O	,	_	0	SENT_87	[p4l15t1546r177b1609],
9	inhibited	VBD	O	inhibit	_	0	SENT_87	[p4l214t1546r499b1600],
10	NET	NN	O	net	nn	12	SENT_87	[p4l535t1549r663b1600],
11	(	CD	NUMBER	(	num	12	SENT_87	[p4l696t1546r945b1613],
12	Takano	NNP	PERSON	Takano	dobj	9	SENT_87	[p4l696t1546r945b1613],
13	et	FW	O	et	nn	14	SENT_87	[p4l981t1554r1041b1600],
14	al.	FW	O	al.	dep	12	SENT_87	[p4l1075t1546r1158b1608],
15	,	,	O	,	_	0	SENT_87	[p4l1075t1546r1158b1608],
16	2013	CD	DATE	2013	num	17	SENT_87	[p4l1195t1546r1370b1613],
17	)	NN	O	)	appos	14	SENT_87	[p4l1195t1546r1370b1613],
18	and	CC	O	and	_	0	SENT_87	[p4l1406t1546r1522b1600],
19	decreased	VBD	O	decrease	conj_and	9	SENT_87	[p4l1558t1546r1874b1600],
20	norepinephrine	NN	O	norepinephrine	nn	22	SENT_87	[p4l1911t1547r2143b1614, p4l15t1633r301b1701],
21	metabolite	NN	O	metabolite	nn	22	SENT_87	[p4l342t1633r682b1688],
22	DHPG	NN	O	dhpg	dobj	19	SENT_87	[p4l723t1636r923b1688],
23	.	.	O	.	_	0	SENT_87	[p4l723t1636r923b1688],

1	Higher	JJR	O	higher	amod	3	SENT_88	[p4l964t1633r1180b1701],
2	COMT	NN	O	comt	nn	3	SENT_88	[p4l1218t1636r1411b1688],
3	activity	NN	O	activity	nsubj	12	SENT_88	[p4l1444t1634r1679b1701],
4	(	CD	NUMBER	(	num	6	SENT_88	[p4l1716t1633r1967b1701],
5	Val/Val	JJ	O	val/val	amod	6	SENT_88	[p4l1716t1633r1967b1701],
6	subjects	NNS	O	subject	dep	3	SENT_88	[p4l2007t1633r2142b1688, p4l7t1720r182b1788],
7	)	JJ	O	)	amod	3	SENT_88	[p4l2007t1633r2142b1688, p4l7t1720r182b1788],
8	during	IN	O	during	_	0	SENT_88	[p4l248t1720r458b1788],
9	NET	NN	O	net	nn	10	SENT_88	[p4l523t1724r650b1774],
10	inhibition	NN	O	inhibition	prep_during	7	SENT_88	[p4l714t1720r1024b1774],
11	may	MD	O	may	aux	12	SENT_88	[p4l1090t1736r1225b1788],
12	correspond	VB	O	correspond	_	0	SENT_88	[p4l1287t1720r1643b1788],
13	with	IN	O	with	_	0	SENT_88	[p4l1708t1720r1854b1774],
14	greater	JJR	O	greater	amod	16	SENT_88	[p4l1918t1728r2146b1788],
15	metabolic	JJ	O	metabolic	amod	16	SENT_88	[p4l15t1808r327b1862],
16	ﬂux	NN	O	ﬂux	prep_with	12	SENT_88	[p4l358t1807r479b1862],
17	of	IN	O	of	_	0	SENT_88	[p4l506t1807r572b1862],
18	norepinephrine	NN	O	norepinephrine	prep_of	16	SENT_88	[p4l596t1808r1091b1875],
19	or	CC	O	or	_	0	SENT_88	[p4l1123t1823r1189b1862],
20	dopamine	NN	O	dopamine	prep_of	16	SENT_88	[p4l1218t1808r1536b1875],
21	via	IN	O	via	_	0	SENT_88	[p4l1566t1808r1658b1862],
22	a	DT	O	a	det	24	SENT_88	[p4l1689t1823r1721b1862],
23	COMT	NN	O	comt	nn	24	SENT_88	[p4l1752t1810r1945b1862],
24	pathway	NN	O	pathway	prep_via	12	SENT_88	[p4l1974t1808r2143b1875, p4l13t1910r154b1962],
25	,	,	O	,	_	0	SENT_88	[p4l1974t1808r2143b1875, p4l13t1910r154b1962],
26	possibly	RB	O	possibly	advmod	27	SENT_88	[p4l184t1895r443b1962],
27	allowing	VBG	O	allow	xcomp	12	SENT_88	[p4l468t1894r741b1962],
28	for	IN	O	for	_	0	SENT_88	[p4l769t1894r857b1949],
29	greater	JJR	O	greater	amod	30	SENT_88	[p4l882t1903r1110b1962],
30	regulation	NN	O	regulation	prep_for	27	SENT_88	[p4l1137t1895r1461b1962],
31	of	IN	O	of	_	0	SENT_88	[p4l1489t1894r1555b1949],
32	emotional	JJ	O	emotional	amod	33	SENT_88	[p4l1575t1895r1896b1949],
33	states	NNS	O	state	prep_of	30	SENT_88	[p4l1925t1903r2120b1949],
34	.	.	O	.	_	0	SENT_88	[p4l1925t1903r2120b1949],

1	The	DT	O	the	det	2	SENT_89	[p4l113t1981r229b2035],
2	power	NN	O	power	nsubj	12	SENT_89	[p4l273t1997r476b2049],
3	of	IN	O	of	_	0	SENT_89	[p4l516t1981r582b2035],
4	trials	NNS	O	trial	prep_of	2	SENT_89	[p4l617t1981r774b2035],
5	seeking	VBG	O	seek	partmod	4	SENT_89	[p4l819t1981r1059b2049],
6	to	TO	O	to	_	0	SENT_89	[p4l1101t1989r1161b2035],
7	separate	JJ	O	separate	amod	8	SENT_89	[p4l1205t1989r1470b2049],
8	responses	NNS	O	response	prep_to	5	SENT_89	[p4l1514t1997r1826b2049],
9	between	IN	O	between	_	0	SENT_89	[p4l1869t1981r2144b2035],
10	COMT	NNP	O	COMT	nn	11	SENT_89	[p4l15t2072r208b2123],
11	genotypes	NNS	O	genotype	prep_between	8	SENT_89	[p4l226t2077r551b2136],
12	depends	VBZ	O	depend	_	0	SENT_89	[p4l578t2069r845b2136],
13	on	IN	O	on	_	0	SENT_89	[p4l872t2084r950b2123],
14	the	DT	O	the	det	16	SENT_89	[p4l975t2069r1076b2123],
15	allele	NN	O	allele	nn	16	SENT_89	[p4l1103t2069r1269b2123],
16	frequencies	NNS	O	frequency	prep_on	12	SENT_89	[p4l1296t2069r1659b2136],
17	of	IN	O	of	_	0	SENT_89	[p4l1687t2069r1752b2123],
18	the	DT	O	the	det	19	SENT_89	[p4l1770t2069r1871b2123],
19	populations	NNS	O	population	prep_of	16	SENT_89	[p4l1898t2069r2142b2136, p4l14t2156r168b2209],
20	studied	VBN	O	study	partmod	19	SENT_89	[p4l192t2155r441b2218],
21	,	,	O	,	_	0	SENT_89	[p4l192t2155r441b2218],
22	and	CC	O	and	_	0	SENT_89	[p4l464t2155r579b2209],
23	the	DT	O	the	det	25	SENT_89	[p4l602t2155r703b2209],
24	gene-dosing	JJ	O	gene-dosing	amod	25	SENT_89	[p4l724t2155r1118b2223],
25	model	NN	O	model	nsubj	26	SENT_89	[p4l1139t2155r1336b2209],
26	assumed	VBD	O	assume	conj_and	12	SENT_89	[p4l1359t2155r1652b2210],
27	.	.	O	.	_	0	SENT_89	[p4l1359t2155r1652b2210],

1	This	DT	O	this	det	2	SENT_90	[p4l1673t2155r1803b2209],
2	study	NN	O	study	nsubjpass	4	SENT_90	[p4l1827t2155r2002b2223],
3	was	VBD	O	be	auxpass	4	SENT_90	[p4l2021t2171r2143b2209],
4	enriched	VBN	O	enrich	dep	9	SENT_90	[p4l14t2243r291b2297],
5	with	IN	O	with	_	0	SENT_90	[p4l321t2243r467b2297],
6	homozygous	JJ	O	homozygous	amod	8	SENT_90	[p4l498t2243r900b2310],
7	Val/Val	JJ	O	val/val	amod	8	SENT_90	[p4l929t2242r1156b2310],
8	genotypes	NNS	O	genotype	prep_with	4	SENT_90	[p4l1186t2251r1511b2310],
9	(	VBP	O	(	_	0	SENT_90	[p4l1542t2243r1712b2310],
10	33	CD	PERCENT	33	num	11	SENT_90	[p4l1542t2243r1712b2310],
11	%	NN	PERCENT	%	dobj	9	SENT_90	[p4l1542t2243r1712b2310],
12	)	CD	NUMBER	)	npadvmod	13	SENT_90	[p4l1542t2243r1712b2310],
13	by	IN	O	by	advmod	11	SENT_90	[p4l1742t2243r1819b2310],
14	including	VBG	O	include	_	0	SENT_90	[p4l1847t2243r2144b2310],
15	subjects	NNS	O	subject	prep_including	11	SENT_90	[p4l15t2330r269b2397],
16	with	IN	O	with	_	0	SENT_90	[p4l306t2330r452b2384],
17	African	JJ	MISC	african	amod	19	SENT_90	[p4l486t2329r714b2384],
18	ancestry	NN	O	ancestry	nn	19	SENT_90	[p4l750t2338r1019b2397],
19	(	NN	O	(	prep_with	15	SENT_90	[p4l1054t2330r1200b2397],
20	25	CD	PERCENT	25	num	21	SENT_90	[p4l1054t2330r1200b2397],
21	%	NN	PERCENT	%	nsubj	9	SENT_90	[p4l1054t2330r1200b2397],
22	of	IN	O	of	_	0	SENT_90	[p4l1237t2329r1303b2384],
23	trial	NN	O	trial	nn	24	SENT_90	[p4l1332t2330r1484b2397],
24	)	NN	O	)	prep_of	21	SENT_90	[p4l1332t2330r1484b2397],
25	relative	JJ	O	relative	advmod	24	SENT_90	[p4l1522t2330r1758b2384],
26	to	TO	O	to	_	0	SENT_90	[p4l1794t2338r1855b2384],
27	trials	NNS	O	trial	prep_to	25	SENT_90	[p4l1891t2330r2048b2384],
28	of	IN	O	of	_	0	SENT_90	[p4l2086t2329r2152b2384],
29	mainly	RB	O	mainly	advmod	31	SENT_90	[p4l15t2416r234b2484],
30	European	JJ	MISC	european	amod	31	SENT_90	[p4l272t2419r573b2484],
31	ancestry	NN	O	ancestry	prep_of	27	SENT_90	[p4l613t2424r892b2484],
32	.	.	O	.	_	0	SENT_90	[p4l613t2424r892b2484],

1	Forty-eight	CD	PERCENT	forty-eight	num	2	SENT_91	[p4l933t2416r1288b2484],
2	percent	NN	PERCENT	percent	nsubj	10	SENT_91	[p4l1327t2424r1568b2484],
3	of	IN	O	of	_	0	SENT_91	[p4l1605t2416r1671b2470],
4	subjects	NNS	O	subject	prep_of	2	SENT_91	[p4l1704t2416r1958b2484],
5	with	IN	O	with	_	0	SENT_91	[p4l1997t2416r2144b2470],
6	African	JJ	MISC	african	amod	7	SENT_91	[p4l12t2503r240b2557],
7	ancestry	NN	O	ancestry	prep_with	4	SENT_91	[p4l264t2511r533b2571],
8	were	VBD	O	be	cop	10	SENT_91	[p4l555t2519r712b2557],
9	Val/Val	JJ	O	val/val	amod	10	SENT_91	[p4l735t2503r962b2571],
10	genotypes	NNS	O	genotype	dep	24	SENT_91	[p4l987t2511r1327b2571],
11	,	,	O	,	_	0	SENT_91	[p4l987t2511r1327b2571],
12	compared	VBN	O	compare	_	0	SENT_91	[p4l1353t2503r1670b2571],
13	with	IN	O	with	prepc_compared_with	10	SENT_91	[p4l1694t2503r1840b2557],
14	only	RB	O	only	quantmod	15	SENT_91	[p4l1865t2503r2003b2571],
15	27	CD	PERCENT	27	num	16	SENT_91	[p4l2025t2506r2144b2557],
16	%	NN	PERCENT	%	pobj	10	SENT_91	[p4l2025t2506r2144b2557],
17	of	IN	O	of	_	0	SENT_91	[p4l14t2590r80b2645],
18	study	NN	O	study	nn	19	SENT_91	[p4l125t2590r300b2658],
19	subjects	NNS	O	subject	prep_of	16	SENT_91	[p4l350t2590r604b2658],
20	with	IN	O	with	_	0	SENT_91	[p4l655t2590r801b2644],
21	European	JJ	MISC	european	amod	23	SENT_91	[p4l853t2594r1155b2658],
22	ancestry	NN	O	ancestry	nn	23	SENT_91	[p4l1206t2598r1475b2658],
23	(	NN	O	(	prep_with	19	SENT_91	[p4l1525t2591r1650b2658],
24	see	VBP	O	see	_	0	SENT_91	[p4l1525t2591r1650b2658],
25	Supplemental	NNP	O	Supplemental	nn	26	SENT_91	[p4l1703t2590r2143b2658],
26	Table	NNP	O	Table	dobj	24	SENT_91	[p4l12t2677r178b2731],
27	2	CD	NUMBER	2	num	26	SENT_91	[p4l207t2677r283b2744],
28	)	CD	NUMBER	)	nsubj	24	SENT_91	[p4l207t2677r283b2744],
29	.	.	O	.	_	0	SENT_91	[p4l207t2677r283b2744],

1	Other	JJ	O	other	amod	2	SENT_92	[p4l116t2764r297b2818],
2	studies	NNS	O	study	nsubj	4	SENT_92	[p4l327t2764r548b2818],
3	have	VBP	O	have	aux	4	SENT_92	[p4l580t2764r726b2818],
4	investigated	VBN	O	investigate	_	0	SENT_92	[p4l757t2764r1143b2832],
5	COMT	NNP	ORGANIZATION	COMT	nn	6	SENT_92	[p4l1174t2767r1368b2818],
6	genotypes	NNS	O	genotype	dobj	4	SENT_92	[p4l1390t2772r1715b2832],
7	according	VBG	O	accord	_	0	SENT_92	[p4l1746t2764r2054b2832],
8	to	TO	O	to	prepc_according_to	4	SENT_92	[p4l2083t2772r2144b2818],
9	antidepressant	JJ	O	antidepressant	amod	10	SENT_92	[p4l15t2851r487b2919],
10	response	NN	O	response	pobj	4	SENT_92	[p4l519t2867r816b2919],
11	,	,	O	,	_	0	SENT_92	[p4l519t2867r816b2919],
12	but	CC	O	but	_	0	SENT_92	[p4l848t2851r954b2905],
13	the	DT	O	the	det	14	SENT_92	[p4l984t2851r1084b2905],
14	results	NNS	O	result	nsubj	15	SENT_92	[p4l1118t2851r1327b2905],
15	appear	VBP	O	appear	conj_but	4	SENT_92	[p4l1359t2867r1578b2919],
16	to	TO	O	to	aux	17	SENT_92	[p4l1607t2859r1668b2905],
17	vary	VB	O	vary	xcomp	15	SENT_92	[p4l1698t2867r1836b2919],
18	with	IN	O	with	_	0	SENT_92	[p4l1865t2851r2011b2905],
19	the	DT	O	the	det	20	SENT_92	[p4l2043t2851r2144b2905],
20	antidepressant	JJ	O	antidepressant	prep_with	17	SENT_92	[p4l15t2939r487b3006],
21	investigated	VBN	O	investigate	partmod	20	SENT_92	[p4l518t2939r904b3006],
22	(	NN	O	(	nn	23	SENT_92	[p4l936t2939r1232b3006],
23	Kocabas	NNS	PERSON	kocaba	dobj	21	SENT_92	[p4l936t2939r1232b3006],
24	,	,	O	,	_	0	SENT_92	[p4l936t2939r1232b3006],
25	2012	CD	DATE	2012	num	26	SENT_92	[p4l1265t2939r1458b3006],
26	)	NN	O	)	appos	23	SENT_92	[p4l1265t2939r1458b3006],
27	.	.	O	.	_	0	SENT_92	[p4l1265t2939r1458b3006],

1	venlafaxine	NN	O	venlafaxine	nsubj	2	SENT_93	[p4l1488t2938r1865b2993],
2	appears	VBZ	O	appear	dep	32	SENT_93	[p4l1897t2954r2143b3006],
3	in	IN	O	in	_	0	SENT_93	[p4l15t3026r74b3079],
4	some	DT	O	some	prep_in	2	SENT_93	[p4l123t3041r289b3080],
5	of	IN	O	of	_	0	SENT_93	[p4l339t3025r405b3080],
6	the	DT	O	the	det	7	SENT_93	[p4l446t3026r546b3080],
7	genome	NN	O	genome	prep_of	4	SENT_93	[p4l595t3026r1036b3093],
8	—	CD	NUMBER	—	num	11	SENT_93	[p4l595t3026r1036b3093],
9	wide	JJ	O	wide	amod	11	SENT_93	[p4l595t3026r1036b3093],
10	association	NN	O	association	nn	11	SENT_93	[p4l1086t3026r1436b3080],
11	analyses	NNS	O	analysis	nsubj	12	SENT_93	[p4l1486t3026r1750b3093],
12	applied	VBD	O	apply	rcmod	7	SENT_93	[p4l1800t3026r2034b3093],
13	to	TO	O	to	_	0	SENT_93	[p4l2084t3034r2144b3080],
14	STAR	NN	O	star	nn	17	SENT_93	[p4l15t3109r251b3166],
15	*	NN	O	*	nn	17	SENT_93	[p4l15t3109r251b3166],
16	D	NN	O	d	nn	17	SENT_93	[p4l15t3109r251b3166],
17	study	NN	O	study	prep_to	12	SENT_93	[p4l305t3112r490b3180],
18	,	,	O	,	_	0	SENT_93	[p4l305t3112r490b3180],
19	however	RB	O	however	advmod	12	SENT_93	[p4l544t3112r831b3175],
20	,	,	O	,	_	0	SENT_93	[p4l544t3112r831b3175],
21	the	DT	O	the	det	24	SENT_93	[p4l884t3112r984b3166],
22	Val158Met	NN	O	val158met	nn	24	SENT_93	[p4l1035t3112r1382b3166],
23	COMT	NN	O	comt	nn	24	SENT_93	[p4l1433t3115r1626b3166],
24	polymorphism	NN	O	polymorphism	nsubjpass	27	SENT_93	[p4l1676t3112r2145b3180],
25	was	VBD	O	be	auxpass	27	SENT_93	[p4l13t3215r135b3253],
26	not	RB	O	not	neg	27	SENT_93	[p4l167t3207r271b3253],
27	included	VBN	O	include	ccomp	12	SENT_93	[p4l300t3199r572b3253],
28	in	IN	O	in	_	0	SENT_93	[p4l605t3200r663b3253],
29	the	DT	O	the	det	31	SENT_93	[p4l693t3199r793b3253],
30	probe	NN	O	probe	nn	31	SENT_93	[p4l825t3199r1007b3267],
31	set	NN	O	set	prep_in	27	SENT_93	[p4l1038t3207r1127b3253],
32	used	VBD	O	use	_	0	SENT_93	[p4l1156t3199r1302b3253],
33	(	CD	NUMBER	(	num	34	SENT_93	[p4l1333t3199r1631b3266],
34	Garriock	NNP	O	Garriock	dobj	32	SENT_93	[p4l1333t3199r1631b3266],
35	et	FW	O	et	nn	36	SENT_93	[p4l1659t3207r1719b3253],
36	al.	FW	O	al.	nsubj	32	SENT_93	[p4l1747t3199r1831b3261],
37	,	,	O	,	_	0	SENT_93	[p4l1747t3199r1831b3261],
38	2010	CD	DATE	2010	num	39	SENT_93	[p4l1862t3199r2053b3266],
39	)	NN	O	)	appos	36	SENT_93	[p4l1862t3199r2053b3266],
40	.	.	O	.	_	0	SENT_93	[p4l1862t3199r2053b3266],

1	In	IN	O	in	_	0	SENT_94	[p4l2085t3202r2144b3253],
2	a	DT	O	a	det	3	SENT_94	[p4l15t3302r47b3340],
3	study	NN	O	study	prep_in	10	SENT_94	[p4l99t3286r273b3354],
4	with	IN	O	with	_	0	SENT_94	[p4l321t3286r467b3340],
5	the	DT	O	the	det	7	SENT_94	[p4l519t3286r619b3341],
6	SNRI	NNP	MISC	SNRI	nn	7	SENT_94	[p4l672t3289r819b3341],
7	duloxetine	NN	O	duloxetine	prep_with	3	SENT_94	[p4l871t3286r1223b3349],
8	,	,	O	,	_	0	SENT_94	[p4l871t3286r1223b3349],
9	there	EX	O	there	expl	10	SENT_94	[p4l1276t3286r1440b3341],
10	was	VBD	O	be	_	0	SENT_94	[p4l1490t3302r1612b3341],
11	no	DT	O	no	det	12	SENT_94	[p4l1665t3302r1741b3341],
12	association	NN	O	association	nsubj	10	SENT_94	[p4l1794t3287r2144b3341],
13	between	IN	O	between	_	0	SENT_94	[p4l14t3373r289b3427],
14	Val158Met	NN	O	val158met	nn	15	SENT_94	[p4l337t3373r684b3427],
15	genotype	NN	O	genotype	prep_between	12	SENT_94	[p4l732t3381r1026b3441],
16	and	CC	O	and	_	0	SENT_94	[p4l1078t3373r1193b3427],
17	treatment	NN	O	treatment	conj_and	12	SENT_94	[p4l1245t3381r1564b3427],
18	response	NN	O	response	nn	20	SENT_94	[p4l1614t3389r1895b3441],
19	(	CD	NUMBER	(	num	20	SENT_94	[p4l1947t3373r2144b3441],
20	Perlis	NNP	PERSON	Perlis	dep	17	SENT_94	[p4l1947t3373r2144b3441],
21	et	FW	O	et	nn	22	SENT_94	[p4l15t3469r74b3515],
22	al.	FW	O	al.	dep	20	SENT_94	[p4l118t3461r202b3523],
23	,	,	O	,	_	0	SENT_94	[p4l118t3461r202b3523],
24	2009	CD	DATE	2009	num	25	SENT_94	[p4l249t3461r449b3528],
25	)	NN	O	)	appos	20	SENT_94	[p4l249t3461r449b3528],
26	,	,	O	,	_	0	SENT_94	[p4l249t3461r449b3528],
27	although	IN	O	although	mark	32	SENT_94	[p4l496t3461r779b3528],
28	other	JJ	O	other	amod	30	SENT_94	[p4l825t3461r995b3515],
29	COMT	NNP	MISC	COMT	nn	30	SENT_94	[p4l1039t3463r1232b3515],
30	SNPs	NNS	MISC	snp	nsubj	32	SENT_94	[p4l1276t3463r1429b3515],
31	did	VBD	O	do	aux	32	SENT_94	[p4l1476t3461r1574b3515],
32	demonstrate	VB	O	demonstrate	advcl	10	SENT_94	[p4l1621t3461r2024b3515],
33	an	DT	O	a	det	34	SENT_94	[p4l2070t3476r2144b3515],
34	association	NN	O	association	dobj	32	SENT_94	[p4l15t3548r365b3602],
35	with	IN	O	with	_	0	SENT_94	[p4l389t3548r536b3602],
36	HAM-D-17	NN	O	ham-d-17	nn	37	SENT_94	[p4l565t3550r903b3601],
37	improvements	NNS	O	improvement	prep_with	32	SENT_94	[p4l933t3548r1411b3615],
38	.	.	O	.	_	0	SENT_94	[p4l933t3548r1411b3615],

1	In	IN	O	in	_	0	SENT_95	[p4l117t3637r176b3688],
2	addition	NN	O	addition	_	0	SENT_95	[p4l213t3634r477b3688],
3	to	TO	O	to	_	0	SENT_95	[p4l515t3642r574b3688],
4	ongoing	JJ	O	ongoing	amod	6	SENT_95	[p4l613t3635r870b3702],
5	scientiﬁc	NN	O	scientiﬁc	nn	6	SENT_95	[p4l907t3634r1189b3688],
6	ﬁndings	NNS	O	ﬁndings	prep_in_addition_to	7	SENT_95	[p4l1226t3634r1480b3702],
7	(	VBP	O	(	_	0	SENT_95	[p4l1518t3634r1750b3701],
8	Licinio	NNP	PERSON	Licinio	dobj	7	SENT_95	[p4l1518t3634r1750b3701],
9	and	CC	O	and	_	0	SENT_95	[p4l1788t3634r1903b3688],
10	Wong	NNP	PERSON	Wong	dobj	7	SENT_95	[p4l1939t3637r2143b3702],
11	,	,	O	,	_	0	SENT_95	[p4l1939t3637r2143b3702],
12	2011	CD	DATE	2011	num	13	SENT_95	[p4l15t3721r188b3788],
13	)	NN	O	)	dobj	7	SENT_95	[p4l15t3721r188b3788],
14	and	CC	O	and	_	0	SENT_95	[p4l222t3721r338b3775],
15	payer	NN	O	payer	nn	16	SENT_95	[p4l373t3737r550b3789],
16	interest	NN	O	interest	dobj	7	SENT_95	[p4l583t3722r826b3775],
17	(	CD	NUMBER	(	num	18	SENT_95	[p4l859t3721r1118b3789],
18	Epstein	NN	PERSON	epstein	dep	16	SENT_95	[p4l859t3721r1118b3789],
19	et	FW	O	et	nn	20	SENT_95	[p4l1152t3729r1211b3775],
20	al.	FW	O	al.	nsubj	7	SENT_95	[p4l1244t3721r1327b3784],
21	,	,	O	,	_	0	SENT_95	[p4l1244t3721r1327b3784],
22	2009	CD	DATE	2009	num	23	SENT_95	[p4l1363t3721r1563b3788],
23	)	NN	O	)	appos	20	SENT_95	[p4l1363t3721r1563b3788],
24	,	,	O	,	_	0	SENT_95	[p4l1363t3721r1563b3788],
25	meaningful	JJ	O	meaningful	amod	26	SENT_95	[p4l1599t3721r1960b3789],
26	integration	NN	O	integration	appos	23	SENT_95	[p4l1996t3722r2143b3775, p5l14t17r241b84],

1	of	IN	O	of	amod	3	SENT_96	[p5l268t16r334b70],
2	pharmacogenomic	JJ	O	pharmacogenomic	amod	3	SENT_96	[p5l353t16r946b84],
3	discoveries	NNS	O	discovery	nsubj	9	SENT_96	[p5l972t16r1323b71],
4	into	IN	O	into	_	0	SENT_96	[p5l1351t17r1474b70],
5	clinical	JJ	O	clinical	amod	6	SENT_96	[p5l1501t16r1723b71],
6	practice	NN	O	practice	prep_into	3	SENT_96	[p5l1750t17r2000b84],
7	will	MD	O	will	aux	9	SENT_96	[p5l2025t16r2144b70],
8	ultimately	RB	O	ultimately	advmod	9	SENT_96	[p5l15t103r342b171],
9	require	VB	O	require	_	0	SENT_96	[p5l372t104r598b171],
10	regulatory	JJ	O	regulatory	amod	11	SENT_96	[p5l630t103r960b171],
11	approval	NN	O	approval	dobj	9	SENT_96	[p5l988t103r1263b171],
12	of	IN	O	of	_	0	SENT_96	[p5l1295t103r1361b157],
13	speciﬁc	NN	O	speciﬁc	nn	14	SENT_96	[p5l1386t103r1621b171],
14	claims	NNS	O	claim	prep_of	11	SENT_96	[p5l1652t103r1852b157],
15	on	IN	O	on	_	0	SENT_96	[p5l1885t119r1963b157],
16	individual	JJ	O	individual	amod	17	SENT_96	[p5l1995t103r2143b157, p5l13t190r209b245],
17	drugs	NNS	O	drug	prep_on	9	SENT_96	[p5l237t191r429b258],
18	.	.	O	.	_	0	SENT_96	[p5l237t191r429b258],

1	The	DT	O	the	det	2	SENT_97	[p5l456t191r572b245],
2	hypothesis	NN	O	hypothesis	nsubj	12	SENT_97	[p5l601t190r941b258],
3	of	IN	O	of	_	0	SENT_97	[p5l971t190r1036b245],
4	superior	JJ	O	superior	amod	5	SENT_97	[p5l1057t191r1323b258],
5	responses	NNS	O	response	prep_of	2	SENT_97	[p5l1349t206r1662b258],
6	to	TO	O	to	_	0	SENT_97	[p5l1690t199r1750b245],
7	venlafaxine	NN	O	venlafaxine	prep_to	5	SENT_97	[p5l1776t190r2144b245],
8	in	IN	O	in	_	0	SENT_97	[p5l15t278r74b331],
9	Val/Val	JJ	O	val/val	amod	11	SENT_97	[p5l104t277r331b345],
10	COMT	NN	O	comt	nn	11	SENT_97	[p5l365t280r559b332],
11	genotypes	NNS	O	genotype	prep_in	7	SENT_97	[p5l583t286r908b345],
12	presents	VBZ	O	present	_	0	SENT_97	[p5l942t286r1210b345],
13	a	DT	O	a	dep	14	SENT_97	[p5l1244t293r1276b332],
14	feasible	JJ	O	feasible	acomp	12	SENT_97	[p5l1309t277r1547b332],
15	a	DT	O	a	det	17	SENT_97	[p5l1581t293r1614b332],
16	priori	FW	O	priori	nn	17	SENT_97	[p5l1642t279r1815b345],
17	test	NN	O	test	dep	14	SENT_97	[p5l1847t286r1963b332],
18	for	IN	O	for	_	0	SENT_97	[p5l1995t277r2083b332],
19	a	DT	O	a	det	22	SENT_97	[p5l2112t293r2145b332],
20	directed	VBN	O	direct	amod	22	SENT_97	[p5l15t364r272b418],
21	clinical	JJ	O	clinical	amod	22	SENT_97	[p5l298t364r519b418],
22	study	NN	O	study	prep_for	17	SENT_97	[p5l545t364r730b432],
23	.	.	O	.	_	0	SENT_97	[p5l545t364r730b432],

1	In	IN	O	in	_	0	SENT_98	[p5l756t367r815b418],
2	a	DT	O	a	det	4	SENT_98	[p5l839t380r871b418],
3	proof-of-concept	JJ	O	proof-of-concept	amod	4	SENT_98	[p5l895t364r1435b432],
4	design	NN	O	design	prep_in	25	SENT_98	[p5l1457t364r1678b432],
5	,	,	O	,	_	0	SENT_98	[p5l1457t364r1678b432],
6	and	CC	O	and	_	0	SENT_98	[p5l1703t364r1819b418],
7	assuming	VBG	O	assume	prep_in	25	SENT_98	[p5l1843t365r2145b432],
8	a	DT	O	a	det	10	SENT_98	[p5l15t468r47b506],
9	standard	JJ	O	standard	amod	10	SENT_98	[p5l71t452r348b506],
10	deviation	NN	O	deviation	dobj	7	SENT_98	[p5l372t452r668b506],
11	of	IN	O	of	_	0	SENT_98	[p5l692t452r758b506],
12	7	CD	NUMBER	7	num	13	SENT_98	[p5l775t455r808b505],
13	points	NNS	O	point	prep_of	10	SENT_98	[p5l834t453r1045b519],
14	,	,	O	,	_	0	SENT_98	[p5l834t453r1045b519],
15	87	CD	NUMBER	87	num	16	SENT_98	[p5l1071t455r1145b506],
16	subjects	NNS	O	subject	nsubj	25	SENT_98	[p5l1171t452r1425b519],
17	per	IN	O	per	_	0	SENT_98	[p5l1450t467r1555b519],
18	genotype	NN	O	genotype	nn	20	SENT_98	[p5l1575t460r1869b519],
19	(	CD	NUMBER	(	num	20	SENT_98	[p5l1893t452r2144b519],
20	Val/Val	NN	O	val/val	prep_per	16	SENT_98	[p5l1893t452r2144b519],
21	vs.	CC	O	vs.	prep	20	SENT_98	[p5l13t554r94b593],
22	Met/Met	NN	O	met/met	nn	23	SENT_98	[p5l130t538r430b606],
23	)	NN	O	)	dep	21	SENT_98	[p5l130t538r430b606],
24	would	MD	O	would	aux	25	SENT_98	[p5l464t538r664b592],
25	have	VB	O	have	_	0	SENT_98	[p5l700t538r847b592],
26	approximately	RB	O	approximately	advmod	29	SENT_98	[p5l882t538r1345b606],
27	80	CD	PERCENT	80	number	28	SENT_98	[p5l1379t541r1498b592],
28	%	NN	PERCENT	%	amod	29	SENT_98	[p5l1379t541r1498b592],
29	chance	NN	O	chance	dobj	25	SENT_98	[p5l1533t538r1751b592],
30	to	TO	O	to	aux	31	SENT_98	[p5l1787t546r1848b592],
31	detect	VB	O	detect	infmod	29	SENT_98	[p5l1883t538r2079b592],
32	a	DT	O	a	det	34	SENT_98	[p5l2112t554r2145b592],
33	mean	NN	O	mean	nn	34	SENT_98	[p5l15t641r190b679],
34	difference	NN	O	difference	dobj	31	SENT_98	[p5l218t625r535b679],
35	of	IN	O	of	_	0	SENT_98	[p5l564t625r629b679],
36	3	CD	NUMBER	3	num	37	SENT_98	[p5l648t628r682b679],
37	points	NNS	O	point	prep_of	34	SENT_98	[p5l714t626r909b693],
38	between	IN	O	between	_	0	SENT_98	[p5l937t625r1213b679],
39	2	CD	NUMBER	2	num	40	SENT_98	[p5l1240t628r1274b679],
40	genotypes	NNS	O	genotype	prep_between	37	SENT_98	[p5l1303t633r1628b693],
41	on	IN	O	on	_	0	SENT_98	[p5l1657t641r1735b679],
42	venlafaxine	NN	O	venlafaxine	prep_on	40	SENT_98	[p5l1760t625r2143b680],
43	.	.	O	.	_	0	SENT_98	[p5l1760t625r2143b680],

1	Randomizing	VBG	O	randomize	csubj	10	SENT_99	[p5l15t713r436b780],
2	only	RB	O	only	advmod	5	SENT_99	[p5l465t713r602b780],
3	homozygous	JJ	O	homozygous	amod	5	SENT_99	[p5l632t713r1033b780],
4	COMT	NNP	O	COMT	nn	5	SENT_99	[p5l1066t715r1260b767],
5	Val/Val	NNP	O	Val/Val	dobj	1	SENT_99	[p5l1288t712r1515b780],
6	vs.	IN	O	vs.	_	0	SENT_99	[p5l1544t728r1626b767],
7	Met/Met	NNP	O	Met/Met	nn	8	SENT_99	[p5l1658t712r1934b780],
8	genotypes	NNS	O	genotype	prep_vs.	5	SENT_99	[p5l1962t728r2144b780, p5l14t808r183b867],
9	would	MD	O	would	aux	10	SENT_99	[p5l234t800r434b854],
10	maximize	VB	O	maximize	_	0	SENT_99	[p5l488t800r798b854],
11	the	DT	O	the	det	12	SENT_99	[p5l851t800r952b854],
12	power	NN	O	power	dobj	10	SENT_99	[p5l1005t815r1208b867],
13	for	IN	O	for	_	0	SENT_99	[p5l1258t799r1347b854],
14	direct	JJ	O	direct	amod	15	SENT_99	[p5l1396t799r1580b854],
15	comparisons	NNS	O	comparison	prep_for	12	SENT_99	[p5l1630t800r2032b867],
16	of	IN	O	of	_	0	SENT_99	[p5l2086t799r2152b854],
17	response	NN	O	response	prep_of	15	SENT_99	[p5l15t902r296b954],
18	to	TO	O	to	_	0	SENT_99	[p5l322t894r383b940],
19	the	DT	O	the	det	21	SENT_99	[p5l406t886r507b940],
20	same	JJ	O	same	amod	21	SENT_99	[p5l533t902r696b940],
21	treatment	NN	O	treatment	prep_to	10	SENT_99	[p5l721t894r1054b948],
22	,	,	O	,	_	0	SENT_99	[p5l721t894r1054b948],
23	minimize	VBP	O	minimize	conj_and	10	SENT_99	[p5l1080t887r1379b940],
24	the	DT	O	the	det	25	SENT_99	[p5l1404t886r1505b940],
25	number	NN	O	number	dobj	23	SENT_99	[p5l1531t886r1782b940],
26	of	IN	O	of	_	0	SENT_99	[p5l1805t886r1871b940],
27	subjects	NNS	O	subject	prep_of	25	SENT_99	[p5l1889t886r2143b954],
28	required	VBN	O	require	partmod	27	SENT_99	[p5l15t974r283b1041],
29	post	NN	O	post	nn	30	SENT_99	[p5l316t982r450b1041],
30	randomization	NN	O	randomization	dobj	28	SENT_99	[p5l481t974r963b1036],
31	,	,	O	,	_	0	SENT_99	[p5l481t974r963b1036],
32	and	CC	O	and	_	0	SENT_99	[p5l996t974r1112b1028],
33	reduce	VB	O	reduce	conj_and	10	SENT_99	[p5l1145t974r1357b1028],
34	the	DT	O	the	det	37	SENT_99	[p5l1389t974r1490b1028],
35	gene-dosing	JJ	O	gene-dosing	amod	37	SENT_99	[p5l1521t974r1915b1041],
36	model	NN	O	model	nn	37	SENT_99	[p5l1946t974r2144b1028],
37	assumptions	NNS	O	assumption	dobj	33	SENT_99	[p5l15t1061r429b1128],
38	.	.	O	.	_	0	SENT_99	[p5l15t1061r429b1128],

1	Similarly	RB	O	similarly	advmod	2	SENT_100	[p5l482t1060r764b1128],
2	identifying	VBG	O	identify	csubj	19	SENT_100	[p5l813t1060r1158b1128],
3	improved	JJ	O	improved	amod	4	SENT_100	[p5l1208t1060r1513b1128],
4	responses	NNS	O	response	dobj	2	SENT_100	[p5l1564t1076r1877b1128],
5	among	IN	O	among	_	0	SENT_100	[p5l1927t1076r2145b1128],
6	COMT	NNP	O	COMT	nn	7	SENT_100	[p5l15t1150r208b1201],
7	genotypes	NNS	O	genotype	prep_among	2	SENT_100	[p5l257t1155r582b1215],
8	treated	VBN	O	treat	partmod	7	SENT_100	[p5l638t1147r863b1201],
9	with	IN	O	with	_	0	SENT_100	[p5l919t1147r1065b1201],
10	other	JJ	O	other	amod	12	SENT_100	[p5l1122t1147r1291b1201],
11	approved	VBN	O	approve	amod	12	SENT_100	[p5l1345t1147r1642b1215],
12	drugs	NNS	O	drug	nsubj	13	SENT_100	[p5l1699t1147r1875b1215],
13	having	VBG	O	have	prepc_with	8	SENT_100	[p5l1932t1147r2145b1215],
14	dopamine	NN	O	dopamine	nn	17	SENT_100	[p5l15t1235r333b1302],
15	or	CC	O	or	_	0	SENT_100	[p5l378t1250r444b1289],
16	norepinephrine	NN	O	norepinephrine	conj_or	14	SENT_100	[p5l486t1235r982b1302],
17	pharmacology	NN	O	pharmacology	dobj	13	SENT_100	[p5l1027t1234r1483b1302],
18	could	MD	O	could	aux	19	SENT_100	[p5l1524t1234r1695b1289],
19	increase	VB	O	increase	_	0	SENT_100	[p5l1741t1235r1999b1289],
20	the	DT	O	the	det	24	SENT_100	[p5l2043t1235r2144b1289],
21	efﬁciency	NN	O	efﬁciency	nn	24	SENT_100	[p5l15t1321r319b1389],
22	and	CC	O	and	_	0	SENT_100	[p5l343t1322r459b1376],
23	cost	NN	O	cost	nn	24	SENT_100	[p5l488t1330r614b1376],
24	effectiveness	NN	O	effectiveness	dobj	19	SENT_100	[p5l640t1321r1047b1376],
25	of	IN	O	of	_	0	SENT_100	[p5l1076t1321r1142b1376],
26	these	DT	O	these	det	28	SENT_100	[p5l1162t1322r1330b1376],
27	drug	NN	O	drug	nn	28	SENT_100	[p5l1359t1321r1506b1389],
28	therapies	NNS	O	therapy	prep_of	24	SENT_100	[p5l1533t1322r1827b1389],
29	overall	RB	O	overall	advmod	19	SENT_100	[p5l1856t1322r2085b1376],
30	.	.	O	.	_	0	SENT_100	[p5l1856t1322r2085b1376],

1	Funding	NNP	O	Funding	_	0	SENT_101	[p5l14t1542r292b1610],

1	This	DT	O	this	det	2	SENT_102	[p5l113t1719r244b1774],
2	study	NN	O	study	nsubjpass	11	SENT_102	[p5l283t1719r468b1787],
3	,	,	O	,	_	0	SENT_102	[p5l283t1719r468b1787],
4	the	DT	O	the	det	5	SENT_102	[p5l505t1719r606b1774],
5	authors	NNS	O	author	nsubjpass	11	SENT_102	[p5l643t1719r899b1782],
6	,	,	O	,	_	0	SENT_102	[p5l643t1719r899b1782],
7	and	CC	O	and	_	0	SENT_102	[p5l937t1719r1052b1774],
8	the	DT	O	the	det	9	SENT_102	[p5l1089t1719r1189b1774],
9	analysis	NN	O	analysis	conj_and	2	SENT_102	[p5l1227t1719r1476b1787],
10	were	VBD	O	be	auxpass	11	SENT_102	[p5l1512t1735r1670b1774],
11	sponsored	VBN	O	sponsor	_	0	SENT_102	[p5l1708t1719r2033b1787],
12	by	IN	O	by	prep	11	SENT_102	[p5l2070t1719r2147b1787],

1	Sepracor	NNP	O	Sepracor	nn	2	SENT_103	[p5l15t1810r293b1874],
2	lnc.	NNP	O	lnc.	_	0	SENT_103	[p5l320t1810r443b1869],
3	,	,	O	,	_	0	SENT_103	[p5l320t1810r443b1869],
4	now	RB	DATE	now	appos	2	SENT_103	[p5l472t1822r611b1861],
5	Sunovion	NNP	ORGANIZATION	Sunovion	nn	7	SENT_103	[p5l637t1808r934b1861],
6	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	nn	7	SENT_103	[p5l962t1807r1481b1861],
7	Inc.	NNP	ORGANIZATION	Inc.	dep	4	SENT_103	[p5l1511t1810r1618b1861],
8	.	.	O	.	_	0	SENT_103	[p5l1511t1810r1618b1861],

1	Acknowledgment	NN	O	acknowledgment	_	0	SENT_104	[p5l11t2027r605b2095],

1	This	DT	O	this	det	2	SENT_105	[p5l113t2213r244b2267],
2	study	NN	O	study	nsubjpass	7	SENT_105	[p5l282t2213r457b2280],
3	and	CC	O	and	_	0	SENT_105	[p5l491t2213r606b2267],
4	its	PRP$	O	its	poss	5	SENT_105	[p5l644t2214r715b2267],
5	analysis	NN	O	analysis	conj_and	2	SENT_105	[p5l753t2213r1002b2280],
6	were	VBD	O	be	auxpass	7	SENT_105	[p5l1038t2228r1195b2267],
7	sponsored	VBN	O	sponsor	_	0	SENT_105	[p5l1234t2213r1559b2280],
8	by	IN	O	by	_	0	SENT_105	[p5l1596t2213r1672b2280],
9	Sepracor	NNP	O	Sepracor	nn	10	SENT_105	[p5l1707t2216r1985b2280],
10	lnc.	NNP	O	lnc.	agent	7	SENT_105	[p5l2020t2216r2143b2275],
11	,	,	O	,	_	0	SENT_105	[p5l2020t2216r2143b2275],
12	now	RB	DATE	now	advmod	10	SENT_105	[p5l15t2316r154b2355],
13	Sunovion	NNP	ORGANIZATION	Sunovion	nn	15	SENT_105	[p5l192t2301r490b2355],
14	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	nn	15	SENT_105	[p5l529t2301r1048b2355],
15	Inc.	NNP	ORGANIZATION	Inc.	dep	10	SENT_105	[p5l1090t2304r1198b2355],
16	.	.	O	.	_	0	SENT_105	[p5l1090t2304r1198b2355],

1	The	DT	O	the	det	2	SENT_106	[p5l1236t2301r1352b2355],
2	authors	NNS	O	author	nsubj	3	SENT_106	[p5l1392t2301r1632b2355],
3	wish	VBP	O	wish	_	0	SENT_106	[p5l1672t2301r1823b2355],
4	to	TO	O	to	aux	5	SENT_106	[p5l1863t2309r1924b2355],
5	thank	VB	O	thank	xcomp	3	SENT_106	[p5l1962t2301r2146b2355],
6	Judy	NNP	PERSON	Judy	nn	7	SENT_106	[p5l7t2388r155b2456],
7	Dunn	NNP	PERSON	Dunn	dobj	5	SENT_106	[p5l179t2391r366b2450],
8	,	,	O	,	_	0	SENT_106	[p5l179t2391r366b2450],
9	PhD	NNP	O	PhD	appos	7	SENT_106	[p5l393t2388r535b2451],
10	,	,	O	,	_	0	SENT_106	[p5l393t2388r535b2451],
11	formerly	RB	O	formerly	advmod	7	SENT_106	[p5l562t2388r837b2456],
12	of	IN	O	of	_	0	SENT_106	[p5l861t2388r927b2442],
13	Sepracor	NNP	O	Sepracor	nn	14	SENT_106	[p5l944t2391r1222b2456],
14	lnc.	NNP	O	lnc.	prep_of	7	SENT_106	[p5l1246t2391r1369b2450],
15	,	,	O	,	_	0	SENT_106	[p5l1246t2391r1369b2450],
16	for	IN	O	for	_	0	SENT_106	[p5l1395t2388r1484b2442],
17	contributions	NNS	O	contribution	prep_for	7	SENT_106	[p5l1506t2388r1932b2442],
18	to	TO	O	to	_	0	SENT_106	[p5l1958t2396r2019b2442],
19	the	DT	O	the	det	20	SENT_106	[p5l2043t2388r2144b2442],
20	design	NN	O	design	prep_to	5	SENT_106	[p5l15t2475r221b2543],
21	and	CC	O	and	_	0	SENT_106	[p5l249t2475r364b2529],
22	conduct	NN	O	conduct	prep_to	5	SENT_106	[p5l393t2475r648b2529],
23	of	IN	O	of	_	0	SENT_106	[p5l674t2475r740b2529],
24	the	DT	O	the	det	27	SENT_106	[p5l760t2475r861b2529],
25	NCTOO584974	NN	O	nctoo584974	nn	27	SENT_106	[p5l889t2478r1336b2529],
26	clinical	JJ	O	clinical	amod	27	SENT_106	[p5l1364t2475r1585b2529],
27	trial	NN	O	trial	prep_of	20	SENT_106	[p5l1613t2475r1756b2530],
28	.	.	O	.	_	0	SENT_106	[p5l1613t2475r1756b2530],

1	Appendix	NNP	O	Appendix	nn	2	SENT_107	[p5l11t2697r335b2764],
2	A.	NNP	O	A.	_	0	SENT_107	[p5l356t2699r420b2751],
3	Supporting	VBG	O	support	dep	2	SENT_107	[p5l474t2697r851b2764],
4	information	NN	O	information	dobj	3	SENT_107	[p5l876t2696r1287b2751],

1	Supplementary	NNP	O	Supplementary	nn	2	SENT_108	[p5l116t2874r605b2941],
2	data	NNS	O	datum	nsubjpass	9	SENT_108	[p5l636t2874r772b2928],
3	associated	VBN	O	associate	partmod	2	SENT_108	[p5l803t2874r1128b2928],
4	with	IN	O	with	_	0	SENT_108	[p5l1160t2874r1306b2928],
5	this	DT	O	this	det	6	SENT_108	[p5l1338t2874r1453b2928],
6	article	NN	O	article	prep_with	3	SENT_108	[p5l1487t2874r1683b2928],
7	can	MD	O	can	aux	9	SENT_108	[p5l1715t2889r1823b2928],
8	be	VB	O	be	auxpass	9	SENT_108	[p5l1855t2874r1927b2928],
9	found	VBN	O	find	_	0	SENT_108	[p5l1961t2874r2143b2928],
10	in	IN	O	in	_	0	SENT_108	[p5l15t2962r74b3015],
11	the	DT	O	the	det	13	SENT_108	[p5l106t2961r207b3015],
12	online	JJ	O	online	amod	13	SENT_108	[p5l241t2961r438b3015],
13	version	NN	O	version	prep_in	9	SENT_108	[p5l470t2962r704b3015],
14	at	IN	O	at	_	0	SENT_108	[p5l737t2969r796b3015],
15	http://dx.doi.org/10.1016/j.psychres.2013	NN	O	http://dx.doi.org/10.1016/j.psychres.2013	prep_at	13	SENT_108	[p5l828t2961r2143b3029],
16	.	.	O	.	_	0	SENT_108	[p5l828t2961r2143b3029],

1	04.021	CD	NUMBER	04.021	_	0	SENT_109	[p5l15t3052r241b3104],
2	.	.	O	.	_	0	SENT_109	[p5l15t3052r241b3104],

1	References	NNS	O	reference	_	0	SENT_110	[p5l14t3257r375b3311],

1	Axelrod	NNP	PERSON	Axelrod	_	0	SENT_111	[p6l12t76r223b126],
2	,	,	O	,	_	0	SENT_111	[p6l12t76r223b126],
3	_	CD	NUMBER	_	num	4	SENT_111	[p6l239t79r284b131],
4	]	NN	O	]	appos	1	SENT_111	[p6l239t79r284b131],
5	.	.	O	.	_	0	SENT_111	[p6l239t79r284b131],

1	,	,	O	,	_	0	SENT_112	[p6l239t79r284b131],
2	Tomchick	NNP	PERSON	Tomchick	nn	4	SENT_112	[p6l305t76r561b126],
3	,	,	O	,	_	0	SENT_112	[p6l305t76r561b126],
4	R.	NNP	O	R.	nsubj	6	SENT_112	[p6l584t79r640b127],
5	,	,	O	,	_	0	SENT_112	[p6l584t79r640b127],
6	1958	CD	DATE	1958	_	0	SENT_112	[p6l665t78r796b120],
7	.	.	O	.	_	0	SENT_112	[p6l665t78r796b120],

1	Enzymatic	JJ	MISC	enzymatic	amod	2	SENT_113	[p6l820t77r1084b131],
2	O-methylation	NN	MISC	o-methylation	_	0	SENT_113	[p6l1105t76r1475b131],
3	of	IN	O	of	_	0	SENT_113	[p6l1496t76r1549b120],
4	epinephrine	NN	O	epinephrine	nn	7	SENT_113	[p6l1564t76r1873b131],
5	and	CC	O	and	_	0	SENT_113	[p6l1896t76r1988b120],
6	other	JJ	O	other	conj_and	4	SENT_113	[p6l2010t76r2146b120],
7	catechols	NNS	O	catechol	prep_of	2	SENT_113	[p6l116t141r362b185],
8	.	.	O	.	_	0	SENT_113	[p6l116t141r362b185],

1	The	DT	O	the	det	2	SENT_114	[p6l383t142r476b185],
2	Journal	NNP	O	Journal	_	0	SENT_114	[p6l492t141r679b196],
3	of	IN	O	of	_	0	SENT_114	[p6l702t141r756b185],
4	Biological	NNP	O	Biological	prep_of	2	SENT_114	[p6l772t141r1015b196],
5	Chemistry	NNP	O	Chemistry	dep	4	SENT_114	[p6l1039t141r1300b196],
6	233	CD	NUMBER	233	num	5	SENT_114	[p6l1321t144r1426b192],
7	,	,	O	,	_	0	SENT_114	[p6l1321t144r1426b192],
8	702-705	CD	NUMBER	702-705	num	5	SENT_114	[p6l1450t144r1679b185],
9	.	.	O	.	_	0	SENT_114	[p6l1450t144r1679b185],

1	Carboni	NNP	PERSON	Carboni	nn	15	SENT_115	[p6l15t208r222b258],
2	,	,	O	,	_	0	SENT_115	[p6l15t208r222b258],
3	E.	NNP	O	E.	appos	15	SENT_115	[p6l242t211r295b258],
4	,	,	O	,	_	0	SENT_115	[p6l242t211r295b258],
5	Tanda	NNP	O	Tanda	appos	15	SENT_115	[p6l312t208r475b258],
6	,	,	O	,	_	0	SENT_115	[p6l312t208r475b258],
7	G.L.	NNP	O	G.L.	appos	15	SENT_115	[p6l495t210r596b258],
8	,	,	O	,	_	0	SENT_115	[p6l495t210r596b258],
9	Frau	NNP	PERSON	Frau	appos	15	SENT_115	[p6l616t211r736b258],
10	,	,	O	,	_	0	SENT_115	[p6l616t211r736b258],
11	R.	NNP	O	R.	appos	15	SENT_115	[p6l755t211r811b258],
12	,	,	O	,	_	0	SENT_115	[p6l755t211r811b258],
13	Di	NNP	O	Di	appos	15	SENT_115	[p6l830t209r895b258],
14	,	,	O	,	_	0	SENT_115	[p6l830t209r895b258],
15	C.G.	NNP	LOCATION	C.G.	_	0	SENT_115	[p6l914t210r1021b258],
16	,	,	O	,	_	0	SENT_115	[p6l914t210r1021b258],
17	1990	CD	DATE	1990	appos	15	SENT_115	[p6l1043t210r1174b252],
18	.	.	O	.	_	0	SENT_115	[p6l1043t210r1174b252],

1	Blockade	NN	O	blockade	nsubj	6	SENT_116	[p6l1194t208r1420b252],
2	of	IN	O	of	_	0	SENT_116	[p6l1439t208r1492b252],
3	the	DT	O	the	det	5	SENT_116	[p6l1503t208r1584b252],
4	noradrenaline	NN	O	noradrenaline	nn	5	SENT_116	[p6l1603t208r1959b252],
5	carrier	NN	O	carrier	prep_of	1	SENT_116	[p6l1978t209r2146b252],
6	increases	VBZ	O	increase	_	0	SENT_116	[p6l116t275r348b318],
7	extracellular	JJ	O	extracellular	amod	9	SENT_116	[p6l390t274r709b318],
8	dopamine	NN	O	dopamine	nn	9	SENT_116	[p6l748t274r1003b328],
9	concentrations	NNS	O	concentration	dobj	6	SENT_116	[p6l1045t275r1422b318],
10	in	IN	O	in	_	0	SENT_116	[p6l1464t275r1510b317],
11	the	DT	O	the	det	13	SENT_116	[p6l1551t274r1632b318],
12	prefrontal	JJ	O	prefrontal	amod	13	SENT_116	[p6l1673t274r1927b328],
13	cortex	NN	O	cortex	prep_in	9	SENT_116	[p6l1968t280r2140b318],
14	:	:	O	:	_	0	SENT_116	[p6l1968t280r2140b318],
15	evidence	NN	O	evidence	dep	9	SENT_116	[p6l116t340r340b383],
16	that	IN	O	that	complm	19	SENT_116	[p6l360t340r462b383],
17	dopamine	NN	O	dopamine	nsubjpass	19	SENT_116	[p6l479t340r733b394],
18	is	VBZ	O	be	auxpass	19	SENT_116	[p6l753t341r789b383],
19	taken	VBN	O	take	dep	15	SENT_116	[p6l808t340r949b383],
20	up	RP	O	up	prt	19	SENT_116	[p6l968t352r1030b394],
21	in	FW	O	in	nn	22	SENT_116	[p6l1050t341r1096b383],
22	vivo	FW	O	vivo	advmod	19	SENT_116	[p6l1113t341r1220b383],
23	by	IN	O	by	_	0	SENT_116	[p6l1237t340r1298b394],
24	noradrenergic	JJ	O	noradrenergic	amod	25	SENT_116	[p6l1315t340r1674b394],
25	terminals	NNS	O	terminal	agent	19	SENT_116	[p6l1691t340r1944b384],
26	.	.	O	.	_	0	SENT_116	[p6l1691t340r1944b384],

1	Journal	NNP	O	Journal	_	0	SENT_117	[p6l1957t340r2144b394],
2	of	IN	O	of	_	0	SENT_117	[p6l116t405r168b449],
3	Neurochemistry	NNP	O	Neurochemistry	prep_of	1	SENT_117	[p6l185t405r596b460],
4	55	CD	NUMBER	55	num	3	SENT_117	[p6l619t408r691b456],
5	,	,	O	,	_	0	SENT_117	[p6l619t408r691b456],
6	1067-1070	CD	DATE	1067-1070	num	3	SENT_117	[p6l717t408r1001b449],
7	.	.	O	.	_	0	SENT_117	[p6l717t408r1001b449],

1	Collins	NNP	PERSON	Collins	nn	3	SENT_118	[p6l15t471r196b522],
2	,	,	O	,	_	0	SENT_118	[p6l15t471r196b522],
3	F.S.	NNP	LOCATION	F.S.	_	0	SENT_118	[p6l225t474r314b522],
4	,	,	O	,	_	0	SENT_118	[p6l225t474r314b522],
5	2010	CD	DATE	2010	appos	3	SENT_118	[p6l342t474r475b515],
6	.	.	O	.	_	0	SENT_118	[p6l342t474r475b515],

1	Research	NNP	O	Research	_	0	SENT_119	[p6l504t471r729b515],
2	agenda	NN	O	agenda	dep	1	SENT_119	[p6l756t471r950b526],
3	.	.	O	.	_	0	SENT_119	[p6l756t471r950b526],

1	Opportunities	NNPS	O	Opportunities	_	0	SENT_120	[p6l979t472r1331b526],
2	for	IN	O	for	_	0	SENT_120	[p6l1360t471r1431b515],
3	research	NN	O	research	prep_for	1	SENT_120	[p6l1457t471r1671b515],
4	and	CC	O	and	_	0	SENT_120	[p6l1699t471r1791b515],
5	NIH	NNP	ORGANIZATION	NIH	prep_for	1	SENT_120	[p6l1820t474r1928b515],
6	.	.	O	.	_	0	SENT_120	[p6l1820t474r1928b515],

1	Science	NN	O	science	_	0	SENT_121	[p6l1957t472r2144b515],

1	Epstein	NN	PERSON	epstein	_	0	SENT_122	[p6l15t605r212b659],
2	,	,	O	,	_	0	SENT_122	[p6l15t605r212b659],
3	R.S.	NNP	PERSON	R.S.	nn	31	SENT_122	[p6l253t606r350b654],
4	,	,	O	,	_	0	SENT_122	[p6l253t606r350b654],
5	Frueh	NNP	PERSON	Frueh	appos	31	SENT_122	[p6l390t604r545b654],
6	,	,	O	,	_	0	SENT_122	[p6l390t604r545b654],
7	F.W.	NNP	O	F.W.	appos	31	SENT_122	[p6l585t607r700b654],
8	,	,	O	,	_	0	SENT_122	[p6l585t607r700b654],
9	Geren	NNP	PERSON	Geren	appos	31	SENT_122	[p6l739t606r903b654],
10	,	,	O	,	_	0	SENT_122	[p6l739t606r903b654],
11	D.	NNP	O	D.	appos	31	SENT_122	[p6l942t607r1003b654],
12	,	,	O	,	_	0	SENT_122	[p6l942t607r1003b654],
13	Hummer	NNP	PERSON	Hummer	appos	31	SENT_122	[p6l1043t607r1282b654],
14	,	,	O	,	_	0	SENT_122	[p6l1043t607r1282b654],
15	D.	NNP	O	D.	appos	31	SENT_122	[p6l1322t607r1382b654],
16	,	,	O	,	_	0	SENT_122	[p6l1322t607r1382b654],
17	McKibbin	NNP	PERSON	McKibbin	appos	31	SENT_122	[p6l1422t604r1677b654],
18	,	,	O	,	_	0	SENT_122	[p6l1422t604r1677b654],
19	S.	NNP	O	S.	appos	31	SENT_122	[p6l1717t606r1768b654],
20	,	,	O	,	_	0	SENT_122	[p6l1717t606r1768b654],
21	O'Connor	NNP	PERSON	O'Connor	appos	31	SENT_122	[p6l1807t606r2053b655],
22	,	,	O	,	_	0	SENT_122	[p6l1807t606r2053b655],
23	S.	NNP	O	S.	appos	31	SENT_122	[p6l2093t606r2143b654],
24	,	,	O	,	_	0	SENT_122	[p6l2093t606r2143b654],
25	Randhawa	NNP	PERSON	Randhawa	appos	31	SENT_122	[p6l116t670r393b720],
26	,	,	O	,	_	0	SENT_122	[p6l116t670r393b720],
27	G.	NNP	O	G.	appos	31	SENT_122	[p6l428t672r489b720],
28	,	,	O	,	_	0	SENT_122	[p6l428t672r489b720],
29	Zelman	NNP	PERSON	Zelman	appos	31	SENT_122	[p6l524t670r725b720],
30	,	,	O	,	_	0	SENT_122	[p6l524t670r725b720],
31	B.	NNP	O	B.	appos	1	SENT_122	[p6l761t673r816b720],
32	,	,	O	,	_	0	SENT_122	[p6l761t673r816b720],
33	2009	CD	DATE	2009	dep	31	SENT_122	[p6l851t672r991b714],
34	.	.	O	.	_	0	SENT_122	[p6l851t672r991b714],

1	Payer	NN	O	payer	nn	2	SENT_123	[p6l1027t673r1166b724],
2	perspectives	NNS	O	perspective	_	0	SENT_123	[p6l1199t671r1515b724],
3	on	IN	O	on	_	0	SENT_123	[p6l1550t682r1612b713],
4	pharmacogenomics	NNS	O	pharmacogenomic	nn	5	SENT_123	[p6l1646t670r2144b724],
5	testing	NN	O	testing	prep_on	2	SENT_123	[p6l115t736r289b790],
6	and	CC	O	and	_	0	SENT_123	[p6l310t735r402b779],
7	drug	NN	O	drug	nn	8	SENT_123	[p6l425t735r543b790],
8	development	NN	O	development	conj_and	5	SENT_123	[p6l565t736r913b790],
9	.	.	O	.	_	0	SENT_123	[p6l565t736r913b790],

1	Pharmacogenomics	NNP	O	Pharmacogenomics	_	0	SENT_124	[p6l937t735r1432b790],
2	10	CD	NUMBER	10	num	1	SENT_124	[p6l1458t738r1525b786],
3	,	,	O	,	_	0	SENT_124	[p6l1458t738r1525b786],
4	149-151	CD	NUMBER	149-151	appos	1	SENT_124	[p6l1551t738r1769b779],
5	.	.	O	.	_	0	SENT_124	[p6l1551t738r1769b779],

1	Garriock	NNP	PERSON	Garriock	nn	5	SENT_125	[p6l15t802r242b852],
2	,	,	O	,	_	0	SENT_125	[p6l15t802r242b852],
3	H.A.	NNP	PERSON	H.A.	appos	5	SENT_125	[p6l282t804r396b852],
4	,	,	O	,	_	0	SENT_125	[p6l282t804r396b852],
5	Kraft	NNP	PERSON	Kraft	_	0	SENT_125	[p6l436t802r570b852],
6	,	,	O	,	_	0	SENT_125	[p6l436t802r570b852],
7	]	CD	NUMBER	]	appos	5	SENT_125	[p6l604t804r696b856],
8	.	.	O	.	_	0	SENT_125	[p6l604t804r696b856],

1	B.	NNP	O	B.	_	0	SENT_126	[p6l604t804r696b856],
2	,	,	O	,	_	0	SENT_126	[p6l604t804r696b856],
3	Shyn	NNP	PERSON	Shyn	nn	10	SENT_126	[p6l736t802r870b856],
4	,	,	O	,	_	0	SENT_126	[p6l736t802r870b856],
5	S.l.	NNP	PERSON	S.l.	appos	10	SENT_126	[p6l911t804r991b852],
6	,	,	O	,	_	0	SENT_126	[p6l911t804r991b852],
7	Peters	NNP	PERSON	Peters	appos	10	SENT_126	[p6l1032t804r1198b852],
8	,	,	O	,	_	0	SENT_126	[p6l1032t804r1198b852],
9	E.	NNP	O	E.	appos	10	SENT_126	[p6l1239t804r1321b856],
10	]	NNP	O	]	appos	1	SENT_126	[p6l1239t804r1321b856],
11	.	.	O	.	_	0	SENT_126	[p6l1239t804r1321b856],

1	,	,	O	,	_	0	SENT_127	[p6l1239t804r1321b856],
2	Yokoyama	NNP	PERSON	Yokoyama	nsubj	4	SENT_127	[p6l1360t802r1633b856],
3	,	,	O	,	_	0	SENT_127	[p6l1360t802r1633b856],
4	]	CD	NUMBER	]	_	0	SENT_127	[p6l1667t804r1754b856],
5	.	.	O	.	_	0	SENT_127	[p6l1667t804r1754b856],

1	S.	NNP	O	S.	nn	18	SENT_128	[p6l1667t804r1754b856],
2	,	,	O	,	_	0	SENT_128	[p6l1667t804r1754b856],
3	Jenkins	NNP	PERSON	Jenkins	appos	18	SENT_128	[p6l1788t802r1989b856],
4	,	,	O	,	_	0	SENT_128	[p6l1788t802r1989b856],
5	G.D.	NNP	PERSON	G.D.	appos	18	SENT_128	[p6l2030t804r2144b852],
6	,	,	O	,	_	0	SENT_128	[p6l2030t804r2144b852],
7	Reinalda	NNP	PERSON	Reinalda	appos	18	SENT_128	[p6l116t868r345b918],
8	,	,	O	,	_	0	SENT_128	[p6l116t868r345b918],
9	M.S.	NNP	LOCATION	M.S.	appos	18	SENT_128	[p6l374t870r489b918],
10	,	,	O	,	_	0	SENT_128	[p6l374t870r489b918],
11	Slager	NNP	PERSON	Slager	appos	18	SENT_128	[p6l518t868r683b923],
12	,	,	O	,	_	0	SENT_128	[p6l518t868r683b923],
13	S.L.	NNP	LOCATION	S.L.	appos	18	SENT_128	[p6l712t870r803b918],
14	,	,	O	,	_	0	SENT_128	[p6l712t870r803b918],
15	McGrath	NNP	PERSON	McGrath	appos	18	SENT_128	[p6l831t868r1063b918],
16	,	,	O	,	_	0	SENT_128	[p6l831t868r1063b918],
17	P.	NNP	O	P.	appos	18	SENT_128	[p6l1091t871r1169b923],
18	_	NNP	O	_	_	0	SENT_128	[p6l1091t871r1169b923],
19	]	NN	O	]	dep	18	SENT_128	[p6l1091t871r1169b923],
20	.	.	O	.	_	0	SENT_128	[p6l1091t871r1169b923],

1	,	,	O	,	_	0	SENT_129	[p6l1091t871r1169b923],
2	Hamilton	NNP	LOCATION	Hamilton	nn	4	SENT_129	[p6l1198t868r1447b918],
3	,	,	O	,	_	0	SENT_129	[p6l1198t868r1447b918],
4	S.P.	NNP	LOCATION	S.P.	nsubj	6	SENT_129	[p6l1475t870r1566b918],
5	,	,	O	,	_	0	SENT_129	[p6l1475t870r1566b918],
6	2010	CD	DATE	2010	_	0	SENT_129	[p6l1594t870r1726b912],
7	.	.	O	.	_	0	SENT_129	[p6l1594t870r1726b912],

1	A	DT	O	a	det	4	SENT_130	[p6l1752t870r1790b911],
2	genomewide	JJ	O	genomewide	amod	4	SENT_130	[p6l1814t868r2144b923],
3	association	NN	O	association	nn	4	SENT_130	[p6l115t934r396b977],
4	study	NN	O	study	_	0	SENT_130	[p6l423t934r562b988],
5	of	IN	O	of	_	0	SENT_130	[p6l586t933r639b977],
6	citalopram	NN	O	citalopram	nn	7	SENT_130	[p6l658t933r931b988],
7	response	NN	O	response	prep_of	4	SENT_130	[p6l957t946r1182b988],
8	in	IN	O	in	_	0	SENT_130	[p6l1208t934r1255b977],
9	major	JJ	O	major	amod	11	SENT_130	[p6l1281t934r1428b988],
10	depressive	JJ	O	depressive	amod	11	SENT_130	[p6l1452t933r1721b988],
11	disorder	NN	O	disorder	prep_in	4	SENT_130	[p6l1746t933r1970b977],
12	.	.	O	.	_	0	SENT_130	[p6l1746t933r1970b977],

1	Biological	JJ	O	biological	_	0	SENT_131	[p6l1996t933r2144b977, p6l115t1000r230b1054],
2	Psychiatry	NNP	O	Psychiatry	dep	1	SENT_131	[p6l254t1000r516b1054],
3	67	CD	NUMBER	67	num	2	SENT_131	[p6l538t1002r611b1050],
4	,	,	O	,	_	0	SENT_131	[p6l538t1002r611b1050],
5	133-138	CD	NUMBER	133-138	num	2	SENT_131	[p6l636t1002r857b1044],
6	.	.	O	.	_	0	SENT_131	[p6l636t1002r857b1044],

1	Gogos	NNP	O	Gogos	nn	27	SENT_132	[p6l15t1068r181b1120],
2	,	,	O	,	_	0	SENT_132	[p6l15t1068r181b1120],
3	J.A.	NNP	PERSON	J.A.	appos	27	SENT_132	[p6l198t1068r293b1120],
4	,	,	O	,	_	0	SENT_132	[p6l198t1068r293b1120],
5	Morgan	NNP	PERSON	Morgan	appos	27	SENT_132	[p6l318t1069r526b1120],
6	,	,	O	,	_	0	SENT_132	[p6l318t1069r526b1120],
7	M.	NNP	O	M.	appos	27	SENT_132	[p6l550t1069r624b1116],
8	,	,	O	,	_	0	SENT_132	[p6l550t1069r624b1116],
9	Luine	NNP	PERSON	Luine	appos	27	SENT_132	[p6l648t1067r797b1116],
10	,	,	O	,	_	0	SENT_132	[p6l648t1067r797b1116],
11	V.	NNP	O	V.	appos	27	SENT_132	[p6l819t1069r880b1116],
12	,	,	O	,	_	0	SENT_132	[p6l819t1069r880b1116],
13	Santha	NNP	PERSON	Santha	appos	27	SENT_132	[p6l905t1066r1088b1116],
14	,	,	O	,	_	0	SENT_132	[p6l905t1066r1088b1116],
15	M.	NNP	O	M.	appos	27	SENT_132	[p6l1113t1069r1186b1116],
16	,	,	O	,	_	0	SENT_132	[p6l1113t1069r1186b1116],
17	Ogawa	NNP	PERSON	Ogawa	appos	27	SENT_132	[p6l1210t1068r1392b1120],
18	,	,	O	,	_	0	SENT_132	[p6l1210t1068r1392b1120],
19	S.	NNP	O	S.	appos	27	SENT_132	[p6l1417t1068r1468b1116],
20	,	,	O	,	_	0	SENT_132	[p6l1417t1068r1468b1116],
21	Pfaff	NNP	PERSON	Pfaff	appos	27	SENT_132	[p6l1492t1066r1615b1116],
22	,	,	O	,	_	0	SENT_132	[p6l1492t1066r1615b1116],
23	D.	NNP	O	D.	appos	27	SENT_132	[p6l1640t1069r1700b1116],
24	,	,	O	,	_	0	SENT_132	[p6l1640t1069r1700b1116],
25	Karayiorgou	NNP	LOCATION	Karayiorgou	appos	27	SENT_132	[p6l1725t1067r2046b1120],
26	,	,	O	,	_	0	SENT_132	[p6l1725t1067r2046b1120],
27	M.	NNP	O	M.	_	0	SENT_132	[p6l2070t1069r2144b1116],
28	,	,	O	,	_	0	SENT_132	[p6l2070t1069r2144b1116],
29	1998	CD	DATE	1998	appos	27	SENT_132	[p6l118t1134r250b1176],
30	.	.	O	.	_	0	SENT_132	[p6l118t1134r250b1176],

1	Catechol	NNP	O	Catechol	_	0	SENT_133	[p6l275t1132r1287b1186],
2	.	.	O	.	_	0	SENT_133	[p6l275t1132r1287b1186],

1	—	NN	O	—	_	0	SENT_134	[p6l275t1132r1287b1186],
2	.	.	O	.	_	0	SENT_134	[p6l275t1132r1287b1186],

1	O	NN	O	o	_	0	SENT_135	[p6l275t1132r1287b1186],
2	.	.	O	.	_	0	SENT_135	[p6l275t1132r1287b1186],

1	—	NN	O	—	_	0	SENT_136	[p6l275t1132r1287b1186],
2	.	.	O	.	_	0	SENT_136	[p6l275t1132r1287b1186],

1	methyltransferase	NN	O	methyltransferase	_	0	SENT_137	[p6l275t1132r1287b1186],
2	.	.	O	.	_	0	SENT_137	[p6l275t1132r1287b1186],

1	—	NN	O	—	_	0	SENT_138	[p6l275t1132r1287b1186],
2	.	.	O	.	_	0	SENT_138	[p6l275t1132r1287b1186],

1	deﬁcient	JJ	O	deﬁcient	amod	2	SENT_139	[p6l275t1132r1287b1186],
2	mice	NNS	O	mouse	nsubj	3	SENT_139	[p6l1309t1133r1429b1175],
3	exhibit	VBP	O	exhibit	_	0	SENT_139	[p6l1453t1132r1630b1175],
4	sexually	RB	O	sexually	advmod	5	SENT_139	[p6l1653t1132r1860b1186],
5	dimorphic	JJ	O	dimorphic	dobj	3	SENT_139	[p6l1882t1132r2145b1186],

1	S.C.	NNP	PERSON	S.C.	nn	2	SENT_140	[p6l698t1262r738b1283],
2	Hopkins	NNP	PERSON	Hopkins	_	0	SENT_140	[p6l750t1261r847b1288],
3	et	FW	O	et	nn	4	SENT_140	[p6l858t1264r881b1283],
4	al.	FW	O	al.	dep	2	SENT_140	[p6l890t1261r915b1283],
5	/	:	O	/	punct	2	SENT_140	[p6l924t1261r936b1288],
6	Psychiatry	NNP	O	Psychiatry	nn	7	SENT_140	[p6l945t1261r1069b1288],
7	Research	NNP	O	Research	dep	2	SENT_140	[p6l1079t1261r1184b1283],
8	208	CD	NUMBER	208	number	9	SENT_140	[p6l1194t1262r1240b1283],
9	(	CD	NUMBER	(	num	10	SENT_140	[p6l1250t1261r1328b1288],
10	2013	CD	DATE	2013	dep	7	SENT_140	[p6l1250t1261r1328b1288],
11	)	CD	NUMBER	)	number	12	SENT_140	[p6l1250t1261r1328b1288],
12	285-287 287	CD	NUMBER	285-287 287	num	10	SENT_140	[p6l2109t1262r2154b1283],[p6l1337t1262r1446b1283],

1	changes	NNS	O	change	_	0	SENT_141	[p6l55t1358r155b1385],
2	in	IN	O	in	_	0	SENT_141	[p6l176t1358r199b1380],
3	catecholamine	NN	O	catecholamine	nn	4	SENT_141	[p6l219t1358r401b1380],
4	levels	NNS	O	level	prep_in	1	SENT_141	[p6l422t1358r492b1380],
5	and	CC	O	and	_	0	SENT_141	[p6l512t1358r558b1380],
6	behavior	NN	O	behavior	prep_in	1	SENT_141	[p6l578t1358r693b1380],
7	.	.	O	.	_	0	SENT_141	[p6l578t1358r693b1380],

1	Proceedings	NNP	O	Proceedings	_	0	SENT_142	[p6l714t1358r864b1385],
2	of	IN	O	of	_	0	SENT_142	[p6l885t1358r911b1380],
3	the	DT	O	the	det	5	SENT_142	[p6l929t1358r968b1380],
4	National	NNP	O	National	nn	5	SENT_142	[p6l990t1358r1094b1380],
5	Malhotra	NNP	PERSON	Malhotra	prep_of	1	SENT_142	[p6l1175t1358r1294b1383],
6	.	.	O	.	_	0	SENT_142	[p6l1175t1358r1294b1383],

1	A.	NN	O	a.	_	0	SENT_143	[p6l1310t1359r1364b1383],
2	I	NNP	O	I	dep	1	SENT_143	[p6l1310t1359r1364b1383],
3	(	CD	NUMBER	(	num	2	SENT_143	[p6l1310t1359r1364b1383],
4	.	.	O	.	_	0	SENT_143	[p6l1310t1359r1364b1383],

1	,	,	O	,	_	0	SENT_144	[p6l1310t1359r1364b1383],
2	Murphy	NNP	PERSON	Murphy	dep	3	SENT_144	[p6l1380t1358r1519b1385],
3	]	NNP	O	]	_	0	SENT_144	[p6l1380t1358r1519b1385],
4	r.	NNP	O	r.	dep	3	SENT_144	[p6l1380t1358r1519b1385],
5	,	,	O	,	_	0	SENT_144	[p6l1380t1358r1519b1385],
6	G.M.	NNP	LOCATION	G.M.	appos	4	SENT_144	[p6l1535t1359r1597b1383],
7	,	,	O	,	_	0	SENT_144	[p6l1535t1359r1597b1383],
8	Kennedy	NNP	PERSON	Kennedy	appos	6	SENT_144	[p6l1613t1358r1728b1385],
9	,	,	O	,	_	0	SENT_144	[p6l1613t1358r1728b1385],
10	]	CD	NUMBER	]	appos	6	SENT_144	[p6l1741t1359r1783b1385],
11	.	.	O	.	_	0	SENT_144	[p6l1741t1359r1783b1385],

1	L.	NNP	O	L.	_	0	SENT_145	[p6l1741t1359r1783b1385],
2	,	,	O	,	_	0	SENT_145	[p6l1741t1359r1783b1385],
3	2004	CD	DATE	2004	appos	1	SENT_145	[p6l1800t1359r1868b1380],
4	.	.	O	.	_	0	SENT_145	[p6l1800t1359r1868b1380],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_146	[p6l1885t1358r2112b1385],
2	of	IN	O	of	_	0	SENT_146	[p6l2128t1358r2154b1380],
3	psychoAcademy	NN	O	psychoacademy	prep_of	1	SENT_146	[p6l6t1391r103b1418, p6l54t1424r170b1451],
4	of	IN	O	of	_	0	SENT_146	[p6l180t1424r206b1445],
5	Sciences	NNPS	O	Sciences	prep_of	3	SENT_146	[p6l213t1424r317b1445],
6	of	IN	O	of	_	0	SENT_146	[p6l329t1424r355b1445],
7	the	DT	O	the	det	9	SENT_146	[p6l362t1424r402b1445],
8	United	NNP	ORGANIZATION	United	nn	9	SENT_146	[p6l413t1424r495b1445],
9	States	NNPS	ORGANIZATION	States	prep_of	1	SENT_146	[p6l507t1425r579b1445],
10	of	IN	ORGANIZATION	of	_	0	SENT_146	[p6l590t1424r616b1445],
11	America	NNP	ORGANIZATION	America	prep_of	1	SENT_146	[p6l623t1424r727b1445],
12	95	CD	ORGANIZATION	95	num	11	SENT_146	[p6l737t1425r773b1449],
13	,	,	O	,	_	0	SENT_146	[p6l737t1425r773b1449],
14	9991-9996	CD	DURATION	9991-9996	num	11	SENT_146	[p6l785t1425r929b1446],
15	.	.	O	.	_	0	SENT_146	[p6l785t1425r929b1446],

1	tropic	JJ	O	tropic	amod	2	SENT_147	[p6l1176t1426r1250b1453],
2	drug	NN	O	drug	_	0	SENT_147	[p6l1260t1426r1318b1453],
3	response	NN	O	response	dep	2	SENT_147	[p6l1328t1432r1445b1453],
4	.	.	O	.	_	0	SENT_147	[p6l1328t1432r1445b1453],

1	American	JJ	MISC	american	amod	2	SENT_148	[p6l1455t1426r1576b1448],
2	journal	NN	O	journal	_	0	SENT_148	[p6l1583t1426r1675b1453],
3	of	IN	O	of	_	0	SENT_148	[p6l1686t1426r1712b1448],
4	Psychiatry	NNP	O	Psychiatry	prep_of	2	SENT_148	[p6l1720t1426r1849b1453],
5	161	CD	NUMBER	161	num	4	SENT_148	[p6l1861t1427r1909b1451],
6	,	,	O	,	_	0	SENT_148	[p6l1861t1427r1909b1451],
7	780-796	CD	NUMBER	780-796	num	4	SENT_148	[p6l1920t1427r2033b1448],
8	.	.	O	.	_	0	SENT_148	[p6l1920t1427r2033b1448],

1	Kocabas	NNP	PERSON	Kocabas	nn	3	SENT_149	[p6l6t1459r112b1484],
2	,	,	O	,	_	0	SENT_149	[p6l6t1459r112b1484],
3	NA	NNP	O	NA	_	0	SENT_149	[p6l135t1460r190b1484],
4	,	,	O	,	_	0	SENT_149	[p6l135t1460r190b1484],
5	2012	CD	DATE	2012	appos	3	SENT_149	[p6l214t1460r280b1481],
6	.	.	O	.	_	0	SENT_149	[p6l214t1460r280b1481],

1	Catechol	NNP	O	Catechol	_	0	SENT_150	[p6l304t1459r678b1486],
2	.	.	O	.	_	0	SENT_150	[p6l304t1459r678b1486],

1	—	NN	O	—	_	0	SENT_151	[p6l304t1459r678b1486],
2	.	.	O	.	_	0	SENT_151	[p6l304t1459r678b1486],

1	O	NN	O	o	_	0	SENT_152	[p6l304t1459r678b1486],
2	.	.	O	.	_	0	SENT_152	[p6l304t1459r678b1486],

1	—	NN	O	—	_	0	SENT_153	[p6l304t1459r678b1486],
2	.	.	O	.	_	0	SENT_153	[p6l304t1459r678b1486],

1	methyltransferase	NN	O	methyltransferase	nn	3	SENT_154	[p6l304t1459r678b1486],
2	(	CD	NUMBER	(	num	3	SENT_154	[p6l701t1459r797b1486],
3	COMT	NNP	MISC	COMT	_	0	SENT_154	[p6l701t1459r797b1486],
4	)	CD	NUMBER	)	num	5	SENT_154	[p6l701t1459r797b1486],
5	pharmacogenetics	NNS	O	pharmacogenetic	dep	3	SENT_154	[p6l820t1459r1048b1486],
6	in	IN	O	in	_	0	SENT_154	[p6l1071t1459r1094b1480],
7	Moron	NNP	O	Moron	prep_in	5	SENT_154	[p6l1178t1462r1267b1486],
8	,	,	O	,	_	0	SENT_154	[p6l1178t1462r1267b1486],
9	]	CD	NUMBER	]	appos	7	SENT_154	[p6l1285t1462r1332b1488],
10	.	.	O	.	_	0	SENT_154	[p6l1285t1462r1332b1488],

1	A.	NN	O	a.	_	0	SENT_155	[p6l1285t1462r1332b1488],
2	,	,	O	,	_	0	SENT_155	[p6l1285t1462r1332b1488],
3	Brockington	NNP	PERSON	Brockington	appos	1	SENT_155	[p6l1355t1461r1511b1488],
4	,	,	O	,	_	0	SENT_155	[p6l1355t1461r1511b1488],
5	A.	NN	O	a.	appos	1	SENT_155	[p6l1532t1462r1562b1486],
6	,	,	O	,	_	0	SENT_155	[p6l1532t1462r1562b1486],
7	Wise	NNP	O	Wise	nn	17	SENT_155	[p6l1583t1461r1652b1486],
8	,	,	O	,	_	0	SENT_155	[p6l1583t1461r1652b1486],
9	KA.	NNP	LOCATION	KA.	appos	17	SENT_155	[p6l1673t1462r1725b1486],
10	,	,	O	,	_	0	SENT_155	[p6l1673t1462r1725b1486],
11	Rocha	NNP	PERSON	Rocha	appos	17	SENT_155	[p6l1748t1461r1827b1486],
12	,	,	O	,	_	0	SENT_155	[p6l1748t1461r1827b1486],
13	B.A.	NNP	O	B.A.	appos	17	SENT_155	[p6l1850t1462r1901b1486],
14	,	,	O	,	_	0	SENT_155	[p6l1850t1462r1901b1486],
15	Hope	NNP	PERSON	Hope	appos	17	SENT_155	[p6l1923t1462r1994b1488],
16	,	,	O	,	_	0	SENT_155	[p6l1923t1462r1994b1488],
17	B.T.	NNP	O	B.T.	appos	1	SENT_155	[p6l2016t1462r2063b1486],
18	,	,	O	,	_	0	SENT_155	[p6l2016t1462r2063b1486],
19	2002	CD	DATE	2002	dep	17	SENT_155	[p6l2085t1462r2154b1483],
20	.	.	O	.	_	0	SENT_155	[p6l2085t1462r2154b1483],

1	Dopamine	NN	O	dopamine	_	0	SENT_156	[p6l6t1496r134b1523],
2	the	DT	O	the	det	7	SENT_156	[p6l55t1526r95b1548],
3	tte3t111	NN	O	tte3t111	nn	7	SENT_156	[p6l113t1529r357b1554],
4	€	CD	NUMBER	€	num	7	SENT_156	[p6l113t1529r357b1554],
5	t1tte5P0T15e	NN	O	t1tte5p0t15e	nn	7	SENT_156	[p6l113t1529r357b1554],
6	Phetlotl/P55	NN	O	phetlotl/p55	nn	7	SENT_156	[p6l376t1526r521b1554],
7	0fm3l	NN	O	0fm3l	dep	12	SENT_156	[p6l540t1526r644b1554],
8	°	CD	NUMBER	°	num	9	SENT_156	[p6l540t1526r644b1554],
9	F	NN	O	f	dep	7	SENT_156	[p6l540t1526r644b1554],
10	d	NN	O	d	dep	12	SENT_156	[p6l652t1526r784b1554],
11	€	CD	NUMBER	€	num	10	SENT_156	[p6l652t1526r784b1554],
12	Pt	NN	O	pt	dep	1	SENT_156	[p6l652t1526r784b1554],
13	€	CD	NUMBER	€	num	14	SENT_156	[p6l652t1526r784b1554],
14	55iV	NN	O	55iv	dep	12	SENT_156	[p6l652t1526r784b1554],
15	€	CD	NUMBER	€	num	16	SENT_156	[p6l652t1526r784b1554],
16	di50FdeT	NN	O	di50fdet	rcmod	14	SENT_156	[p6l802t1526r1004b1553],
17	(	CD	NUMBER	(	num	18	SENT_156	[p6l802t1526r1004b1553],
18	MDD	NN	ORGANIZATION	mdd	dep	16	SENT_156	[p6l802t1526r1004b1553],
19	)	SYM	O	)	dep	16	SENT_156	[p6l802t1526r1004b1553],
20	-	:	O	-	_	0	SENT_156	[p6l802t1526r1004b1553],
21	CNS	NN	O	cn	nn	23	SENT_156	[p6l1022t1527r1071b1548],
22	81	CD	NUMBER	81	num	23	SENT_156	[p6l1090t1527r1108b1548],
23	uptake	NN	O	uptake	dep	1	SENT_156	[p6l1244t1531r1328b1558],
24	through	IN	O	through	_	0	SENT_156	[p6l1336t1531r1437b1558],
25	the	DT	O	the	det	27	SENT_156	[p6l1454t1531r1494b1552],
26	norepinephrine	NN	O	norepinephrine	nn	27	SENT_156	[p6l1512t1531r1707b1558],
27	transporter	NN	O	transporter	prep_through	23	SENT_156	[p6l1725t1534r1867b1558],
28	in	IN	O	in	_	0	SENT_156	[p6l1875t1531r1898b1552],
29	brain	NN	O	brain	nn	30	SENT_156	[p6l1916t1531r1980b1552],
30	regions	NNS	O	region	prep_in	27	SENT_156	[p6l1998t1531r2089b1558],
31	with	IN	O	with	_	0	SENT_156	[p6l2097t1531r2154b1552],
32	low	JJ	O	low	amod	33	SENT_156	[p6l6t1566r52b1588],
33	levels	NNS	O	level	prep_with	30	SENT_156	[p6l59t1566r129b1588],

1	NeU1	NN	O	neu1	nn	4	SENT_157	[p6l56t1595r212b1622],
2	‘	CD	NUMBER	‘	num	4	SENT_157	[p6l56t1595r212b1622],
3	0108iC31	NN	O	0108ic31	nn	4	SENT_157	[p6l56t1595r212b1622],
4	Di501	NN	O	di501	_	0	SENT_157	[p6l225t1595r434b1622],
5	‘	CD	NUMBER	‘	num	6	SENT_157	[p6l225t1595r434b1622],
6	d	NN	O	d	dep	4	SENT_157	[p6l225t1595r434b1622],
7	€	CD	MONEY	€	number	8	SENT_157	[p6l225t1595r434b1622],
8	1	CD	MONEY	1	dep	4	SENT_157	[p6l225t1595r434b1622],
9	‘	NN	O	‘	dep	8	SENT_157	[p6l225t1595r434b1622],
10	5	CD	NUMBER	5	num	9	SENT_157	[p6l225t1595r434b1622],
11	.	.	O	.	_	0	SENT_157	[p6l225t1595r434b1622],

1	—	NN	O	—	_	0	SENT_158	[p6l225t1595r434b1622],
2	.	.	O	.	_	0	SENT_158	[p6l225t1595r434b1622],

1	Dl	NN	O	dl	_	0	SENT_159	[p6l225t1595r434b1622],
2	‘	CD	NUMBER	‘	num	4	SENT_159	[p6l225t1595r434b1622],
3	Ug	NN	O	ug	nn	4	SENT_159	[p6l225t1595r434b1622],
4	Targets	NNS	O	target	dep	1	SENT_159	[p6l444t1596r534b1622],
5	11	CD	NUMBER	11	dep	4	SENT_159	[p6l547t1596r579b1620],
6	.	.	O	.	_	0	SENT_159	[p6l547t1596r579b1620],

1	254-272	CD	NUMBER	254-272	_	0	SENT_160	[p6l591t1596r704b1617],
2	.	.	O	.	_	0	SENT_160	[p6l591t1596r704b1617],

1	of	IN	O	of	dep	6	SENT_161	[p6l1182t1601r1208b1623],
2	the	DT	O	the	det	4	SENT_161	[p6l1216t1601r1256b1623],
3	douamine	NN	O	douamine	nn	4	SENT_161	[p6l1268t1601r1393b1625],
4	transporter	NN	O	transporter	pobj	1	SENT_161	[p6l1405t1604r1553b1625],
5	:	:	O	:	_	0	SENT_161	[p6l1405t1604r1553b1625],
6	evidence	NN	O	evidence	_	0	SENT_161	[p6l1566t1601r1676b1623],
7	from	IN	O	from	_	0	SENT_161	[p6l1689t1601r1748b1623],
8	knock-out	JJ	O	knock-out	amod	10	SENT_161	[p6l1759t1601r1885b1623],
9	mouse	NN	O	mouse	nn	10	SENT_161	[p6l1897t1608r1978b1623],
10	lines	NNS	O	line	prep_from	6	SENT_161	[p6l1990t1601r2053b1623],
11	.	.	O	.	_	0	SENT_161	[p6l1990t1601r2053b1623],

1	lournal	NN	O	lournal	_	0	SENT_162	[p6l2067t1601r2154b1625],
2	of	IN	O	of	_	0	SENT_162	[p6l6t1637r32b1659],
3	Leuchter	NNP	LOCATION	Leuchter	nn	17	SENT_162	[p6l48t1637r162b1662],
4	,	,	O	,	_	0	SENT_162	[p6l48t1637r162b1662],
5	A.F.	NNP	LOCATION	A.F.	appos	17	SENT_162	[p6l174t1638r223b1662],
6	,	,	O	,	_	0	SENT_162	[p6l174t1638r223b1662],
7	Cook	NNP	PERSON	Cook	appos	17	SENT_162	[p6l237t1637r304b1662],
8	,	,	O	,	_	0	SENT_162	[p6l237t1637r304b1662],
9	I.A.	NNP	O	I.A.	appos	17	SENT_162	[p6l317t1638r361b1662],
10	,	,	O	,	_	0	SENT_162	[p6l317t1638r361b1662],
11	Hunter	NNP	PERSON	Hunter	appos	17	SENT_162	[p6l375t1638r468b1662],
12	,	,	O	,	_	0	SENT_162	[p6l375t1638r468b1662],
13	A.M.	NNP	O	A.M.	appos	17	SENT_162	[p6l480t1638r542b1662],
14	,	,	O	,	_	0	SENT_162	[p6l480t1638r542b1662],
15	Korb	NNP	PERSON	Korb	appos	17	SENT_162	[p6l556t1637r620b1662],
16	,	,	O	,	_	0	SENT_162	[p6l556t1637r620b1662],
17	A.S.	NNP	O	A.S.	prep_of	1	SENT_162	[p6l632t1638r683b1662],
18	,	,	O	,	_	0	SENT_162	[p6l632t1638r683b1662],
19	2009	CD	DATE	2009	appos	17	SENT_162	[p6l696t1638r765b1659],
20	.	.	O	.	_	0	SENT_162	[p6l696t1638r765b1659],

1	A	DT	O	a	det	3	SENT_163	[p6l777t1638r796b1658],
2	new	JJ	O	new	amod	3	SENT_163	[p6l809t1643r862b1658],
3	paradigm	NN	O	paradigm	dep	10	SENT_163	[p6l874t1637r993b1664],
4	for	IN	O	for	_	0	SENT_163	[p6l1006t1637r1040b1658],
5	the	DT	O	the	det	8	SENT_163	[p6l1053t1637r1092b1658],
6	Neurosciénce	NNP	O	Neurosciénce	nn	8	SENT_163	[p6l1219t1633r1385b1667],
7	22	CD	NUMBER	22	num	8	SENT_163	[p6l1397t1646r1433b1670],
8	’	NN	O	’	prep_for	3	SENT_163	[p6l1397t1646r1433b1670],
9	389	CD	NUMBER	389	dep	10	SENT_163	[p6l1443t1633r1557b1667],
10	_	NN	O	_	_	0	SENT_163	[p6l1443t1633r1557b1667],
11	'	''	O	'	_	0	SENT_163	[p6l1443t1633r1557b1667],
12	395	CD	NUMBER	395	dep	10	SENT_163	[p6l1443t1633r1557b1667],
13	_	NN	O	_	dep	12	SENT_163	[p6l1443t1633r1557b1667],
14	'	''	O	'	_	0	SENT_163	[p6l2088t1633r2096b1637],

1	prediction	NN	O	prediction	_	0	SENT_164	[p6l56t1670r184b1697],
2	of	IN	O	of	_	0	SENT_164	[p6l199t1670r225b1691],
3	antidepressant	JJ	O	antidepressant	amod	5	SENT_164	[p6l236t1670r422b1697],
4	treatment	NN	O	treatment	nn	5	SENT_164	[p6l436t1673r562b1691],
5	response	NN	O	response	prep_of	1	SENT_164	[p6l576t1676r693b1697],
6	.	.	O	.	_	0	SENT_164	[p6l576t1676r693b1697],

1	Dialogues	NNS	O	dialogue	_	0	SENT_165	[p6l709t1670r830b1697],
2	in	IN	O	in	_	0	SENT_165	[p6l846t1670r869b1691],
3	Clinical	JJ	O	clinical	amod	4	SENT_165	[p6l884t1670r974b1691],
4	Neuroscience	NN	O	neuroscience	prep_in	1	SENT_165	[p6l990t1671r1050b1691, p6l56t1704r172b1725],
5	11	CD	NUMBER	11	dep	1	SENT_165	[p6l184t1704r216b1728],
6	,	,	O	,	_	0	SENT_165	[p6l184t1704r216b1728],
7	435-446	CD	NUMBER	435-446	appos	5	SENT_165	[p6l226t1704r341b1725],
8	.	.	O	.	_	0	SENT_165	[p6l226t1704r341b1725],

1	Licinio	NNP	PERSON	Licinio	_	0	SENT_166	[p6l6t1737r120b1763],
2	,	,	O	,	_	0	SENT_166	[p6l6t1737r120b1763],
3	]	CD	NUMBER	]	appos	1	SENT_166	[p6l6t1737r120b1763],
4	.	.	O	.	_	0	SENT_166	[p6l6t1737r120b1763],

1	,	,	O	,	_	0	SENT_167	[p6l6t1737r120b1763],
2	Wong	NNP	PERSON	Wong	nn	4	SENT_167	[p6l128t1738r208b1763],
3	,	,	O	,	_	0	SENT_167	[p6l128t1738r208b1763],
4	M.L.	NNP	LOCATION	M.L.	nsubj	6	SENT_167	[p6l218t1738r273b1761],
5	,	,	O	,	_	0	SENT_167	[p6l218t1738r273b1761],
6	2011	CD	DATE	2011	_	0	SENT_167	[p6l282t1737r346b1758],
7	.	.	O	.	_	0	SENT_167	[p6l282t1737r346b1758],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_168	[p6l355t1736r598b1763],
2	of	IN	O	of	_	0	SENT_168	[p6l607t1736r633b1758],
3	antidepressant	JJ	O	antidepressant	amod	5	SENT_168	[p6l638t1736r823b1763],
4	treatment	NN	O	treatment	nn	5	SENT_168	[p6l831t1739r956b1758],
5	effects	NNS	O	effect	prep_of	1	SENT_168	[p6l964t1736r1050b1758],
6	.	.	O	.	_	0	SENT_168	[p6l964t1736r1050b1758],

1	Dialogues	NNS	O	dialogue	_	0	SENT_169	[p6l56t1770r176b1796],
2	in	IN	O	in	_	0	SENT_169	[p6l188t1770r211b1791],
3	Clinical	JJ	O	clinical	amod	4	SENT_169	[p6l222t1770r312b1791],
4	Neuroscience	NN	O	neuroscience	prep_in	1	SENT_169	[p6l324t1770r490b1791],
5	13	CD	NUMBER	13	dep	1	SENT_169	[p6l503t1771r536b1794],
6	,	,	O	,	_	0	SENT_169	[p6l503t1771r536b1794],
7	63-71	CD	NUMBER	63-71	appos	5	SENT_169	[p6l547t1771r628b1791],
8	.	.	O	.	_	0	SENT_169	[p6l547t1771r628b1791],

1	Lotta	NNP	PERSON	Lotta	nn	5	SENT_170	[p6l6t1804r73b1828],
2	,	,	O	,	_	0	SENT_170	[p6l6t1804r73b1828],
3	T.	NNP	O	T.	appos	5	SENT_170	[p6l84t1804r109b1828],
4	,	,	O	,	_	0	SENT_170	[p6l84t1804r109b1828],
5	Vidgren	NNP	PERSON	Vidgren	_	0	SENT_170	[p6l121t1803r226b1830],
6	,	,	O	,	_	0	SENT_170	[p6l121t1803r226b1830],
7	]	CD	NUMBER	]	appos	5	SENT_170	[p6l235t1804r257b1830],
8	.	.	O	.	_	0	SENT_170	[p6l235t1804r257b1830],

1	,	,	O	,	_	0	SENT_171	[p6l235t1804r257b1830],
2	Tilgmann	NNP	O	Tilgmann	dep	4	SENT_171	[p6l268t1803r393b1830],
3	,	,	O	,	_	0	SENT_171	[p6l268t1803r393b1830],
4	C.	NNP	O	C.	_	0	SENT_171	[p6l405t1804r432b1827],
5	,	,	O	,	_	0	SENT_171	[p6l405t1804r432b1827],
6	Ulmanen	NNP	LOCATION	Ulmanen	dep	4	SENT_171	[p6l444t1803r563b1827],
7	,	,	O	,	_	0	SENT_171	[p6l444t1803r563b1827],
8	1.	CD	NUMBER	1.	nsubj	12	SENT_171	[p6l576t1804r594b1828],
9	,	,	O	,	_	0	SENT_171	[p6l576t1804r594b1828],
10	Melen	NNP	PERSON	Melen	dep	8	SENT_171	[p6l607t1803r690b1827],
11	,	,	O	,	_	0	SENT_171	[p6l607t1803r690b1827],
12	K.	NNP	O	K.	ccomp	4	SENT_171	[p6l703t1804r731b1827],
13	,	,	O	,	_	0	SENT_171	[p6l703t1804r731b1827],
14	Julkunen	NNP	PERSON	Julkunen	amod	12	SENT_171	[p6l740t1803r859b1830],
15	,	,	O	,	_	0	SENT_171	[p6l740t1803r859b1830],
16	l.	NNP	O	l.	appos	12	SENT_171	[p6l872t1804r891b1827],
17	,	,	O	,	_	0	SENT_171	[p6l872t1804r891b1827],
18	Taskinen	NNP	PERSON	Taskinen	nn	20	SENT_171	[p6l902t1803r1018b1828],
19	,	,	O	,	_	0	SENT_171	[p6l902t1803r1018b1828],
20	J.	NNP	O	J.	dobj	12	SENT_171	[p6l1027t1804r1049b1830],
21	,	,	O	,	_	0	SENT_171	[p6l1027t1804r1049b1830],
22	1995	CD	DATE	1995	dep	20	SENT_171	[p6l57t1837r121b1858],
23	.	.	O	.	_	0	SENT_171	[p6l57t1837r121b1858],

1	Kinetics	NNS	O	kinetics	nsubj	8	SENT_172	[p6l138t1836r236b1858],
2	of	IN	O	of	_	0	SENT_172	[p6l252t1836r278b1858],
3	human	JJ	O	human	amod	7	SENT_172	[p6l291t1836r378b1858],
4	soluble	JJ	O	soluble	amod	7	SENT_172	[p6l394t1836r483b1858],
5	and	CC	O	and	_	0	SENT_172	[p6l498t1836r544b1858],
6	membrane	NN	O	membrane	amod	7	SENT_172	[p6l560t1836r787b1858],
7	—	NN	O	—	prep_of	1	SENT_172	[p6l560t1836r787b1858],
8	bound	VBD	O	bind	_	0	SENT_172	[p6l560t1836r787b1858],
9	catechol	NN	O	catechol	nn	10	SENT_172	[p6l803t1836r906b1858],
10	Omethyltransferase	NN	O	omethyltransferase	dobj	8	SENT_172	[p6l922t1836r1050b1863, p6l55t1869r200b1891],
11	:	:	O	:	_	0	SENT_172	[p6l922t1836r1050b1863, p6l55t1869r200b1891],
12	a	DT	O	a	det	14	SENT_172	[p6l210t1876r223b1891],
13	revised	VBN	O	revise	amod	14	SENT_172	[p6l231t1869r321b1891],
14	mechanism	NN	O	mechanism	dep	10	SENT_172	[p6l329t1869r473b1891],
15	and	CC	O	and	_	0	SENT_172	[p6l482t1869r527b1891],
16	description	NN	O	description	dep	10	SENT_172	[p6l536t1869r676b1896],
17	of	IN	O	of	_	0	SENT_172	[p6l684t1869r710b1891],
18	the	DT	O	the	det	20	SENT_172	[p6l716t1869r755b1891],
19	thermolabile	JJ	O	thermolabile	amod	20	SENT_172	[p6l763t1869r923b1891],
20	variant	NN	O	variant	prep_of	16	SENT_172	[p6l931t1870r1020b1891],
21	of	IN	O	of	_	0	SENT_172	[p6l1027t1869r1053b1891],
22	the	DT	O	the	det	23	SENT_172	[p6l55t1902r95b1924],
23	enzyme	NN	O	enzyme	prep_of	20	SENT_172	[p6l106t1909r209b1929],
24	.	.	O	.	_	0	SENT_172	[p6l106t1909r209b1929],

1	Biochemistry	NNP	O	Biochemistry	_	0	SENT_173	[p6l221t1902r385b1929],
2	34	CD	NUMBER	34	num	1	SENT_173	[p6l395t1903r432b1927],
3	,	,	O	,	_	0	SENT_173	[p6l395t1903r432b1927],
4	4202-4210	CD	DURATION	4202-4210	appos	1	SENT_173	[p6l442t1903r585b1924],
5	.	.	O	.	_	0	SENT_173	[p6l442t1903r585b1924],

1	Perlis	NNP	PERSON	Perlis	nn	21	SENT_174	[p6l7t2013r80b2038],
2	,	,	O	,	_	0	SENT_174	[p6l7t2013r80b2038],
3	R.H.	NNP	O	R.H.	appos	21	SENT_174	[p6l95t2014r149b2038],
4	,	,	O	,	_	0	SENT_174	[p6l95t2014r149b2038],
5	Fijal	NNP	O	Fijal	appos	21	SENT_174	[p6l164t2013r219b2040],
6	,	,	O	,	_	0	SENT_174	[p6l164t2013r219b2040],
7	B.	NNP	O	B.	appos	21	SENT_174	[p6l234t2014r261b2037],
8	,	,	O	,	_	0	SENT_174	[p6l234t2014r261b2037],
9	Adams	NNP	PERSON	Adams	appos	21	SENT_174	[p6l274t2013r366b2037],
10	,	,	O	,	_	0	SENT_174	[p6l274t2013r366b2037],
11	D.H.	NNP	PERSON	D.H.	appos	21	SENT_174	[p6l380t2014r437b2037],
12	,	,	O	,	_	0	SENT_174	[p6l380t2014r437b2037],
13	Sutton	NNP	PERSON	Sutton	appos	21	SENT_174	[p6l452t2014r539b2037],
14	,	,	O	,	_	0	SENT_174	[p6l452t2014r539b2037],
15	V.K.	NNP	PERSON	V.K.	appos	21	SENT_174	[p6l552t2014r606b2037],
16	,	,	O	,	_	0	SENT_174	[p6l552t2014r606b2037],
17	Trivedi	NNP	PERSON	Trivedi	appos	21	SENT_174	[p6l619t2013r712b2037],
18	,	,	O	,	_	0	SENT_174	[p6l619t2013r712b2037],
19	M.H.	NNP	LOCATION	M.H.	appos	21	SENT_174	[p6l727t2014r790b2037],
20	,	,	O	,	_	0	SENT_174	[p6l727t2014r790b2037],
21	Houston	NNP	LOCATION	Houston	_	0	SENT_174	[p6l804t2014r915b2037],
22	,	,	O	,	_	0	SENT_174	[p6l804t2014r915b2037],
23	]	CD	NUMBER	]	appos	21	SENT_174	[p6l926t2014r968b2040],
24	.	.	O	.	_	0	SENT_174	[p6l926t2014r968b2040],

1	P.	NNP	O	P.	_	0	SENT_175	[p6l926t2014r968b2040],
2	,	,	O	,	_	0	SENT_175	[p6l926t2014r968b2040],
3	2009	CD	DATE	2009	appos	1	SENT_175	[p6l982t2014r1051b2034],
4	.	.	O	.	_	0	SENT_175	[p6l982t2014r1051b2034],

1	Variation	NN	O	variation	_	0	SENT_176	[p6l56t2048r171b2070],
2	in	IN	O	in	_	0	SENT_176	[p6l197t2048r219b2069],
3	catechol	NN	O	catechol	prep_in	1	SENT_176	[p6l244t2048r615b2075],
4	.	.	O	.	_	0	SENT_176	[p6l244t2048r615b2075],

1	—	NN	O	—	_	0	SENT_177	[p6l244t2048r615b2075],
2	.	.	O	.	_	0	SENT_177	[p6l244t2048r615b2075],

1	O	NN	O	o	_	0	SENT_178	[p6l244t2048r615b2075],
2	.	.	O	.	_	0	SENT_178	[p6l244t2048r615b2075],

1	—	NN	O	—	_	0	SENT_179	[p6l244t2048r615b2075],
2	.	.	O	.	_	0	SENT_179	[p6l244t2048r615b2075],

1	methyltransferase	NN	O	methyltransferase	nsubjpass	3	SENT_180	[p6l244t2048r615b2075],
2	is	VBZ	O	be	auxpass	3	SENT_180	[p6l641t2048r659b2070],
3	associated	VBN	O	associate	_	0	SENT_180	[p6l684t2048r812b2070],
4	with	IN	O	with	_	0	SENT_180	[p6l836t2048r894b2070],
5	duloxetine	NN	O	duloxetine	nn	6	SENT_180	[p6l919t2048r1051b2070],
6	response	NN	O	response	prep_with	3	SENT_180	[p6l57t2090r167b2110],
7	in	IN	O	in	_	0	SENT_180	[p6l179t2084r202b2105],
8	a	DT	O	a	det	10	SENT_180	[p6l214t2090r226b2105],
9	clinical	JJ	O	clinical	amod	10	SENT_180	[p6l238t2083r324b2105],
10	trial	NN	O	trial	prep_in	3	SENT_180	[p6l336t2083r386b2105],
11	for	IN	O	for	_	0	SENT_180	[p6l398t2083r433b2105],
12	major	JJ	O	major	amod	14	SENT_180	[p6l444t2084r516b2110],
13	depressive	JJ	O	depressive	amod	14	SENT_180	[p6l527t2083r659b2110],
14	disorder	NN	O	disorder	prep_for	10	SENT_180	[p6l670t2083r779b2105],
15	.	.	O	.	_	0	SENT_180	[p6l670t2083r779b2105],

1	Biological	JJ	O	biological	_	0	SENT_181	[p6l791t2083r911b2110],
2	Psychiatry	NNP	O	Psychiatry	dep	1	SENT_181	[p6l923t2083r1052b2110],
3	65	CD	NUMBER	65	num	2	SENT_181	[p6l57t2120r93b2143],
4	,	,	O	,	_	0	SENT_181	[p6l57t2120r93b2143],
5	785-791	CD	NUMBER	785-791	num	2	SENT_181	[p6l105t2120r216b2140],
6	.	.	O	.	_	0	SENT_181	[p6l105t2120r216b2140],

1	Takano	NNP	PERSON	Takano	_	0	SENT_182	[p6l6t2152r101b2177],
2	,	,	O	,	_	0	SENT_182	[p6l6t2152r101b2177],
3	A.	NN	O	a.	appos	1	SENT_182	[p6l110t2153r140b2177],
4	,	,	O	,	_	0	SENT_182	[p6l110t2153r140b2177],
5	Halldin	NNP	PERSON	Halldin	nn	11	SENT_182	[p6l151t2152r247b2177],
6	,	,	O	,	_	0	SENT_182	[p6l151t2152r247b2177],
7	C.	NNP	O	C.	appos	11	SENT_182	[p6l257t2153r284b2177],
8	,	,	O	,	_	0	SENT_182	[p6l257t2153r284b2177],
9	Farde	NNP	O	Farde	appos	11	SENT_182	[p6l295t2152r368b2177],
10	,	,	O	,	_	0	SENT_182	[p6l295t2152r368b2177],
11	L.	NNP	O	L.	appos	1	SENT_182	[p6l379t2153r403b2177],
12	,	,	O	,	_	0	SENT_182	[p6l379t2153r403b2177],
13	2013	CD	DATE	2013	appos	1	SENT_182	[p6l413t2153r478b2174],
14	.	.	O	.	_	0	SENT_182	[p6l413t2153r478b2174],

1	SERT	NNP	ORGANIZATION	SERT	_	0	SENT_183	[p6l489t2153r550b2173],
2	and	CC	O	and	_	0	SENT_183	[p6l558t2152r603b2173],
3	NET	NNP	O	NET	nn	4	SENT_183	[p6l614t2153r664b2173],
4	occupancy	NN	O	occupancy	conj_and	1	SENT_183	[p6l671t2158r803b2179],
5	by	IN	O	by	_	0	SENT_183	[p6l813t2152r843b2179],
6	venlafaxine	NN	O	venlafaxine	prep_by	4	SENT_183	[p6l851t2152r996b2173],
7	and	CC	O	and	_	0	SENT_183	[p6l1006t2152r1051b2173],
8	milnacipran	NN	O	milnacipran	prep_by	4	SENT_183	[p6l57t2187r207b2214],
9	in	IN	O	in	_	0	SENT_183	[p6l220t2187r242b2208],
10	nonhuman	JJ	O	nonhuman	amod	11	SENT_183	[p6l255t2187r392b2209],
11	primates	NNS	O	primate	prep_in	4	SENT_183	[p6l404t2187r521b2214],
12	:	:	O	:	_	0	SENT_183	[p6l404t2187r521b2214],
13	a	DT	O	a	det	15	SENT_183	[p6l536t2193r548b2209],
14	PET	NN	O	pet	nn	15	SENT_183	[p6l561t2188r607b2208],
15	study	NN	O	study	dep	1	SENT_183	[p6l618t2187r691b2214],
16	.	.	O	.	_	0	SENT_183	[p6l618t2187r691b2214],

1	Psychopharmacology	NNP	O	Psychopharmacology	nn	6	SENT_184	[p6l705t2187r971b2214],
2	(	NNP	O	(	nn	6	SENT_184	[p6l983t2187r1051b2214],
3	Berl	NNP	ORGANIZATION	Berl	nn	6	SENT_184	[p6l983t2187r1051b2214],
4	)	NN	O	)	nn	6	SENT_184	[p6l983t2187r1051b2214],
5	226	CD	NUMBER	226	num	6	SENT_184	[p6l57t2224r102b2244],
6	(	NN	O	(	_	0	SENT_184	[p6l113t2223r154b2249],
7	1	CD	NUMBER	1	num	8	SENT_184	[p6l113t2223r154b2249],
8	)	NN	O	)	dep	6	SENT_184	[p6l113t2223r154b2249],
9	,	,	O	,	_	0	SENT_184	[p6l113t2223r154b2249],
10	147-153	CD	NUMBER	147-153	appos	8	SENT_184	[p6l166t2224r273b2244],
11	.	.	O	.	_	0	SENT_184	[p6l166t2224r273b2244],

